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DNA alkylating agents are commonly considered toxic due to the irreversible nature 
of the lesions that they form and the failure of DNA repair enzymes to remove their lesions. 
However, compounds that alkylate DNA in a reversible manner may not share the same 
toxicity as irreversible alkylating agents. Quinone methides (QMs) are a class of transient 
electrophiles that reversibly alkylate DNA. A bifunctional QM conjugated to the DNA 
intercalator acridine (bisQMAcr) has previously been synthesized in order to examine the 
dynamics of reaction with DNA. BisQMAcr’s reversible chemistry facilitates its stepwise 
migration from one end of a duplex DNA to the other in a bipedal manner. However, 
bisQMAcr requires 7 days to traverse 10 base pairs, which may be too slow to be effective in 
vivo to evade DNA repair.  
Two monofunctional QMs were linked together using a flexible polyammonium alkyl 
chain (diQMs) to potentially facilitate faster QM migration. Additionally, BisQMs 
conjugated to weakly intercalative quinoxalines were synthesized to avoid the strength of 
acridine’s intercalation that may have suppressed QM migration. However, neither of the 
new QMs alkylated DNA reversibly. Thus, bisQMAcr remains the most dynamic QM 
synthesized to date. 
The environment within cells likely influences the potency of QMs’ reversible DNA 
alkylation, since cellular DNA is packaged around histone proteins to form nucleosomes. The 
assembly of DNA into nucleosomes weakens QMs’ potency as DNA alkylating agents by 
90% relative to DNA free in solution. Nucleosomes possess an additional protective function 
against bisQMAcr’s DNA alkylation, as the histone proteins serve as terminal acceptors of 
bisQMAcr’s DNA adducts. BisQMAcr can release from its adducts on DNA and alkylate the 
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histones, leaving the DNA unmodified. However, QM alkylation of the histones does not 
interfere with their assembly into nucleosomes, as adducts formed in the core regions of the 
protein that may not disrupt with the necessary DNA-protein contacts for nucleosome 
formation.   
The ability of DNA polymerases and helicases to modulate the dynamics of 
bisQMAcr’s DNA alkylation and of bisQMAcr’s crosslinks to inhibit replication was also 
investigated to determine whether biological machines may hasten QM migration. The 
Klenow Exo
-
 and φ29 DNA polymerases were unable to cause bisQMAcr’s crosslinks to 
break apart and failed to extend DNA primers in the presence of the crosslinks. However, the 
T7 bacteriophage gene 4 protein (T7GP4) DNA helicase was able to unwind DNA 
containing reversible QM crosslinks. The helicase induced dissociation of only 40% of 
bisQMAcr’s crosslinks, while the remaining 60% remained intact. Irreversible DNA 
crosslinks formed by mechlorethamine completely resisted unwinding by the T7GP4 
helicase, suggesting that only reversible crosslinks separate during DNA unwinding. 
Reversible QM crosslinks may not pose an absolute block to replication like many 
irreversible crosslinking agents do. The ability of a helicase to remove QM adducts from 
DNA essentially affords DNA repair without relying on specific DNA repair proteins.  
This work describes the potency of reversible QM alkylation in a biological setting. 
Transfer of reversible adducts to the histone proteins and loss of DNA adducts by helicases’ 
translocation may afford their repair by means of their intrinsic reversible chemistry. 
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Chapter 1: Introduction 
 
1.1 DNA Damage 
 Deoxyribonucleic acid (DNA) encodes all of the genetic information that regulates an 
organism’s chemical and biochemical processes, as well as their phenotypic characteristics. 
However, DNA is susceptible to various forms of damage that can interfere with the 
processing of the information contained in DNA. This damage can arise from many sources 
that are both exogenously and endogenously generated. As such, our DNA is constantly 
exposed to agents that can wreak havoc on our cells (Figure 1.1). Chemicals found in the 
environment, such as acrolein which is a constituent of cigarette smoke, may act as 
electrophiles that react with the nucleophilic bases within DNA.
1
 Polycyclic aromatic 
hydrocarbons (PAHs) are widespread in the environment, as they are generated from the 
burning of fuel.
2
 Once ingested, PAHs require metabolic activation via oxidation to unleash 
their toxicity through DNA damage.
3
 Exposure to the sun’s UV light can result in skin cancer 
via the formation of bulky photochemical DNA lesions.
4
 In addition, organisms are exposed 
to ionizing radiation produced from the sun, lightning, nuclear reactors, and x-ray tubes.
5
 
Ionizing radiation induces DNA damage via radical-mediated hydrogen atom abstraction that 
causes DNA strand scission.
6
 Lastly, countless drugs damage our DNA, either as their 
mechanism of action or as an undesired side effect. Many anticancer drugs, such as 
temozolomide and chlorambucil, function as alkylating agents that transfer an alkyl group to 
DNA to induce apoptosis of diseased cells.
7, 8 
Damage can occur to DNA’s phosphodiester backbone as well as on its nucleobases. 
This compromises DNA’s structural integrity by strand scission, which will lead to a loss of 
2 
 




genetic information or improper regulation of the genome. Although the half-life for 
spontaneous hydrolytic strand cleavage is greater than 30,000,000 years, alkaline conditions 





 Hydrolysis can also damage the nucleobases to create mutations in the DNA 
sequence. For instance, hydrolytic deamination of cytosine (C) generates uracil (U), a non-
native DNA base that may lead to mutations in the genetic code. Uracil forms Watson-Crick 
base pairs with adenine (A), and will create C:G to T:A transversions in the DNA sequence 
after DNA replication. Lesions on the nucleobases may not only interfere with hydrogen-
bonding between the nucleobases within duplex DNA, but also disrupt replication, 
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transcription, and translation of an organism’s genetic information. Oxidative damage to the 
bases can also change the hydrogen bonding pattern with DNA, resulting in mutations. For 
example, oxidation of guanine to form 8-oxo-guanine creates G to T substitutions in DNA by 
forming Watson- Crick base pairs with adenine instead of cytosine after replication.
11
 
Adducts on the bases can also disrupt transmission of the genetic code by polymerases and 
helicases that act on DNA. Covalent DNA crosslinks generated by bifunctional DNA 
alkylating agents are considered toxic to cells due to posing blocks to DNA replication.
12
 
DNA crosslinks prevent strand separation, which is required for the transmission of the 




1.2 Impact of DNA Damage 
 Any form of DNA damage has the potential to impair the chemical and biochemical 
processes that regulate transmission of the genetic code (Figure 1.1). Some forms of DNA 
damage may not harm cells, but others may lead to effects as drastic as apoptosis. Small 
modifications to the nucleobases, such as oxidation of cytosine to 5-hydroxy-C, may not 
affect cellular viability if they do not impair DNA replication. However, incorrect replication 
of modified bases may result in mutations due to the formation of incorrect base pairs. For 
instance, 5-hydroxy-C will produce a C to T transition via formation of the highly miscoding 
5-hydroxy-U following deamination.
14
 Base transitions will not cause apoptosis, but the point 
mutations that result may affect protein folding or abolish essential protein activities.
15 
 Cells contain repair mechanisms to reverse the deleterious effects of DNA damage. 
Different repair pathways have evolved for different types of lesions, with numerous steps 
and enzymes often required to afford repaired DNA. The simplest mechanism is direct 
reversal of the DNA damage. However, only a handful of enzymes exist that repair a few 
4 
 





methyltransferase removes a methyl group from the O
6
- position of guanine to generate the 
unmodified nucleobase, while the oxygenase AlkB restores adenine and cytosine from N
1
-




 Most lesions are repaired by the 
creation of strand breaks in the DNA, before restoration of the DNA to its unmodified state. 
Small, non-bulky lesions on the nucleobases are repaired by base excision repair (BER).
17
 
BER involves the action of specific glycosylases, the enzymes responsible for cleaving the 
glycosidic bond of damaged nucleobases, for specific DNA lesions.
17
 Thus, BER is restricted 
to only those specific lesions that are recognized by a particular DNA glycosylase. 
Nucleotide excision repair (NER) is less stringent for repairing DNA lesions, as one network 
of enzymes recognizes a wide variety of lesions. Generally, bulky lesions and some inter-
strand crosslinks are repaired by NER via a complex and well-coordinated network of 
enzymes that recognize and excise the damage before restoring the resulting gap in the DNA 
sequence.
18
 Lesions that create double strand breaks in DNA have the potential to cause 
significant damage to cells by fragmenting an organism’s genome, and therefore are repaired 
by a well-synchronized network of enzymes during homologous recombination. Although no 
universal mechanism for repair of one of the most deleterious DNA lesions, DNA inter-
strand crosslinks (ICLs), exists, a wide array of processes repair ICLs.
19, 20
 A complex 
network of proteins from various pathways, such as those associated with Fanconi Anemia 
and translesion synthesis polymerases, function to repair ICLs. However, ICL repair does not 
always succeed due to the bulk of their lesions, their presence on both strands of duplex 
DNA, and their severe distortion of DNA’s structure.
19
 As a consequence, cells may enter 
apoptosis or cancer may develop as a result of ICLs. Investigating the biological 
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consequences of DNA ICLs may provide an assessment of their role in the development of 
disease and their potential as a chemotherapeutic mechanism. 
 Some forms of damage may not require repair and may not cause toxicity to cells. 
Some lesions, such as ICLs, are considered toxic due to the irreversibility of their DNA 
adducts in the absence of DNA repair pathways. However, DNA adducts that form reversibly 
may not harm cells in such a manner. These adducts may not require the cell’s repair 
mechanisms, as their intrinsic reversible covalent chemistry may afford their removal from 
DNA. On the other hand, reversible chemistry may enhance the lesion’s toxicity if the 
reactive moiety were regenerated and able to react with a new site on the DNA molecule 
after its removal from its first site of reaction. Reversible DNA lesions warrant investigations 
to evaluate their toxicity, which may inform the development of drugs that function with 
reversible covalent chemistry. 
 
1.3 DNA Alkylation 
 Alkylating agents not only contain electrophiles for covalent DNA modification, but 
also often possess a moiety that directs their binding to DNA. Without localization to DNA, 
alkylating agents’ potency will suffer due to off-target reactions with other nucleophiles 
present in cells. Bifunctional alkylating agents, or crosslinking agents, predominate over 
Figure 1.2 Types of DNA adducts formed by DNA alkylating agents. 
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monofunctional alkylating agents in the clinic since DNA ICLs are more deleterious than 
mono adducts. ICLs affect both DNA strands in the duplex, while monoadducts damage only 
one strand and may be more easily repaired. Crosslinking agents form a variety of adducts 
with biological nucleophiles (Figure 1.2). Mono adducts form when only one electrophile 
reacts with DNA to form an adduct that may be less challenging to repair than DNA 
crosslinks. A variety of crosslinks can form, depending on which DNA strand reacts with the 
electrophile. ICLs are considered more deleterious than intra-strand crosslinks because they 
prevent separation of DNA’s strands, which is necessary for replication and transcription. 
DNA inter-helical and DNA-protein crosslinks may pose even greater challenges for cells to 
overcome than DNA ICLs by interfering with the proteins that process DNA and posing 
large roadblocks DNA processing. In particular, DNA-protein crosslinks are large, toxic 
lesions that impede chromatin-based processes such as transcription and DNA unwinding.
21 
 The ICLs generated by DNA crosslinking agents serve as a chemotherapeutic 
mechanism. Crosslinking agents selectively and irreversibly alkylate the DNA in cancerous 
Scheme 1.1 Mechanism of DNA crosslinking by nitrogen mustards. 
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cells to induce their apoptosis. Several exogenous crosslinking agents have been developed 
as therapeutic agents that are used in the clinic. Nitrogen mustards are among one of the 
earliest classes of alkylating agents to be used as chemotherapeutics. Nitrogen mustards react 
irreversibly at the N7 position of guanines (dGN7) in 5’-GNC-3’ sequences (Scheme 1.1).
13, 
22
 The nitrogen mustard first undergoes an intramolecular substitution reaction to generate 
the reactive aziridinium ion. The resulting positive charge assists in localizing the compound 
to DNA for reaction. The nucleophilic dGN7 then reacts with the aziridinium ion to form a 
nitrogen mustard- DNA mono adduct. Subsequent formation of a second aziridinium and 
nucleophilic substitution with a second dGN7 generates the DNA ICL.  
 Mitomycin C is another chemotherapeutic agent that functions by forming 
irreversible DNA ICLs. Unlike the nitrogen mustards, mitomycin C requires reductive 
activation to uncover the electrophilic species capable of alkylating DNA (Scheme 1.2).
23, 24
 
Mitomycin C’s selectivity for cancer cells arises from the hypoxic conditions characteristic 
of some tumor cells. Upon reduction, mitomycin C binds DNA’s minor groove to position 
the resulting electrophilic quinone methide (QM) to react with the N2 position of guanine 
Scheme 1.2 Mechanism of DNA ICL formation by mitomycin C. 
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(dGN2). Subsequent loss of carbamate unveils a second electrophile that reacts with a second 
dGN2 to form an irreversible ICL. The irreversible ICLs generated by nitrogen mustards and 
mitomycin C halt biochemical processes that require separation of DNA’s strands. Both 
compounds suffer from off-target reactions with DNA from healthy cells, which limits their 
efficacy.  
 The effectiveness of chemotherapeutic DNA alkylating agents often suffers from 
repair of their lesions by the cell’s repair mechanisms. However, drugs that alkylate DNA 
reversibly may improve their potency. Once repaired, the alkylating agent may be able to 
regenerate its reactive moiety. This would allow a reversible alkylating agent to alkylate 
DNA again, either at the same site or at a different nucleophilic site within DNA. The natural 
product Ecteinascidin 743 (Et 743) reversibly alkylates DNA at dGN2s (Figure 1.3). 
Repeated capture and release of Et 743 by reversible covalent reaction with DNA permits its 
migration from sites of greatest kinetic selectivity to sites of greatest thermodynamic 
stability.
25
 Et 743’s diffusion through DNA essentially extends the drug’s effective lifetime. 





Thus, Et 743’s intrinsic reversible chemistry may enhance its potency as a chemotherapeutic 
drug by permitting it to evade repair of its DNA adducts. 
 The endogenously generated alkylating agent acrolein also forms reversible adducts 
with DNA.
26
 Acrolein is a toxic component of cigarette smoke that is produced in vivo from 
oxidation of the glycerol contained in cigarettes.
27
 Acrolein forms DNA ICLs by initially 
reacting with dGN2 via Michael addition, before subsequent addition of a second dGN2 to 
the aldehyde (Scheme 1.3).
28
 In addition, acrolein can react intramolecularly with the N1 
position of guanine (dGN1) to form an adduct on a single guanine residue. These adducts 
cause mutagenic stress on cells that triggers DNA repair pathways or apoptosis.
29, 30
 
However, the reversibility of acrolein’s DNA adduct may reduce acrolein’s toxicity. 
Regeneration of acrolein will leave the DNA unmodified, essentially affording repair of the 
DNA. Acrolein may then re-alkylate the DNA, causing more damage, or alkylate another 
nucleophile present in cells. Thus, the reversibility of some alkylating agents may either 
enhance their toxicity by extending the electrophile’s effective lifetime, or reduce their 
toxicity by affording DNA repair. 




1.4 Quinone Methides 
Quinone methides (QMs) are another class of endogenously generated electrophiles 
that alkylate DNA. QMs are transient electrophilic intermediates that are often formed in vivo 
following metabolic activation.
31
 QMs are involved in plant lignification and are components 
of natural products, such as the taxodiones and celastrol.
31
 Drugs, such as tamoxifen, 
mitomycin C, and some of the nitric oxide (NO)-precursors to the non-steroidal anti-
inflammatory drugs (NSAIDs), and the food additive butylated hydroxytoluene (BHT) form 
QMs upon metabolic activation (Figure 1.4).
23, 32-35
 QMs may form as a result of oxidation, 
ester hydrolysis, or photochemical activation.
36
 Once generated, QMs act as both desired 
metabolites that assist in a drug’s mechanism of action, and as undesired byproducts of 
metabolism. BHT, contained in many processed foods, forms a potentially toxic QM upon 
oxidation. The BHT-QM may then interfere with cellular processes by alkylating DNA and 
protein nucleophiles.  
QMs react as Michael acceptors with a wide variety of nucleophiles found in 
biological systems, such as thiols, water, amino acids, and DNA’s nucleobases. QMs form 
either as the para-QM isomer, or the more reactive ortho-QM isomer (Figure 1.4).
36
 QMs are 
unique alkylating agents, as their alkylation can be either reversible or irreversible, 
depending on the pKa of the conjugate base of the QM-adduct and the electronics of the QM. 
Ortho-QMs form a variety of reversible and irreversible adducts with DNA (Scheme 1.4).
37
 
The strong nucleophiles within DNA form reversible adducts with QMs due to the low pKa 
of the adduct’s conjugate base. The kinetically favorable, reversible QM-DNA adducts 
evolve over time to form the thermodynamically stable, irreversible adducts. Owing to their 
reversible DNA alkylation and relative ease of activation, QMs may find application as 
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potential chemotherapeutic agents. However, QMs also exist as naturally occurring 
electrophiles with the potential to create toxicity for cells. Thus, understanding how their 
Figure 1.4 Structures and formation of quinone methides from drugs and food 





reversible alkylation modulates their effects on a biological system may reveal new 
mechanisms by which reversible chemistry interferes with biochemical processes.  
 Bifunctional QMs (bisQMs) have been synthesized to explore reversible DNA ICLs. 
However, bisQMs must be generated from their stable precursors (bisQMPs) bearing a silyl 
protecting group, due to the transient lifetime of QMs. Fluoride activates the reactive QM 
Scheme 1.4 DNA adducts formed by ortho-QMs. Reversible adducts are labeled in blue, 






upon removal of the silyl protecting group (Scheme 1.5).
39
 To increase bisQM’s affinity for 
DNA, the intercalator acridine was appended to the bisQMP scaffold (bisQMPAcr) (Figure 
1.5). Acridine positions the bisQM within close proximity to DNA’s nucleophiles for DNA 
alkylation, rather than reaction with the surrounding water molecules.
40, 41
 BisQMAcr’s 
reversible alkylation of DNA was demonstrated by its ability to isomerize from an intra-
strand DNA crosslink to a DNA ICL in the presence of complementary DNA sequences.
42
 
BisQMAcr’s reversible alkylation prolonged its lifetime, as evidenced by the observation that 
its DNA adducts survived multiple exchanges of DNA strands.
43
  
 BisQMAcr possesses the ability to migrate along a DNA duplex by reacting 
reversibly at dGN7s to traverse duplex DNA in a bipedal fashion.
41
 Migration was only 
possible when the methylene bridged linkage to the acridine was replaced with an electron-
rich ether linkage. Increased electron density hastens the rate of QM regeneration to facilitate 
migration. BisQMAcr’s ability to migrate along DNA may be a promising attribute for the 
development of a chemotherapeutic agent. Nevertheless, the impact of its reversible covalent 
chemistry on a biological system is not known. QM migration was demonstrated in vitro 
using DNA free in solution. However, the environment in cells may affect bisQMAcr’s 
migration along DNA. Cells contain numerous nucleophiles, such as thiols, water, 






deoxynucleotide triphosphates (dNTPs), and amino acids, which may compete with DNA for 
bisQMAcr’s alkylation. BisQMAcr’s migration may occur too slowly to impact cellular 
survival, as DNA repair would occur more quickly than QM regeneration. In addition, 
cellular DNA is intricately packaged with proteins as chromosomes. DNA packaging may 
alter bisQMAcr’s profile of DNA alkylation and may affect its ability to bind and react with 
duplex DNA. Thus, how bisQMAcr responds to components of a cell’s in vivo environment 
must be assessed in order to determine its potential potency.  
 The goal of this dissertation is to understand how the proteins involved in DNA 
packaging and processing affect bisQMAcr’s dynamic DNA alkylation. The development of 
QMs with hastened migration along DNA was pursued to enhance the potential toxicity of 
QMs in a biological setting. BisQMAcr’s migration may occur too slowly to be effective as a 
chemotherapeutic in vivo. Thus, a QM that migrates on a faster timescale would provide the 
most relevant compound to study biochemically. To begin to understand the biological 





consequences of QMs’ dynamic DNA alkylation, the response of QMs to DNA packaging 
was investigated. DNA in eukaryotic cells is not free in solution, but rather packaged around 
histone proteins to form nucleosomes. These investigations also addressed the question of 
whether nucleophiles found in proteins would react with QMs when both DNA and proteins 
are present. Finally, the effect of QM alkylation on DNA processing was investigated to 
probe how QMs may affect regulation and repair of the genetic code in cells. Numerous 
proteins that process DNA, such as polymerases and helicases, act as biological machines, 
with the potential to modulate QMs’ migration through DNA. This dissertation will 
contribute to understanding the effects of dynamic alkylation on the proteins that are 
involved in DNA packaging and processing. The findings presented here may expand the 
design of chemotherapeutic agents based on dynamic DNA alkylation by evaluating how 


















 DNA crosslinking can be detrimental to cells, but may also be leveraged as a 
mechanism for treating diseases. Many anticancer drugs are based on the cytotoxicity of 
DNA crosslinking agents. However, drugs such as nitrogen mustards and cisplatin often form 
a wide spectrum of products, with DNA crosslinks representing only a small fraction of 
these. Additionally, these drugs often lack specificity for specific cell types and 
biomolecules. Thus, efforts are needed to design crosslinking agents conjugated to ligands 
that direct reaction to DNA in order to limit undesired off-target reactions.  
 Compounds that form reversible DNA crosslinks may be advantageous over drugs 
that react irreversibly since any off-target adducts may not persist. Conjugation of a bisQM 
to the intercalator acridine localizes the reactive species to DNA to limit undesired quenching 
by water.
40
 BisQMAcr requires a 100-fold lower concentration than a bisQM lacking 
acridine to crosslink DNA to the same extent (50 μM vs 5 mM).
41
 BisQMAcr’s dynamics of 
DNA crosslinking extended the lifetime of the reactive QM and allowed for crosslinks to 
transfer between different DNA targets  (Scheme 2.1).
42-43
 BisQMs’ dynamic covalent 
crosslinking of DNA may be a promising attribute for the design of a chemotherapeutic drug. 
Regeneration of a drug’s reactive intermediate may allow the drug to re-alkylate DNA at a 
different site once the original crosslink is repaired by DNA repair enzymes. Dynamic DNA 
crosslinking may increase a drug’s potency by essentially allowing the compound to evade 
17 
 
repair of its own DNA adducts.  
 Migration of crosslinks through DNA signifies that the alkylating agent regenerates 
its reactive species from an initial crosslink to eventually form a new crosslink downstream 
of the original adduct. However, only an electron-rich analogue of bisQMAcr (ebisQMAcr), 
but not bisQMAcr could migrate through DNA (Scheme 2.2).
41
 The addition of an electron-
donating group to the QM’s ring system increases the rate of QM formation and regeneration 
from its DNA adducts.
44
 Furthermore, the added electron density increases the stability of the 
QM intermediate, which slows its rate of alkylation.
5
 Thus, the QM has more time to diffuse 
and adjust its orientation within duplex DNA to alkylate adjacent nucleophiles. Improper 
Scheme 2.1 Dynamics of bisQM’s DNA crosslinks. A) A single-stranded 
oligonucleotide is treated with bisQM to form an intra-strand DNA crosslink. Upon 
addition of the complementary DNA strand, bisQM’s crosslink isomerizes to form an 
inter-strand DNA crosslink. B) A bisQM DNA inter-strand crosslink is formed, with 
one of the strands containing a toe-hold region. Upon addition of a DNA strand 
complementary to the strand containing the toe-hold, bisQM’s original DNA crosslink 























orientation of the QM may lead to irreversible reaction with water, which will hinder its 
migration along duplex DNA. Migration of ebisQMAcr’s crosslink through DNA occurred in 
a bipedal manner by reacting reversibly with dGN7s.  However, migration occurred slowly, 
as ebisQMAcr required 7 days to traverse 7-10 base pairs within DNA (Figure 2.1).
41
 The net 
rate of migration occurred too slowly to be effective in vivo, since DNA is processed on a 
much faster time scale by repair and processing enzymes. The thermodynamics of acridine’s 
intercalation may have retarded migration, since acridine might be required to dissociate 
from the DNA in order for migration to occur. In addition, bisQMs’ sequential formation of 
its two reactive intermediates may also slow the rate of migration, since one electrophile 
must react before the other QM is generated. To address the slow kinetics of migration, 
bisQMs conjugated to di- and tri-alkylammonium chains were synthesized (bisQMN2 and 
bisQMN3, respectively) (Scheme 2.3).
45-46
 These bisQMs were designed to localize to DNA’s 
phosphodiester backbone via electrostatic, rather than intercalative interactions, which was 
hypothesized to hasten their migration along DNA. However, neither bisQMN2 and 
bisQMN3, nor their electron-rich analogues were able to migrate along DNA. The  
Scheme 2.2 Structures of the tert-butyl-dimethylsilyl protected precursors to 





compounds transferred their alkylation between DNA strands to isomerize from an intra- to 
inter-strand crosslink, but in lower yields than that observed for bisQMAcr. The ammonium-
linked bisQMs may bind the DNA in a manner that directs the QM to react to form 
irreversible DNA adducts.
45-47
 More efforts are needed to explain the ammonium-linked 
bisQMs’ failure to migrate along DNA and to further elucidate the effect of conjugated 
ligands on QM’s dynamic DNA crosslinking.  
 Additionally, bifunctional QMs linked to alkylammonium chains in which the 
reactive QM intermediates are separated onto distinct aromatic ring systems (diQMs) were 
Figure 2.1 Migration of ebisQMAcr’s crosslinks along duplex DNA from 
Fakhari et al.
41
 Migration was observed by the appearance of new DNA 





synthesized in order to investigate the hypothesis that sequential QM formation may hinder 
bisQMs’ migration along DNA.
45, 46, 48, 49
 Separation of the QM intermediates in diQMs may 
permit independent QM reactions.
48, 49
 Previous work suggests that photoinducible diQMs 
form DNA ICLs at lower concentrations than their bisQM counterparts.
50
  Thus, diQMs 
could hasten QM migration along DNA, as well as increase the yield of QM crosslinks that 
are able to migrate.  
 Here, we compare the efficiency, kinetics, and dynamics of DNA crosslinking by 
ammonium-linked diQMs relative to their bisQM counterparts. In addition, bisQMs linked to 
weakly intercalative quinoxalines were synthesized and their DNA alkylation profile was 
Scheme 2.3 A) Structures of the tert-butyl-dimethylsilyl protected precursors to 
bisQMN2 and bisQMN3. B) Structures of the tert-butyl-dimethylsilyl protected 
precursors to diQMN2 and diQMN3. 
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studied to determine weak intercalators enhance QM migration relative to acridine. Our 
results provide insight into how different ligands alter QMs’ reaction with DNA and 
highlight the importance of a DNA-binding ligand for facilitating DNA crosslinking. 
 
2.2 Results and Discussion 
 2.2.1 Decoupled QM Formation for Crosslinking Duplex DNA 
DiQMPN2 and diQMPN3 were synthesized by Dr. Mark Hutchinson, as described 
previously, in order to examine the reversibility of reaction with DNA in the absence of the 
geometric constraints of a bisQM.
45, 46
 The kinetics of DNA alkylation by diQMs was 
investigated to determine their efficiency of DNA crosslink formation. Duplex OD1/[
32
P]-
OD2 in MES (10 mM) and NaF (10 mM) was treated alternatively with diQMPN2 (500 µM) 
and diQMPN3 (50 µM) for 0- 24 h (Figure 2.2A). Both compounds were slow to react with 
DNA, requiring 4 h before any adducts were observed by denaturing polyacrylamide gel 
electrophoresis (PAGE) (Figure 2.2B). BisQMN2 and bisQMN3 react faster than the 
corresponding diQMs, as adducts were detected within 1 h and complete crosslinking of the 
DNA was achieved by 4 h. DiQMN2 required a 10-fold higher concentration than diQMN3 to 
form a similar yield of DNA adducts.  The tri-ammonium chain likely binds DNA with 
greater affinity than the di-ammonium chain due to its increased positive charge. The 
disparity in concentrations required for alkylation is not surprising, as a similar trend was 
evident for the ammonium-linked bisQMs.
45
 Both diQMs reacted to form < 50% yield of 
DNA crosslinks after 24 h. In addition, the diQMs reacted to form a mixture of both DNA 
ICLs and single-stranded DNA alkylation. The presence of bands that smear on the gel and 





 One reactive intermediate may alkylate the DNA, while the other arm reacts 
with water. Another diQM molecule may then alkylate the same DNA strand, leaving 
multiple mono-adducts on the DNA. Additionally, the diQMs may react to form intra-strand 
rather than inter-strand DNA crosslinks, which could also result in bands that smear on the 
gel. Samples containing DiQMPN3 were treated with hot piperidine to determine whether the 
Figure 2.2 Kinetics of DNA alkylation by diQMN2 and diQMN3. A) Scheme depicting 
the experimental setup. B) Duplex OD1/[
32
P]-OD2 DNA(3 µM) in MES (10 mM, pH 7) 
and NaF (10 mM) was treated alternatively with diQMPN2 (500 µM) and diQMPN3 (50 
µM) in 20% acetonitrile for 0- 24 h at room temperature. Products were separated by 
denaturing PAGE (20%) and quantified by phosphorimagery. “SS” and “xL” samples 
contain OD1/[
32
P]-OD2 in MES (10 mM, pH 7), NaF (10 mM), and 20% acetonitrile with 
and without bisQMPN3 (100 µM), respectively. Samples were incubated for 24 h. C) 
Piperidine-induced fragmentation of DNA treated with diQMPN3 for 0-24 h. Samples 
were treated with piperidine (10%) for 30 min after reaction to induce fragmentation at 
sites of dGN7 alkylation. Products were separated by denaturing PAGE (20%), visualized 




diQM reacts to form reversible dGN7 adducts. Preferential reaction at dGN7s will be vital 
for facilitating the diQM’s migration along DNA through dynamic covalent chemistry. 
DiQMN3 reacted at dGN7s after 4 h, but also reacted at other nucleophilic sites within DNA 
to form persistent non-piperidine labile adducts (Figure 2.2C). Reaction at sites that form 
non-piperidine labile adducts occurred more rapidly than at dGN7. The appearance of 
adducts at time zero indicates that reaction occurred so quickly that adducts formed within 
the minutes required to set up, freeze, and thaw samples. The appearance of multiple bands 
that migrate more slowly than the parent DNA lends support to diQMN3’s sequential 
monoalkylation of DNA.  
The ammonium-linked diQMs react more slowly and form a lower yield of crosslinks 
than their bisQM counterparts (Figure 2.2B, xL lane).  The bisQMs primarily form DNA 
ICLs, whereas the diQMs also react to form a series of sequential monoadducts in addition to 
a low yield of ICLs. These differences in the profile of DNA alkylation between the bisQMs 
and diQMs suggests that decoupled QM formation does alter the QM’s reactivity by allowing 
the two reactive intermediates to react independently of one another. However, the 
independence of the two QMs lowers the yield of crosslinking by permitting the formation of 
monoadducts, intra-strand crosslinks, or irreversible quenching by water. Additionally, 
diQMN3 possesses conformational flexibility that may allow the two reactive QMs to react 
with a wide range of sites within DNA. The two electrophiles in bisQMs cannot alter their 
orientation relative to one another due to the rigid, planar ring system connecting them. Thus, 
bisQMs are constrained to react at two nucleophiles within spatial proximity to one another, 
while the diQMs are flexible to react with nucleophiles covering a wider spatial array. 
24 
 
It is vital to determine the length of time required for full quenching of QMs by water 
in order to ensure that the results of strand transfer and exchange experiments are actually a 
result of reversible alkylation, and not alkylation by free QM that had persisted in solution 
(Scheme2.1). DiQMPN3 was incubated in aqueous buffer and NaF for 0-72 h, at which point 
the duplex DNA OD1/[
32
P]-OD2 was added, and incubated for an additional 24 h (Figure 
2.3A).  DiQMN3 was not fully quenched by water after 72 h, as DNA alkylation was still 
observed (Figure 2.3B). Water may react with one of the reactive QM intermediates, but not 
the other. This would allow DiQMN3 to alkylate DNA after a 72 h incubation in aqueous 
buffer. In order to overcome the slow quenching, excess QM were removed via ethanol 
precipitation prior to examining its reversibility.  
The dynamics of diQMN3’s DNA alkylation were assessed by isomerization of its 
Figure 2.3 Quenching of diQMN3 by water. A) Scheme depicting the experimental setup. B) 
DiQMPN3 (50 µM) was incubated in MES (10 mM, pH 7), NaF (10 mM), and 20% acetonitrile 
for 0-72 h. After the indicated time, duplex DNA OD1/[
32
P]-OD2 (3 µM) was added for an 






adducts from an intra- to an inter-strand DNA crosslink. DiQMN3 was initially trapped with 
single-stranded OD3 for 24 h before removal of excess QM via ethanol precipitation. [
32
P]-
OD2 was added to determine whether diQMN3’s DNA adducts on OD3 would dissipate and 
allow regenerated diQMN3 to react with the newly added DNA strand (Figure 2.4A). No 
DNA ICLs were observed, but a new band appeared on the gel that migrated slightly more 
slowly than parent OD2 (Figure 2.4B). This band signifies monoadducts, indicating that 
DiQMN3 can reversibly alkylate, but not crosslink DNA. DiQMN3 may transfer its adducts 
as monoadducts, rather than crosslinks, due to quenching of one reactive QM by water, while 
the other QM alkylates DNA. Both reactive intermediates may release simultaneously from 
their initial DNA adducts due to the independent formation of the QMs and flexibility of the 
QMs’ conformation that is inherent to diQMs. DiQMN3 will essentially behave as a 
monoQM once water quenches one of its electrophiles. The bisQM counterpart to diQMN3 
transfers its adducts to form ICLs rather than monoadducts, but forms a similar yield of ICLs 
as that for diQMN3’s adducts. The preference for transferring its alkylation as monoadducts 
rather than ICLs likely stems from decoupling of the reactive QM intermediates. Both 
diQMN3 and bisQMN3 transfer their DNA adducts in a lower yield than that for bisQMAcr.
41
 
The ammonium chains may cause a lower yield of reversible QM-DNA adducts, which 




DiQMN3 is primarily captured by nucleophiles that result in non-piperidine labile 
adducts, rather than by dGN7 (Figure 2.4C). These adducts are irreversible, which will halt 
diQMN3’s migration along DNA. The ammonium chain likely localizes diQMN3 to the 
Figure 2.4 Transfer of DiQMN3’s adducts between DNA strands. A) Scheme 
depicting the experimental setup. B) OD3 (3 µM) in MES (10 mM, pH 7) and 
NaF (10 mM) was treated with diQMPN3 (50 µM) for 24 h. Excess QM was 
removed from the DNA by ethanol precipitation. The precipitated DNA was 
resuspended in buffer and [
32
P]-OD2 was added and the reaction was incubated 
for 0-24 h. The products were separated by denaturing PAGE (20%) and 
visualized by phosphorimagery. C) Piperidine-induced fragmentation of the 
samples from (B). Samples were treated with piperidine (10%) for 30 min after 
reaction to induce fragmentation at sites of dGN7 alkylation. Products were 




minor groove of DNA, where it will have access to nucleophiles that form irreversible QM-
DNA adducts. Crystal structures exist of polyammonium compounds bound to DNA’s minor 
groove, suggesting minor groove binding as the means by which these compounds recognize 
Figure 2.5 Alkylation of single-stranded and duplex DNA by diQMN3. A) Scheme 
depicting the experimental setup. B) Either OD4/[
32
P]-OD2 duplex DNA or single-stranded 
[
32
P]-OD2 in MES (10 mM, pH 7) and NaF (10 mM) was treated with diQMPN3 (50 µM) 
in 20% acetonitrile for 0-48 h. Products were separated by denaturing PAGE (20%). “Ss” 
and “xL” samples contain OD4/[
32
P]-OD2 in MES (10 mM, pH 7), NaF (10 mM), and 
acetonitrile (20%) with and without bisQMPN3 (100 µM) for 24 h. The “alk” sample 
contains [
32
P]-OD2 in MES (10 mM, pH 7), NaF (10 mM), and acetonitrile (20%) with 
bisQMPN3 (100 µM) for 24 h. C) Piperidine-induced fragmentation of the samples from 
(B). Samples were treated with piperidine (10%) for 30 min after reaction to induce 
fragmentation at sites of dGN7 alkylation. Products were separated by denaturing PAGE 






 Furthermore, bisQMN3 also formed irreversible DNA adducts, most likely by 
binding DNA’s minor groove.
45, 46
 On the other hand, acridine likely delivers bisQMAcr to 
the major groove of DNA where the dGN7 nucleophile is available to form reversible QM-
DNA adducts. Thus, the disparity between bisQMAcr’s and bisQMN3’s and diQMN3’s 
abilities to transfer their DNA adducts likely stems from the binding mode of their ligands.  
A low yield of strand transfer could also occur if the initial oligonucleotide used to 
trap diQMN3 were over-alkylated and prevented annealing of the complementary target 
sequence. DiQMN3’s alkylation of single-stranded and duplex DNA was compared to 
determine whether diQMN3’s low yield of transfer results from over-alkylation of single-
stranded DNA. Single-stranded [
32
P]-OD2 and duplex [
32
P]-OD2/OD4 were alternatively 
treated with diQMN3 before separation of the products by denaturing PAGE (Figure 2.5A). 
Reaction in both single-stranded and duplex DNA produced products with similar migration 
on the gel (Figure 2.5B). In both cases, the band’s migration retards over time, consistent 
with sequential monoalkylations.
40
 DiQMN3 likely behaves as a monoQM in both single-
stranded and duplex DNA, as the majority of its products represent sequential monoadducts 
rather than DNA ICLs. Treatment of the samples with piperidine confirmed the sequential 
adduct formation in both single-stranded and duplex DNA, as several distinct non-piperidine 
labile bands were observed (Figure 2.5C). The presence of several distinct high molecular 
weight bands suggests that diQMN3 over- alkylates the DNA, which may prevent 
hybridization of the complementary strand and preclude strand transfer.   
To determine whether diQMN3’s dynamics continue beyond transfer of its adducts to 
a new DNA strand, its ability retain its DNA adducts upon an exchange of DNA strands was 





P]-OD1 was added to determine whether diQMN3’s adducts exchanged to alkylate 
OD1 (Figure 2.6A). However, no alkylation of OD1 was apparent, lending further support to 
the notion that the non-piperidine labile adducts observed from strand transfer represent 
irreversible QM-DNA adducts (Figure 2.6B). The dynamics of diQMN3’s DNA alkylation 
are not maintained beyond transfer between complementary DNA sequences. DiQMN3 does 
not support exchange of adducts between multiple DNA strands, as bisQMAcr had.
43
 The 
formation of irreversible DNA adducts will prevent diQMN3’s migration along DNA, as 
ebisQMAcr required reversible adducts to extend its lifetime for further reaction. 
To circumvent diQMN3’s preference for forming irreversible DNA adducts, duplex 
DNA containing sticky ends was utilized to measure diQMN3’s diffusion through DNA. 
OD5/OD6 duplex DNA was initially treated with diQMN3 to trap initial QM-DNA adducts 
Figure 2.6 Exchange of diQMN3’s alkylation between DNA strands. A) Scheme depicting 
the experimental setup. B) Initial DNA adducts were formed by treating OD3 (3 µM) in MES 
(10 mM, pH 7), NaF (10 mM), and 20% acetonitrile with diQMPN3 (50 µM) for 24 h. Excess 
QM was removed via ethanol precipitation and OD2 (3 µM) was then added and incubated 
for 24 h. [
32
P]-OD1 (3 µM) was then added for 0-24 h. Products were separated by denaturing 





before removing excess QM via ethanol precipitation. The preannealed duplex [
32
P]-
OD7/OD8 was then added to observe diffusion of diQMN3 through DNA (Figure 2.7A). 
New adducts were evident by PAGE in as few as 4 h, with the yield increasing over 96 h. 
The majority of products formed were monoadducts, with a 3% yield of DNA ICLs detected 
(Figure 2.7B). DiQMN3 reacted with dGN7s to form reversible adducts and with the weak 
nucleophiles such as dGN2, dAN6, and dGN1 to form irreversible adducts (Figure 2.7C). 
DiQMN3’s yield of adducts may be low due to the evolution of its reversible adducts to 
irreversible adducts. Formation of irreversible adducts prevents further QM reaction. 
DiQMN3 diffuses freely through duplex DNA, as opposed to migrating in a bipedal manner 
like ebisQMAcr. A monoQM linked to acridine (monoQMAcr) migrated through DNA via 
free diffusion.
53, 54
 Once regenerated from a DNA-adduct, a monoQM is not anchored to the 
DNA in the same manner than a bisQM is. Thus, monoQMs may diffuse through the DNA 
before reacting to form a new adduct. DiQMN3’s migration resembles that of a monoQM, 
rather than a bisQM. DiQMN3 essentially functions as a monofunctional QM, since water 
quenches one of its reactive intermediates. Ultimately, diQMN3 may migrate along DNA and 
do so quite rapidly, but as a monoalkylating agent, rather than a crosslinking agent. Even so, 
its migration stops after the formation of irreversible adducts. Efforts would be needed to 
improve diQMN3’s yield of reversible adduct formation in order to enhance its potential 








Figure 2.7 Migration of diQMN3 along DNA containing sticky ends.A) 
Scheme depicting the experimental setup. B) Duplex DNA OD5/OD6 (3 µM) 
in MES (10 mM, pH 7), NaF (10 mM), and 20% acetonitrile was treated with 
diQMPN3 (50 µM) for 24 h. Excess QM was removed via ethanol precipitation. 
[
32
P]-OD7/OD8 was then added for 0-96 h. Products were separated by 
denaturing PAGE (20%) and visualized by phosphorimagery. C) Piperidine-
induced fragmentation of the samples from (B). Samples were treated with 
piperidine (10%) for 30 min after reaction to induce fragmentation at sites of 
dGN7 alkylation. Products were separated by denaturing PAGE (20%), 





2.2.2 Synthesis of an Electron-Rich Analogue of DiQMPN3 
 DiQMN3’s dynamic DNA alkylation suffered from irreversible quenching by water 
and a lack of specificity for forming reversible adducts. Addition of electron density to the 
QM ring systems may improve target selectivity by decreasing the rate of Michael 
addition.
41, 44, 45
The synthesis of an electron-rich analogue of diQMPN2 was not pursued due 
to the low affinity for and alkylation of DNA by diQMN2. Synthesis of the electron-rich 
analogue of diQMPN3 (ediQMPN3) was performed similarly to that of diQMPN3 (Scheme 
2.4).
45, 46
 The synthesis was initiated with mono-hydroxymethylation of 2-(4-
hydroxyphenoxy) acetic acid 1. Hydroxymethylation was initially attempted using 
phenylboronic acid and formaldehyde.
55
 However, hydroxymethyl signals at approximately 
4.5 ppm were never evident by 
1
H NMR. The phenylboronic acid may have chelated the 
carboxylic acid, preventing the formation of the hydroxymethyl- phenylboronic acid 
Scheme 2.4 Synthesis of ediQMPN3. 
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intermediate. The use of sodium tetraborate successfully resulted in 
monohydroxymethylation to yield intermediate 2, which did not require purification.
56
 
The phenolic and benzylic alcohols were then protected with a tert-butyl-
dimethylsilyl (TBDMS) protecting group.  The product was carried forth without further 
purification despite the presence of TBDMS-OH byproducts in the 
1
H NMR spectrum. The 
product was purified after reduction with borane-THF, since the conversion of a carboxylic 
acid to its corresponding alcohol facilitates silica column flash chromatography. The primary 
alcohol was activated as a leaving group using methanesulfonyl chloride (MsCl) to facilitate 
subsequent nucleophilic substitution with the alkylamine.
57
   
Nucleophilic substitution of the mesylated alcohol 5 with the alkylamine was 
performed overnight at 75 °C using 1 equivalent of the alkylamine to 2 equivalents of 
mesylated alcohol 5.
50
  Product 6 was purified from unreacted starting material 5 by flash 
column chromatography. A 1:1 mixture of hexanes:ethyl acetate was first used to remove 
unreacted starting material and any residual TBDMS-OH that remained from prior steps, 
followed by elution of the desired product with a mixture of 99% methanol/1% triethylamine. 
The TBDMS-protected benzylic alcohols were then unmasked for their eventual acetylation. 
Selective deprotection of the benzylic, but not secondary, phenolic TBDMS-protected 
alcohols was achieved using para-toluenesulfonic acid (p-TsOH).
58
 A 1.5-fold excess of p-
TsOH was needed since p-TsOH could also protonate the amines. Product 7 was separated 
from the resulting TBDMS-OH via a hexane:methanol wash. Product 7 partitioned into the 
methanol layer, while the byproducts remained in the hexanes layer.  The benzylic alcohols 
were then acetylated using acetyl chloride and triethylamine, and the product was purified by 
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flash column chromatography by washing with ethyl acetate, followed by elution with a 
mixture of 99% methanol/1% triethylamine to afford pure 8.      
 Methylation of the amines to afford ediQMPN3 proved challenging and could not be 
accomplished successfully (Table 2.1).  Methylation with methyl iodide was performed for 2 
min, as opposed to the 1 h reaction time required for diQMPN3, since methylation of 
ebisQMPN3 was complete within this time frame.
45, 46
 Methylation of ebisQMPN3 had 
proven to be more difficult to achieve than that for bisQMPN3. Following the 2 min reaction 
time, solvent was immediately removed and the crude residue was purified using a C-18 
reverse phase Sep Pak by washing with a gradient of acetonitrile. However, attempted 
purification did not change the purity of the crude mixture. A myriad of products were 
evident by 
1
H NMR, including the appearance of new signals in the aromatic region.  A 
downfield shift of the methylene protons at 1.78 ppm, which would have indicated 
quaternization of the amines, was not evident.  Methyl iodide most likely reacts with the 
aromatic enol leading to a spectrum of products that may result in dearomatization, as well as 
cleavage of the alkylamine chain. Although decomposition was evident for this step of the 
synthesis of ebisQMPN3 as well, the issue was less severe than for ediQMPN3. EdiQMPN3 
contains two aromatic enols that magnified the decomposition observed following the 2 min 
reaction. Neither decreasing the reaction time to 30 sec nor conducting the reaction under 
anhydrous conditions led to any improvements in the product purity. In order to reduce the 
reaction rate to attempt to shift the selectivity of methylation to the amines rather than the 
enol, the reaction was performed at 0 °C. But, decomposition still occurred.  Next, the 
number of equivalents of methyl iodide was reduced in order to try to gain selectivity for N- 
methylation.  One equivalent of MeI per amine did not lead to reaction, while some 
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decomposition and unreacted starting material were detected when 2 equivalents of MeI per 
amine were used. Neither the more reactive dimethylsulfate (DMS) nor DMSO with 
triethylamine and formaldehyde
 
yielded the desired product either, as both reagents produced 
mixtures whose 
1
H NMR spectra showed even more decomposition than reactions with 
methyl iodide, possibly due to the elevated temperatures that were required for reaction and 
the greater reactivity of the methylating agents.
59-61
 Next, MeI was once again utilized but 
with added LiBr. The lithium cations may chelate the oxygen atom, preventing its reaction 
and directing methylation to the amines. Selectivity for N-methylation over O-methylation 
was achieved via lithium chelation of aminoalcohols.
62
 However, the desired product was not 
generated, as decomposition was still evident by 
1
H NMR. 
 To achieve selectivity for N-alkylation rather than O-alkylation, ethyl iodide, rather 
than methyl iodide was used, since it is a less reactive alkylating agent.  Ethylation was 
attempted using 100 equivalents of ethyl iodide per amine and stirring for 2 h at room 
temperature.  The 
1
H spectrum contained fewer products after 2 h reaction with ethyl iodide 
than were detected for reactions with methyl iodide. New signals did not appear in the 
aromatic region of the 
1
H NMR spectra, as had been the case for reaction with methyl iodide. 
Reaction with ethyl iodide may lead to less decomposition than that observed in prior 
experiments due to the slower rate of reaction. The reaction mixture was subjected to cation 
exchange chromatography to remove any undesired byproducts and unreacted starting 
material. However, no product was recovered from the column, indicating that the desired 
alkylation of the amines was likely not attained. The synthesis of ediQMPN3 was abandoned 






 2.2.3 Synthesis and DNA Alkylation of Quinoxaline-linked BisQMs 
 BisQMAcr’s ability to dynamically alkylate and migrate along DNA, and the failure 
of bisQMPN2 and bisQMP3 to migrate along DNA suggests that intercalation, rather than 
electrostatic interactions with DNA’s backbone may be the ideal binding mode to promote 
dynamic QM reaction with DNA. However, acridine may intercalate too strongly to promote 
migration that is fast enough to be effective in vivo. Quinoxalines are “minimal intercalators” 
Reagent Equivalents Time Temperature Notes 
MeI 300 2 min Room temp.  
MeI 300 30 sec Room temp.  
MeI 300 2 min Room temp. Anhydrous 
MeI 300 30 sec Room temp. Anhydrous 
MeI 300 30 sec 0 ºC Anhydrous 
MeI 300 2 min 0 ºC Anhydrous 
MeI 3 2 min Room temp Anhydrous 
MeI 6 2 min Room temp Anhydrous 
DMS 9 2 h 50 ºC  
DMSO 300 24 h 150 ºC  
MeI/LiBr 300 (MeI) 
5 (LiBr) 
2 min Room temp.  
MeI/LiBr 6 (MeI) 
5 (LiBr) 
2 min Room temp.  
EtI 300 2 h Room temp.  
EtI 300 2 h Room temp. Cation exchange 
purification 
EtI 6 2 h Room temp. Cation exchange 
purification 
Table 2.1 Conditions attempted for the methylation of product 8 
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that weakly intercalate DNA .
63
 A bisQM conjugated to a quinoxaline may migrate more 
quickly than ebisQMAcr, as the thermodynamics governing its association and dissociation 
from DNA may be weaker than that for acridine. Furthermore, the quinoxaline scaffold 
offers many opportunities for functionalization to modulate its binding to DNA.
64
 Here, we 
synthesized four quinoxaline-conjugated bisQMs and assessed their ability to dynamically 
alkylate DNA. 
 
  2.2.3.1 Synthesis and DNA Alkylation of BisQMPQuin1 
 We first synthesized a bisQMP linked to quinoxaline-2-carboxylic acid 17 in order to 
determine the ability of an unfunctionalized quinoxaline to localize bisQMs to DNA to form 
reversible adducts. The succinimide activated ester of bisQMP was synthesized as previously 
described, in order to couple the bisQMP to the quinoxalines (Scheme 2.5).
40
 To activate the 
quinoxaline as a nucleophile, the carboxylic acid was activated with succinimide to facilitate 
amide bond formation with mono-Boc-protected diaminopropane 16 (Scheme 2.6).
65
  




The Boc protecting group was then removed using trifluoroacetic acid (TFA) to yield the 
TFA salt of the aminoquinoxaline 20 (Scheme 2.6).  The coupling of 20 to 14 was achieved 
by employing an excess of triethylamine in order to produce the nucleophilic amine and a 
salt between TFA and triethylamine.  The salt was removed via aqueous washes, and pure 
bisQMPQuin1 was obtained following organic extraction.  
Scheme 2.6 Synthesis of bisQMPQuin1 
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 The efficiency of DNA ICL formation by bisQMQuin1 was determined by treating 
duplex DNA OD1/[
32
P]-OD2 with increasing concentrations of bisQMPQuin1 (0- 2000 µM) 
for 24 h (Figure 2.8A).  DNA ICLs formed with increasing concentrations of bisQMQuin1 
Figure 2.8 Dependence of DNA crosslinking on the concentration of bisQMQuin1. A) 
Scheme depicting the experimental setup. B) OD1/[
32
P]-OD2 (3 µM) was treated with 
varying concentrations of bisQMPQuin1 for 24 h in MES (10 mM, pH 7), NaF (10 
mM), and 20% acetonitrile at room temperature. Products were separated by 
denaturing PAGE (20%). “Ss” and “xL” samples include OD1/[
32
P]-OD2, MES (10 
mM, pH 7), NaF (10 mM), and 20% acetonitrile in the presence and absence of 
bisQMPAcr (100 µM), respectively. C) Piperidine-induced fragmentation of the 
samples from (B). Samples were treated with piperidine (10%) for 30 min after 
reaction to induce fragmentation at sites of dGN7 alkylation. Products were separated 






(Figure 2.8B).  Crosslink formation occurred with a yield of 11% with 2 mM of the QM, 
much less efficient than bisQMAcr’s 100% yield of crosslink formation at 100 μM of QM. 
Quinoxaline may not have a strong affinity for DNA, which could explain the low yield of 
DNA crosslinking, even at high QM concentrations. BisQMQuin1 primarily alkylated 
dGN7s to form reversible QM-DNA adducts (Figure 2.8C). 
Intercalators recognize and bind to noncanonical DNA structures, such as bulges, 
mismatches and abasic sites, due to the distortion created in the DNA.  These sites provide 
increased space for the intercalator to bind, and facilitate the local DNA unwinding that 
intercalation induces. Thus, bisQMQuin1 may bind more easily to, and hence react with a 
greater yield with DNA containing noncanonical structures.  The dependence of DNA 
crosslinking on bisQMPQuin1’s concentration was examined using the duplex DNA 
OD1/[
32
P]-OD9, which contained a T-T bulge in the sequence (Figure 2.9A).  ICL formation 
at 2 mM of bisQMPQuin1 occurred in approximately 50% yield, a dramatic improvement 
over the 11% yield using a standard DNA duplex (Figure 2.9B).  Piperidine fragmentation of 
the alkylated DNA indicated that bisQMQuin1 preferentially alkylates dGN7s adjacent to the 
T-T bulge (Figure 2.9C).  The presence of the bulge improves bisQMQuin1’s binding 
affinity to DNA at this region by providing a pocket for intercalation. Furthermore, the 
preference for alkylating dGN7s at the T-T bulge suggests that bisQMQuin1 intercalates the 
DNA and that intercalation directs the QM to dGN7s for covalent reaction. However, 
BisQMQuin1 will likely not improve the rate of migration of bisQMs along DNA, due to the 
low yields of ICLs formed and the high concentration of QM required to form ICLs. 





Figure 2.9 Inter-strand crosslink formation by bisQMQuin1 with DNA containing 
a T-T bulge. A) Scheme depicting the experimental setup. B) OD1/[
32
P]-OD9 (3 
µM) was treated with varying concentrations of bisQMPQuin1 for 24 h in MES 
(10 mM, pH 7), NaF (10 mM), and 20% acetonitrile. Products were separated by 
denaturing PAGE (20%). “Ss” and “xL” samples include OD1/[
32
P]-OD9, MES 
(10 mM, pH 7), NaF (10 mM), and 20% acetonitrile in the presence and absence of 
bisQMPAcr (100 µM), respectively. C) Piperidine-induced fragmentation of the 
samples from (B). Samples were treated with piperidine (10%) for 30 min after 
reaction to induce fragmentation at sites of dGN7 alkylation. Products were 






2.2.3.2 Synthesis and DNA Alkylation of BisQMPQuin2 
Mahata et al reported that the benzyl moiety in quinoxaline compounds acts as an 
intercalation switch that permits quinoxalines to not only bind, but intercalate DNA.
63
 Thus, 
we synthesized a new quinoxaline-linked bisQMP (bisQMPQuin2) that contains a benzyl 
moiety in order to improve association of the compounds to DNA. The synthesis began with 
a nucleophilic aromatic substitution reaction to substitute benzylamine for a chloride on 1,2-
dichloroquinoxaline (Scheme 2.7).
66
  Intermediate 23 was purified from unreacted starting 
material 22 via flash column chromatography.  The remaining steps of the synthesis 
proceeded analogously to those for bisQMPQuin1.   
The efficiency of DNA crosslinking by bisQMQuin2 was assessed by treating 
OD1/[
32
P]-OD2 with increasing concentrations of bisQMPQuin2 for 24 h (Figure 2.10A). 
Scheme 2.7 Synthesis of bisQMPQuin 2 
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Surprisingly, no ICLs were detected with as high as 2 mM of bisQMPQuin2 (Figure 2.10B).  
BisQMQuin2 may bind DNA, but in a conformation that precludes QM alkylation. The 
benzyl moiety may bind the DNA place the QM aromatic ring too far from the bases to 
alkylate them.   
 
2.2.3.3 Synthesis and DNA Alkylation of BisQMPQuin3 
BisQMPAcr is linked to acridine via a two carbon diamino-linker, as opposed to the 
three carbon diamino-linker used for bisQMPQuin1 and bisQMPQuin2.  Thus, using the two 
Figure 2.10 Dependence of DNA crosslinking on the concentration of bisQMQuin2. A) 
Scheme depicting the experimental setup. B) OD1/[
32
P]-OD2 (3 µM) was treated with 
varying concentrations of bisQMPQuin1 for 24 h in MES (10 mM, pH 7), NaF (10 mM), 
and 20% acetonitrile. “Ss” and “xL” samples include OD1/[
32
P]-OD2, MES (10 mM, pH 
7), NaF (10 mM), and 20% acetonitrile in the presence and absence of bisQMPAcr (100 





carbon diamino-linker to conjugate quinoxaline to the bisQMP may improve its ability to 
alkylate DNA by placing QM closer to the nucleophiles of DNA. BisQMPQuin3 was 
synthesized in the same manner as bisQMPQuin1 (Scheme 2.8).  
To determine the effect of the amine linker length of DNA alkylation, OD1/[
32
P]-
OD2 was treated with increasing concentrations of bisQMPQuin3 for 24 h. BisQMPQuin3 
reacted to form a mixture of both crosslinking and monoalkylation at as low as 100 μM of the 
QM (Figure 2.11A).  The shorter linker length afforded a significant improvement in DNA 
alkylation, as the total yield of reaction was greater than 50% with 2 mM of bisQMPQuin3.  
BisQMQuin3 may have overcome the low yields of DNA alkylation achieved by 
bisQMQuin1 and bisQMQuin2 by decreasing the distance between the QM and DNA’s 




nucleophilies to facilitate alkylation. BisQMQuin3 reacted primarily at dGN7s to form 
reversible DNA, but also at DNA’s weaker nucleophiles to form irreversible, non-piperidine 
labile adducts in a small, but noticeable yield (Figure 2.11B).  
BisQMQuin3’s relatively high efficiency of ICL formation prompted an investigation 
of its dynamics of crosslinking. OD3 was treated with bisQMPQuin3 for 24 h to trap the 
QM’s initial adducts and to ensure that any unreacted QM had been fully quenched by water 
(Appendix B, Figure B.32). [
32
P]-OD2 was then added to the reaction to capture 
bisQMQuin3 once it regenerates from its adducts with OD3. No ICLs were detected after 24 
h, indicating that bisQMQuin3’s DNA alkylation is not dynamic (Figure 2.12). The failure to 
transfer its adducts between DNA strands is surprising given that bisQMQuin3 primarily 
alkylates dGN7s in duplex DNA (Figure 2.11B). However, bisQMQuin3 may bind single-
stranded DNA differently than duplex DNA, as intercalation would be impaired with a single 
DNA sequence. A different binding mode with single-stranded DNA could lead different 
sites of reaction. BisQMQuin3 may form irreversible adducts in single-stranded DNA, which 
would prevent its ability to transfer its adducts between DNA strands. Mahata et al reported 
that quinoxalines lacking a benzyl group do not intercalate DNA, but rather bind in a non-
intercalation event.
63
 Thus, combination of the shorter diamino-linker with the addition of a 
benzyl group may not only improve bisQMQuins’ affinity for DNA, but also its efficiency of 








Figure 2.11 Dependence of DNA crosslinking on the concentration of bisQMQuin3. A) 
Scheme depicting the experimental setup. B) OD1/[
32
P]-OD2 (3 µM) was treated with 
varying concentrations of bisQMPQuin1 for 24 h in MES (10 mM, pH 7), NaF (10 mM), 
and 20% acetonitrile. Products were separated by denaturing PAGE (20%). “Ss” and 
“xL” samples include OD1/[
32
P]-OD2, MES (10 mM, pH 7), NaF (10 mM), and 20% 
acetonitrile in the presence and absence of bisQMPAcr (100 µM), respectively. C) 
Piperidine-induced fragmentation of the samples from (B). Samples were treated with 
piperidine (10%) for 30 min after reaction to induce fragmentation at sites of dGN7 
alkylation. Products were separated by denaturing PAGE (20%), visualized, and 




2.2.3.4 Synthesis and DNA Alkylation of BisQMPQuin4 
  A shorter diamino-linker between the quinoxaline and bisQMP fragments improved 
DNA alkylation efficiency. Thus, addition of a benzyl group to bisQMPQuin4 may further 
improve the yield of alkylation and direct alkylation to dGN7s via intercalation. 
BisQMPQuin4 was synthesized using the synthetic procedures established for synthesizing 
bisQMPQuin2 (Scheme 2.9). Treatment of OD1/[
32
P]-OD2 with increasing concentrations of 
bisQMPQuin4 revealed very little DNA alkylation (Figure 2.13A). BisQMQuin4 forms ICLs 
with an approximate yield of 10% when 2 mM of the QM is utilized (Figure 2.13B). 
However, the yield of ICLs is too low to pursue further studies with this compound, despite 
improvements in alkylation efficiency over bisQMQuin2. Regardless, the detection of 
alkylation by bisQMQuin4 supports the hypothesis that the benzyl moiety may result in 
Figure 2.12 Transfer of bisQMQuin3’s adducts between DNA strands. A) Scheme 
depicting the experimental setup. B) OD3 (3 µM) in MES (10 mM, pH 7) and NaF 
(10 mM) was treated with diQMPN3 (50 µM) for 24 h. Excess QM was removed 
from the DNA by ethanol precipitation. The precipitated DNA was resuspended in 
buffer and [
32
P]-OD2 was added and the reaction was incubated for 0-24 h. The 






binding of the quinoxaline to DNA in a manner that precludes QM reaction.  Shortening the 
linkage between the QMP and the quinoxaline may have improved the alkylation efficiency 
by placing the QMP in closer proximity to both the quinoxaline and the DNA once it was 
bound.  
Additional functionalization of the quinoxaline scaffold will be necessary in order to 
develop a bisQM that migrates along DNA on a physiologically relevant time scale. Nitro-
functionalized quinoxalines are abundant in the literature as DNA intercalators, probes for 
live cell imaging, and anti-cancer, anti-fungal, and anti-tuberculosis agents.
67, 68
 Several 
quinoxalines have been designed that contain the nitro-functionality, in addition to other 
functional groups that may direct binding to DNA, such as the naphthyl group. A former 
Scheme 2.9 Synthesis of bisQMPQuin4. 
49 
 
undergraduate student in the Rokita Lab worked on the synthesis and DNA alkylation 
efficiencies of several new bisQMPQuins, none of which dynamically alkylate DNA. 
 
2.3 Summary 
 DiQMs conjugated to alkylammonium chains were evaluated as dynamic DNA 
alkylating agents and compared with their bisQM counterparts. DiQMs primarily behaved as 
monoalkylating agents, as one of the QM intermediates reacted irreversibly with water. 
DiQMN3 alkylated DNA dynamically by transferring its adducts between DNA strands. 
However, its adducts transferred as monoadducts, rather than ICLs. The ability of monoQMs 
Figure 2.13 Dependence of DNA crosslinking on the concentration of bisQMQuin4. 
A) Scheme depicting the experimental setup. B) OD1/[
32
P]-OD2 (3 µM) was treated 
with varying concentrations of bisQMPQuin1 for 24 h in MES (10 mM, pH 7), NaF 
(10 mM), and 20% acetonitrile. Products were separated by denaturing PAGE (20%). 
“Ss” and “xL” samples include OD1/[
32
P]-OD2, MES (10 mM, pH 7), NaF (10 mM), 






to diffuse through DNA may have accounted for diQMN3’s higher yield of strand transfer 
compared with that for bisQMN3. Once released from its initial DNA adduct, diQMN3 is free 
to diffuse through the DNA, while bisQMs are still anchored to the DNA strand by one of 
their two reactive QMs. DiQMN3’s dynamics of alkylation ceased upon transfer of its 
adducts to a new DNA strand, as it transferred irreversible sites on the acceptor strand, 
preventing its further migration along DNA. However, diQMN3’s behavior as a monoQM 
permitted its migration through DNA containing sticky ends by means of free diffusion upon 
regeneration from its original adduct. However, migration occurred through sequential 
monoalkylations, rather than via new ICL formation, as was the case for ebisQMAcr. The 
evolution of diQMN3’s reversible DNA adducts to irreversible adducts prevent migration. 
Moreover, conjugation to alkylammonium chains likely directs the QM to nucleophiles in the 
minor groove that will react irreversibly. Our findings suggest that ebisQMAcr’s migration 
along DNA was facilitated by acridine’s delivery of the QM to the major groove for 
reversible reaction at dGN7.   
 Weakly intercalative quinoxalines were conjugated to bisQMs to hasten their 
migration by facilitating more facile dissociation from DNA than acridine. However, the 
quinoxalines likely bind DNA too weakly to enable QM alkylation. The quinoxalines may 
not even intercalate with DNA, but rather bind the grooves, as both reversible adducts at 
dGN7 and irreversible adducts with DNA’s weak nucleophiles were formed. 
 Our efforts failed to develop a bifunctional QM with hastened migration along DNA 
via dynamic covalent chemistry. Our studies of ammonium-linked diQMs and quinoxaline-
linked bisQMs highlight the delicate balance between DNA binding and reactivity that is 
necessary to achieve dynamic DNA alkylation. An alternate approach to facilitating QM 
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migration through DNA may draw from the use of biological machines that generate 
mechanical force while traversing DNA. Such an enzyme may be able to catalyze 
bisQMAcr’s migration along DNA by providing a mechanical “push”. 
 
2.4 Materials and Methods 
 2.4.1 Materials 
Organic reagents and starting materials were purchased from Sigma- Aldrich and 
Acros Organics and used without further purification.  Solvents and salts were purchased 
from Sigma- Aldrich and Fisher Scientific.  Silica gel (SiliaFlash P60, 230-400 mesh, 40-63 
µm) for flash column chromatography was purchased from Silicycle.  C18-Sep Pak cartridges 
were purchased from Waters.  All deuterated solvents for NMR spectroscopy were purchased 
from Cambridge Isotope Laboratories.  NMR spectra were recorded on a Bruker AM400 
spectrometer and referenced to residual protons in the deuterated solvents.  Chemical shifts 
are reported in parts per million (ppm).  High resolution mass spectrometry (HRMS) was 
obtained by Dr. Phil Mortimer using fast atom bombardment ionization with a VG 7070SE 
mass spectrometer. ESI HRMS was performed using UPLC-MS on an Acquity UPLC H-
Class/Xevo G2 QTof from Waters. DiQMPN2, and DiQMPN3 were synthesized by Dr. Mark 
Hutchinson as described previously.
45, 46
 The succinimide-activated ester 13 was synthesized 
as previously described.
40
 Oligonucleotides were synthesized by Integrated DNA 
Technologies (IDT) with standard desalting and used without further purification.  - [
32
P]- 
ATP was purchased from Perkin Elmer.  T4 polynucleotide kinase and proteinase K were 
purchased from New England Biolabs. All aqueous solutions used water purified to a 
resistivity of greater than 17.8 M.  DNA concentrations were measured from their 
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absorption at 260 nm using an Agilent UV-Vis spectrophotometer and calculated using their 
260 values provided by IDT.  Detection of radiolabeled oligonucleotides was carried out 
using a Typhoon 9410 phosphorimager and quantified using ImageQuant TL software. 
 
2.4.2 Methods 
2-(4-Hydroxy-3-(hydroxymethyl)phenoxy)acetic acid (2). 2-(4-
Hydroxyphenoxy)acetic acid (1) (0.50 g, 2.97 mmol) was dissolved in 5 M aq. NaOH (1.37 
mL), 1.3 mL of 37% aq. formaldehyde, and 15 mL of water. The solution was stirred at 55° 
C for 24 h. The solution was cooled to room temperature and the pH was adjusted to 2 with 
HCl.  The product was extracted with ethyl acetate (3x50 mL). The organic phases were 
combined and washed with brine (2x50 mL), dried with MgSO4, filtered, and concentrated 
under reduced pressure to yield 2 as a pink oil (0.54 g, 2.7 mmol, 92% yield). 
1
H NMR (400 
MHz, CD3OD)  ppm 4.51 (s, 2H), 4.57 (s, 2H), 6.65 (s, 2H), 6.87 (s, 1H). 
13
C NMR (101 
MHz, CD3OD)  ppm 59.0, 64.8, 113.5, 113.8, 114.7, 127.7, 148.6, 150.7, 171.3. FAB 





methyl)phenoxy)acetic acid (3). Compound 2 (0.54 g, 2.7 mmol) was dissolved in 25 mL 
anhydrous DMF. To the solution was added tert-butyldimethylchlorosilane (1.03 g, 6.81 
mmol) and imidazole (0.930 g, 13.6 mmol). The reaction was stirred at room temperature 
under N2 for 16 h. The reaction was quenched by the addition of 50 mL of H2O and the 
product extracted with ethyl acetate (3x50 mL). The organic phases were pooled, washed 
with brine (2x50 mL), sat. ammonium chloride (2x50 mL), dried with MgSO4, filtered and 
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concentrated under vacuum to yield compound 3 as a yellow oil (0.99 g, 2.32 mmol, 85% 
yield). 
1
H NMR (400 MHz, CDCl3)  ppm 0.09 (s, 6H) 0.18 (s, 6H), 0.94 (s, 9H), 0.98 (s, 
9H), 4.61 (s, 2H), 4.70 (s, 2H), 6.66 (t, J = 3.50 Hz, 2H), 7.07 (s, 1H). 
13
C NMR (101 MHz, 
CDCl3)  ppm -5.60, -4.40, 18.0, 18.3, 25.5, 25.8, 60.3, 65.7, 113.0, 113.3, 118.4, 133.3, 






methyl)phenoxy)ethan-1-ol (4). Borane/THF (1 M), (40 mL, 40 mmol) was added slowly to 
a solution of compound 3 (0.99 g, 2.3 mmol) in 20 mL of anhydrous THF while stirring 
under N2. Stirring was continued for 2 h under N2 and then the reaction was quenched by the 
addition of 50 mL of H2O. The product was extracted with ethyl acetate (3x50 mL). The 
organic layers were pooled, washed with water (2x50 mL), brine (50 mL), dried with 
MgSO4, filtered, and concentrated under reduced pressure to yield a pale yellow oil. The 
compound was purified using flash silica column chromatography with 4:1 hexanes:ethyl 
acetate to yield compound 4 as a clear viscous oil (0.48 g, 1.2 mmol, 52% yield). 
1
H NMR 
(400 MHz, CDCl3)  ppm 0.10 (s, 6H),  0.18 (s, 6H), 0.95 (s, 9H), 0.99 (s, 9H), 3.93 (t, J= 
4.36 Hz, 2H), 4.03 (t, J = 4.15 Hz, 2H),  4.71 (s, 2H), 6.66 (d, J = 1.77 Hz, 2H), 7.06 (s, 1H). 
13
C NMR (101 MHz, CDCl3)  ppm -5.80, -4.70, 17.8, 18.0, 25.3, 25.6, 60.1, 61.2, 69.2, 








methyl)phenoxy)ethyl methanesulfonate (5). Methanesulfonyl chloride (0.199 g, 1.74 
mmol, 135 µL) was added dropwise to a solution of 4 (0.48 g, 1.2 mmol) in 15 mL of CH2Cl2 
and triethylamine (243 µL, 1.74 mmol). The reaction was stirred for 2 h at room temperature. 
The reaction was quenched by the addition of 50 mL of H2O and the product was extracted 
with CH2Cl2 (3x50 mL). The organic layers were pooled and washed with water (2x50 mL), 
dried with MgSO4, filtered, and concentrated to yield 5 as an opaque viscous oil (0.47 g, 0.97 
mmol, 83% yield). 
1
H NMR (400 MHz, CDCl3)  ppm 0.10 (s, 6H), 0.18 (s, 6H), 0.95 (s, 
9H), 0.99 (s, 9H), 3.08 (s, 3H), 4.19 (m, 2H), 4.56 (m, 2H), 4.71 (s, 2H), 6.65 (t, J = 2.69 Hz, 
2H), 7.04 (d, J = 3.27 Hz, 1H). 
13
C NMR (101 MHz, CDCl3)  ppm -5.30, -4.20, 18.3, 18.5, 
25.8, 26.0, 37.9, 60.5, 66.4, 68.5, 113.2, 113.3, 118.6, 133.6, 146.4, 152.5. FAB HRMS m/z 















dimethylpropane-1,3-diamine (6). To a solution of 5 (0.47 g, 0.97 mmol) in 3 mL of 
CH3CN and trimethylamine (134 µL, 0.97 mmol) was added N,N-bis[3-
(methylamino)propyl] methylamine (97 µL, 0.48 mmol). The reaction was stirred at 75 °C 
for 16 hours. The solution was diluted with 150 mL ethyl acetate, washed with saturated 
aqueous NaHCO3 (3x50 mL), dried with MgSO4, filtered, and concentrated under vacuum to 
yield an orange oil.  The compound was purified using flash silica column chromatography 
with 1:1 hexanes:ethyl acetate, followed by methanol/NEt3 to yield 6 as an orange oil (0.38 g, 
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0.39 mmol, 82% yield). 
1
H NMR (400 MHz, CDCl3)  ppm 0.08 (s, 12H), 0.15 (s, 12H), 
0.93 (s, 18H), 0.97 (s, 18H), 1.79 (m, 4H), 2.32 (s, 6H), 2.41 (s, 3H), 2.51 (t, J = 7.64 Hz, 
4H), 2.64 (q, J = 10.18 Hz, 4H), 2.77 (m, 4H), 4.00 (m, 4H), 4.69 (s, 4H), 6.62 (t, J = 1.38 
Hz, 4H), 7.01 (s, 2H). 
13
C NMR (101 MHz, CDCl3)  ppm -5.50, -4.40, 18.0, 18.3, 25.6, 
25.8, 42.6, 55.5, 56.0, 56.1, 60.4, 66.2, 112.8, 112.9, 118.2, 132.8, 145.4, 153.1. FAB HRMS 






Toluenesulfonic acid (0.239 g, 1.25 mmol) was added to a solution of 6 (0.378 g, 0.390 
mmol) in 5 mL methanol and stirred for 1 h at room temperature. The product was diluted 
with 100 mL of ethyl acetate, washed with saturated aqueous NaHCO3 (2x50 mL), dried with 
MgSO4, filtered, and concentrated under reduced pressure. The crude product was dissolved 
in 2 mL methanol and washed with 5 mL hexane to remove residual TBDMS, and 
concentrated under reduced pressure to yield 7 as an orange oil (0.14 g, 0.19 mmol, 48% 
yield). 
1
H NMR (400 MHz, CDCl3)  ppm 0.18 (s, 12H), 0.98 (s, 18H), 1.66 (m, 4H), 2.18 
(s, 3H), 2.29 (s, 6H), 2.33 (m, 4H), 2.44 (m, 4H), 2.73 (m, 4H), 3.98 (m, 4H), 4.60 (s, 4H), 
6.66 (q, J = 2.70 Hz, 4H), 6.91 (s, 2H). 
13
C NMR (101 MHz, CDCl3)  ppm -3.70, 18.7, 26.3, 
42.7, 43.5, 56.2, 56.4, 56.6, 58.9, 61.9, 67.0, 114.5, 115.0, 119.5, 133.1, 147.4, 153.7. FAB 








diacetate (8). Acetyl chloride (0.37 g, 0.47 mmol, 34 µL) was added to a solution of 7 (0.138 
g, 0.190 mmol) in 5 mL CH2Cl2 and triethylamine (66 µL, 0.47 mmol) and stirred at room 
temperature for 1 h. The reaction was diluted with 100 mL of CH2Cl2, washed with saturated 
aqueous NaHCO3 (2x50 mL), dried with MgSO4, filtered, and concentrated under reduced 
pressure to a yellow oil.  The compound was purified using flash silica chromatography with 
methanol/triethylamine to yield 8 as a pale yellow oil (0.085 g, 0.10 mmol, 55% yield). 
1
H 
NMR (400 MHz, CDCl3)  ppm 0.18 (s, 12H), 0.97 (s, 18H), 1.69 (m, 4H), 2.24 (s, 3H), 2.31 
(s, 6H), 2.41 (m, 4H), 2.47 (m, 4H), 2.76 (t, J = 6.01 Hz, 4H), 3.99 (m, 4H), 5.05 (s, 4H), 
6.71 (q, J = 2.61 Hz, 4H), 6.85 (s, 2H),. 
13
C NMR (101 MHz, CDCl3)  ppm -4.90, 17.5, 
20.4, 25.1, 34.1, 34.6, 42.2, 47.7, 55.0, 55.4, 55.7, 61.5, 65.9, 114.4, 115.5, 118.6, 126.5, 





tert-Butyl (3-aminopropyl)carbamate (16). To a solution of methanol (15 mL), 36% 
aqueous HCl (3.36 mL, 40.5 mmol) was added at 0 °C and stirred for 15 min.  Stirring was 
continued at room temperature for an additional 15 min before adding 15 (3.38 mL, 3.00 g, 
40.5 mmol) at 0 °C.  The reaction mixture was then stirred at room temperature for 15 min.  
Water (10 mL) was added and the mixture was stirred for an additional 30 min at room 
temperature.  To the reaction mixture was added Boc2O (8.80 g, 40.5 mmol) in methanol (15 
mL), and the mixture was stirred for 1 h.  Organic solvents were removed under reduced 
pressure. The mixture was then washed with ether (2x100 mL) to remove unreacted 1,3- 
diaminopropane.  The product was extracted from the aqueous phase with CH2Cl2 (2x100 
mL), washed with brine (100 mL), dried with MgSO4, filtered, and concentrated under 
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reduced pressure to yield 15 (3.40 g, 19.5 mmol, 49% yield) as a pale yellow oil. 
1
H NMR 
(400 MHz, CDCl3) δ ppm 1.36 (s, 9H), 1.57 (quin, 2H, J = 12.11 Hz), 2.72 (t, 2H, J=10.09 
Hz), 3.11 (t, 2H, J=10.09 Hz), 5.18 (s, 1H). 
13
C NMR (101 MHz, CDCl3) δ ppm 28.4, 32.7, 
38.3, 39.4, 79.0, 156.1. FAB HRMS m/z Calcd for C8H18N2O2 175.1402, found 175.1449 
[M+H]
+
.     
 
2,5-Dioxopyrrolidin-1-yl quinoxaline-2-carboxylate (18). N-Hydroxysuccinimide 
17 (0.346 g, 3.45 mmol) was added to an anhydrous DMF solution (10 mL) of 16 (0.300 g, 
1.72 mmol).  This mixture was cooled to 0 °C and combined with 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC, 0.660 g, 3.45 mmol).  The mixture was then 
stirred overnight under N2 at room temperature. The reaction mixture was diluted with brine 
(50 mL), and extracted with  Et2O (3x50 mL). The organic phases were pooled and washed 
with sat. ammonium chloride (2x50 mL) and brine (50 mL), dried with MgSO4, filtered, and 
concentrated under reduced pressure to yield 18 (0.143 g, 0.530 mmol, 31% yield) as a 
brown solid.
 1
H NMR (400 MHz, CDCl3) δ ppm 2.95 (s, 4H), 7.93 (m, 2H), 8.17 (dd, 1H, 
J=1.59, 8.43 Hz), 8.26 (dd, 1H, J=1.59, 8.43 Hz), 9.52 (s, 1H). 
13
C NMR (101 MHz, CDCl3) 
δ ppm 25.4, 25.6, 25.7, 129.4, 130.7, 131.6, 133.6, 138.8, 141.5, 144.1, 144.9, 159.7, 169.2.  
 
 tert-Butyl (3-(quinoxaline-2-carboxamido)propyl)carbamate (19). To a solution 
of 18 (0.143 g, 0.530 mmol) in anhydrous CH3CN (10 mL) was added 15 (0.111 g, 0.630 
mmol) and triethylamine (176 µL, 1.26 mmol).  The reaction was stirred under N2 for 2 h and 
then quenched with 50 mL of H2O and 2 mL of acetic acid.  The product was extracted with 
ether (3x50 mL).  The organic phases were pooled and washed with brine (2x50 mL) and sat. 
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NaHCO3 (3x50 mL), dried with MgSO4, filtered, and concentrated under reduced pressure to 
yield 19 (0.15 g, 0.45 mmol, 87% yield) as a light brown solid. 
1
H NMR (400 MHz, CDCl3) 
δ ppm1.83 (quin, 2H, J=6.64 Hz), 3.24 (q, 2H, J=6.64 Hz), 3.60 (q, 2H, J=6.57 Hz), 5.03 (s, 
1H,), 8.10 (m, 2H), 8.16 (dd, 2H, J=1.90, 6.18 Hz), 8.19, (dd, 2H, J=1.90, 6.18 Hz), 8.24 (s, 





3-(Quinoxaline-2-carboxamido)propan-1-aminium 2,2,2-trifluoroacetate (20). To 
a solution of 19 (0.15 g, 0.45 mmol) in CH2Cl2 (5 mL) was added trifluoroacetic acid (5 mL).  
The reaction mixture was stirred for 30 min at room temperature.  The product was 
concentrated under vacuum to yield 20 (0.15 g, 0.45 mmol) as a light brown solid that was 
used without further purification. 
 
(2-((tert-Butyldimethylsilyl)oxy)-5-(3-oxo-3-((3-(quinoxaline-2-
carboxamido)propyl)amino)propyl)-1,3-phenylene)bis(methylene) diacetate (21, 
BisQMPQuin1). To a solution of 14 (0.080 g, 0.19 mmol) in anhydrous CH3CN (10 mL) 
was added 20 (0.79 g, 0.23 mmol) and triethylamine (210 μL, 1.50 mmol).  The reaction was 
stirred for 2 h at room temperature under N2 and then quenched by addition of 50 mL of H2O 
and 2 mL of acetic acid.  The product was extracted with Et2O (3x50 mL). The organic 
phases were pooled and washed with brine (2x50 mL) and sat. NaHCO3 (3x50 mL), dried 
with MgSO4, filtered, and concentrated under reduced pressure to yield 21 (0.060 g, 0.09 
mmol, 50% yield).  
1
H NMR (400 MHz, CDCl3) δ ppm 0.16 (s, 6H), 0.99 (s, 9H), 1.75 (q, 
2H, J=6.32 Hz), 2.09 (s, 6H,), 2.57 (t, 2H, J=8.16 Hz), 2.95 (t, 2H, J=8.16 Hz), 3.31 (q, 2H, 
59 
 
J=6.52 Hz), 3.48 (q, 2H, J=6.52 Hz), 5.06 (s, 4H), 6.60 (s, 1H), 7.16 (s, 2H), 7.86 (m, 2H), 
8.11 (d, 2H, J=8.36 Hz), 8.20, (d, 2H, J=8.36 Hz), 8.31 (s, 1H), 9.63 (s, 1H). 
13
C NMR (101 
MHz, CDCl3) δ ppm -3.7, 1.0, 8.5, 18.6, 21.0, 25.9, 30.3, 36.1, 36.2, 38.4, 61.9, 125.5, 127.0, 
130.1, 131.8, 134.0, 143.6, 149.8, 164.4, 170.9, 173.2. FAB HRMS m/z Calcd for 
C33H44N4O7Si 637.3013, found 637.3056 [M+H]
+
.     
 
N-benzyl-3-chloroquinoxalin-2-amine (23). To a solution of 2,3- 
dichloroquinoxaline 22 (1.0 g, 5.0 mmol) in ethanol (20 mL) was added dried benzylamine 
(1.1 mL, 10 mmol).  The mixture was then heated under reflux for 6 h and the solvent was 
removed under reduced pressure.  The resulting yellow residue was subjected to silica gel 
flash column chromatography (9:1 hexanes:ethyl acetate) to yield 23 as a yellow solid (0.95 
g, 3.5 mmol, 70% yield). 
1
H NMR (400 MHz, CDCl3) δ ppm 4.80 (d, J = 5.7, 2H), 5.86 (br, 
1H), 7.35 (m, 1H), 7.44 (m, 5H), 7.60 (m, 1H), 7.76 (dq, J = 0.60, 1H) 7.83 (dq, J = 0.60, 
1H). 
13
C NMR (101 MHz, CDCl3) δ ppm 45.2, 124.8, 125.7, 127.3, 127.5, 128.4, 129.8, 





tert-Butyl (3-((3-(benzylamino)quinoxalin-2-yl)amino)propyl)carbamate (24). To 
a solution of 23 (0.2 g, 0.7 mmol) in ethanol (15 mL) was added 16 (1.02 g, 5.90 mmol) and 
triethylamine (206 µL, 1.40 mmol). The mixture was then heated under reflux for 8 h.  The 
solvent was removed under reduced pressure.  The resulting yellow residue was subjected to 
silica gel flash column chromatography (3:1 hexanes:ethyl acetate) to yield 24 as a pale 





NMR (400 MHz, CDCl3) δ ppm 1.43 (s, 9H), 1.76 (q, J = 6.75, 2H), 3.19 (q, J = 6.75, 2H), 
3.65 (q, J = 6.75, 2H), 4.79 (d, J = 5.0, 2H), 5.51 (br, 1H), 5.58 (br, 1H), 6.02 (br, 1H), 7.32 
(m, 5H), 7.44 (d, J = 7.9, 2H), 7.66 (q, J = 3.5, 2H). 
13
C NMR (101 MHz, CDCl3) δ ppm 
27.9, 29.1, 36.7, 36.9, 45.4, 79.3, 123.9, 124.1, 124.6, 125.1, 126.9, 128.1, 136.4, 136.6, 






trifluoroacetate (25). To a solution of 24 (0.08 g, 0.19 mmol) in DCM (5 mL) was added 
trifluoroacetic acid (5 mL).  The reaction mixture was stirred for 30 min at room temperature.  
The product was concentrated under vacuum to yield 25 (0.080 g, 0.19 mmol) as a yellow oil 
that was used without further purification.   
 
(5-(3-((3-((3-(Benzylamino)quinoxalin-2-yl)amino)propyl)amino)-3-oxopropyl)-
2-((tert-butyldimethylsilyl)oxy)-1,3-phenylene)bis(methylene) diacetate (26, 
BisQMPQuin2). To a solution of 14 (0.083 g, 0.16 mmol) in anhydrous CH3CN (10 mL) 
was added 25 (0.080 g, 0.19 mmol) and triethylamine (179 μL, 1.30 mmol).  The reaction 
was stirred for 2 h at room temperature under N2.  The reaction was then quenched by the 
addition of 40 mL of H2O and 2 mL of acetic acid.  The product was extracted with Et2O 
(3x50 mL).  The organic phases were pooled and washed with brine (2x50 mL) and sat. 
NaHCO3 (3x50 mL), dried with MgSO4, filtered, and concentrated under reduced pressure to 
yield 26 (0.060 g, 0.080 mmol, 53% yield).  
1
H NMR (400 MHz, CDCl3) δ ppm 0.16 (s, 6H), 
1.00 (s, 9H), 1.70 (q, J = 6.5, 2H), 2.03 (s, 6H), 2.44 (t, J = 7.90, 2H), 2.81 (t, J = 7.90, 2H), 
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3.25 (q, J = 6.50, 2H), 3.49 (t, J = 6.50, 2H), 4.78 (s, 2H), 5.04 (s, 4H), 5.70 (br, 1H), 6.05 
(br, 1H), 6.40 (br, 1H), 7.09 (s, 2H), 7.27 (m, 5H), 7.42 (d, J = 7.10, 2H), 7.50 (t, J = 5.40, 
1H), 7.60 (t, J = 5.40, 1H). 
13
C NMR (101 MHz, CDCl3) δ ppm -3.6, 18.8, 21.1, 29.5, 30.4, 
30.9, 36.4, 37.6, 38.5, 45.9, 70.0, 124.3, 124.5, 124.8, 125.7, 127.2, 127.4, 128.1, 128.4, 
128.5, 128.6, 128.9, 130.0, 136.9, 139.1, 144.0, 144.4, 149.9, 171.1, 172.9. FAB HRMS m/z 
Calcd for C39H51N5O6Si 714.3642, found 714.3678 [M+H]
+
.      
 
tert-Butyl (2-aminoethyl)carbamate (28). To a solution of methanol (8 mL), 36% 
aqueous HCl (1.38 mL, 16.6 mmol) was added at 0 °C and stirred for 15 min.  The reaction 
mixture was then stirred at room temperature for an additional 15 min before adding ethane-
1,2-diamine 27 (1.11 mL, 1.00 g, 16.6 mmol) at 0 °C.  The reaction mixture was then stirred 
at room temperature for 15 min.  Water (5 mL) was added and stirred for an additional 30 
min at room temperature.  To the reaction mixture was added Boc2O (3.6 g, 16.6 mmol) in 
methanol (15 mL), and the mixture was stirred for 1 h.  The mixture was concentrated under 
reduced pressure, then washed with ether (2x50 mL) to remove unreacted ethane-1,2-
diamine.  The product was extracted from the aqueous phase with CH2Cl2 (2x50 mL), 
washed with brine (50 mL), dried with MgSO4, filtered, and concentrated under reduced 
pressure to yield 28 (1.15 g, 7.20 mmol, 43% yield) as a yellow oil. 
1
H NMR (400 MHz, 
CDCl3) δ ppm 1.33 (s, 9H), 1.93 (br, 2H), 2.70 (t, J=5.82 Hz, 2H), 3.06 (q, J=5.98 Hz, 2H), 
5.33 (br, 1H). 
tert-Butyl (2-(quinoxaline-2-carboxamido)ethyl)carbamate (29). To a solution of 
18 (0.133 g, 0.490 mmol) in anhydrous CH3CN (10 mL) was added 28 (0.095 g, 0.59 mmol) 
and triethylamine (165 µL, 1.19 mmol).  The reaction was stirred under N2 for 2 h and then 
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quenched with 50 mL of H2O and 2 mL of acetic acid.  The product was extracted with ether 
(3x50 mL).  The organic phases were pooled, washed with brine (2x50 mL) and sat. NaHCO3 
(3x50 mL), dried with MgSO4, filtered, and concentrated under reduced pressure to yield 29 
(0.064 g, 0.20 mmol, 42% yield) as a yellow solid. 
1
H NMR (400 MHz, CDCl3) δ ppm 1.42 
(s, 9H), 3.46 (q, J=7.04 Hz, 2H), 3.67 (q, J=5.97 Hz, 2H), 5.16 (br, 1H), 7.81 (m, 2H), 8.06 
(dd, J=1.94, 7.43 Hz, 1H), 8.16 (dd, J=1.94, 7.43 Hz, 1H), 8.37 (br, 1H), 9.64 (s, 1H). 
13
C 
NMR (101 MHz, CDCl3) δ ppm 28.3, 40.3, 79.6, 129.4, 129.6, 130.8, 131.6, 140.2, 143.3, 
143.7, 143.8, 156.5, 164.0.  
 
2-(Quinoxaline-2-carboxamido)ethan-1-aminium 2,2,2-trifluoroacetate (30). To a 
solution of 29 (0.064 g, 0.20 mmol) in CH2Cl2 (5 mL) was added trifluoroacetic acid (5 mL).  
The reaction mixture was stirred for 30 mins at room temperature.  The product was 
concentrated under vacuum to yield 30 (0.067 g, 0.20 mmol) as a yellow oil that was used 
without further purification.   
 
(2-((tert-Butyldimethylsilyl)oxy)-5-(3-oxo-3-((2-(quinoxaline-2-
carboxamido)ethyl)amino)propyl)-1,3-phenylene)bis(methylene) diacetate (31, 
BisQMPQuin3). To a solution of 14 (0.045 g, 0.086 mmol) in anhydrous CH3CN (10 mL) 
was added 30 (0.034 g, 0.10 mmol) and triethylamine (97 μL, 0.69 mmol).  The reaction was 
stirred for 2 h at room temperature under N2.  The reaction was then quenched by the 
addition of 40 mL of H2O and 2 mL of acetic acid.  The product was extracted with Et2O 
(3x50 mL).  The organic phases were pooled, washed with brine (2x50 mL) and sat. NaHCO3 
(3x50 mL), dried with MgSO4, filtered, and concentrated under reduced pressure to yield 31 
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(0.025 g, 0.040 mmol, 47% yield).  
1
H NMR (400 MHz, CDCl3) δ ppm 0.16 (s, 6H), 1.00 (s, 
9H), 2.08 (s, 6H), 2.48 (t, J = 8.09, 2H), 2.89 (t, J = 8.09, 2H), 3.57 (q, J = 6.11, 2H), 3.66 (q, 
J = 6.11, 2H), 5.04 (s, 4H), 6.27 (br, 1H), 7.11 (s, 2H), 7.87 (m, 2H), 8.12 (dd, J = 2.20, 7.69, 
1H), 8.17 (dd, J = 2.20, 7.69, 1H), 8.36 (br, 1H), 9.63 (s, 1H). 
13
C NMR (101 MHz, CDCl3) δ 
ppm -3.9, 21.1, 25.7, 30.2, 30.7, 34.1, 38.2, 40.1, 67.2, 125.4, 126.7, 129.4, 129.6, 129.9, 
130.8, 131.6, 134.0, 140.1, 142.9, 143.5, 143.9, 149.6, 164.5, 170.8, 172.7. ESI HRMS m/z 
Calcd for C32H42N4O7Si 623.2856, found  623.2896 [M+H]
+
.      
 
tert-Butyl (2-((3-(benzylamino)quinoxalin-2-yl)amino)ethyl)carbamate (32). To a 
solution of 23 (0.20 g, 0.70 mmol) in ethanol (15 mL) was added 28 (0.480 g, 2.95 mmol) 
and triethylamine (621 µL, 4.20 mmol).  The mixture was then heated under reflux for 16 h.  
The solvent was removed under reduced pressure.  The resulting yellow residue was 
subjected to silica gel flash column chromatography (3:1 hexanes:ethyl acetate) to yield 32 as 
a yellow oil (0.170 g, 0.400 mmol, 58% yield) in addition to unreacted starting materials. 
1
H 
NMR (400 MHz, CDCl3) δ ppm 1.33 (s, 9H), 3.39 (q, J= 5.79 Hz, 2H), 3.62 (q, J= 5.41 Hz, 
2H), 4.76 (s, 2H), 5.59 br, 1H), 7.30 (dd, J= 2.90, 6.98 Hz, 5H), 7.42 (d, J= 7.46 Hz, 2H), 
7.61 (m, 2H) 
13
C NMR (101 MHz, CDCl3) δ ppm 28.2, 40.6, 43.1, 45.7, 80.0, 124.4, 124.5, 
125.5, 127.2, 128.2, 128.4, 136.7, 138.6, 143.8, 144.0, 158.1. ESI HRMS m/z Calcd for 





trifluoroacetate (33). To a solution of 32 (0.050 g, 0.13 mmol) in CH2Cl2 (5 mL) was added 
trifluoroacetic acid (5 mL).  The reaction mixture was stirred for 30 mins at room 
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temperature.  The product was concentrated under vacuum to yield 33 (0.050 g, 0.13 mmol) 
as a yellow solid that was used without further purification. ESI HRMS m/z Calcd for 





((tert-butyldimethylsilyl)oxy)-1,3-phenylene)bis(methylene) diacetate (34, 
BisQMPQuin4). To a solution of 14 (0.053 g, 0.10 mmol) in anhydrous CH3CN (10 mL) 
was added 33 (0.050 g, 0.12 mmol) and triethylamine (112 μL, 0.800 mmol).  The reaction 
was stirred for 2 h at room temperature under N2.  The reaction was then quenched by the 
addition of 40 mL of H2O and 2 mL of acetic acid.  The product was extracted with Et2O 
(3x50 mL).  The organic phases were pooled, washed with brine (2x50 mL) and sat. NaHCO3 
(3x50 mL), dried with MgSO4, filtered, and concentrated under reduced pressure to yield 34 
(0.050 g, 0.070 mmol, 70% yield) as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ ppm 0.15 
(s, 6H), 0.99 (s, 9H), 2.04 (s, 6H), 2.32 (t, J= 8.07 Hz, 2H), 2.69 (t, J= 7.99 Hz, 2H), 3.47 (q, 
J= 7.07 Hz, 2H), 3.66 (q, J= 5.53 Hz, 2H), 4.76 (s, 2H), 4.99 (s, 4H), 6.94 (s, 2H), 7.29 (m, 
5H), 7.39 (d, J= 8.38 Hz, 2H), 7.43 (m, 1H), 7.50 (m, 1H). 
13
C NMR (101 MHz, CDCl3) δ 
ppm 3.9, 20.8, 25.7, 30.1, 30.5, 37.9, 41.1, 41.5, 45.5, 61.7, 124.3, 124.4, 125.5, 126.7, 
127.1, 128.1, 128.2, 128.3, 129.9, 133.5, 136.9, 138.7, 149.7, 168.9, 170.8, 173.7. ESI 
HRMS m/z Calcd for C38H49N5O6Si 700.3486, found 700.3508 [M+H]
+
.      
 
General Oligonucleotide Studies. Duplex DNA was annealed by heating the [
32
P]- 
DNA (2.8 M) with its complementary strand (3.0 M) in MES (10 mM, pH 7) and NaF (10 
mM) at 95 C for 2 minutes followed by slow cooling to room temperature.  Crosslinking 
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experiments involved the addition of the quinone methide precursor in acetonitrile to the 
above mixture, yielding a final reaction volume of 20 L., containing a final concentration of 
20% acetonitrile.  Reactions were quenched by the addition of 2X formamide loading dye 
(0.05% bromophenol blue and 0.05% xylene cyanol in formamide) and frozen in liquid 
nitrogen. Samples were thawed for 5 min at room temperature, analyzed by 20% denaturing 
polyacrylamide gel electrophoresis (PAGE), and visualized by phosphorimagery.  Samples 
were quantified using ImageQuant TL software by and yields were reported as the intensity 
of each band relative to the total signal intensity per lane.  
 
Piperidine Cleavage of Alkylated Oligonucleotides. Frozen samples of DNA 
treated with QMs were lyophilized and dissolved in 10% piperidine (30 µL). The samples 
were heated at 90 ºC for 30 min and then lyophilized. To remove residual piperidine, samples 
were dissolved in water (30 µL) and lyophilized in three consecutive repetitions.  Samples 
were dissolved in water (10 µL) and combined with formamide containing bromophenol blue 
and xylene cyanol (10 µL). Samples were analyzed by 20% denaturing PAGE, visualized, 
and quantified by phosphorimagery. 
 
Ethanol Precipitation of DNA. To each sample was added NaOAc (0.3 M, pH 5.2) 
and 10 volumes of cold ethanol. The samples were incubated on dry ice for 30 min. The 
samples were centrifuged to pellet the DNA (13, 200 g, 15 min). The supernatant was 
carefully removed via pipette and the remaining pellet was lyophilized to dryness. The 
samples were resuspended in MES (10 mM, pH 7.0), NaF (10 mM), acetonitrile (20%), and 
water to a final volume of 20 L. 
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Chapter 3: Effect of Nucleosome Assembly on BisQMAcr’s Alkylation 
 
3.1 Introduction 
Many anticancer drugs, such as the electrophilic compounds temozolomide and the 
nitrogen mustard chlorambucil, damage cellular DNA and induce apotosis of the cancer 
cells.
9, 13
 The effectiveness of DNA alkylating agents is often investigated in vitro using 
DNA that lacks the proteins associated with chromatin. However, this state of DNA does not 
reflect its in vivo environment and may not provide an accurate measure of the clinical 
efficacy of these compounds. Cellular DNA does not exist free in solution, but rather is 
wrapped around octamers containing two copies each of the four core histone proteins (H2A, 
H2B, H3, and H4) to form nucleosome core particles (NCPs).
69-71
 Nucleosome assembly 
alters DNA’s duplex geometry, solvent accessibility, and electrostatic environment. All of 
these factors may alter DNA’s reactivity relative to that in its unpackaged state.
72
 Therefore, 
investigating the potency of DNA alkylating agents within nucleosomes should more 
accurately reflect a compound’s reactivity in a cellular environment and serve as a model 
system for understanding how DNA packaging into chromatin in vivo will affect DNA 
alkylation. 
 The assembly of DNA into the NCP has been shown to alter the profile of DNA 
alkylation of drugs and toxins relative to unpackaged DNA. Compounds that target the minor 
groove, such as mitomycin C and duocarmycin B2 experience suppressed reaction with 
nucleosomal versus free DNA.
73, 74
  However, this suppression is not observed in all minor 
groove alkylating agents, as yatakemycin’s alkylation is unaffected by NCP assembly.
75
 





 and aflatoxin B1 was universally suppressed by the NCP across all 
dGN7s.
76
 The deformation of groove structure and the steric block provided by the histones 
generally limit groove binding and intercalation. On the other hand, some intercalators, such 
as N-(2,3-epoxypropyl)-1,8-naphthalimide, can bind the nucleosomal DNA where the DNA 
helix stretches through the dyad axis.
77
 The yield of DNA alkylation may also be limited by 
competition with the histone proteins for reaction.  For instance, acrolein, an exogenous toxin 
found in the environment as a constituent of cigarette smoke, alkylates the histone proteins in 
addition to DNA.
78
 Unlike most alkylating agents, not only does nucleosome assembly 
influence acrolein’s alkylation, but also acrolein’s alkylation modulates DNA packaging. 
Acrolein’s alkylation of the histones influences nucleosome formation and maintenance by 
preventing histone acetylation and thereby disassembling the nucleosome.
79
 The histones can 




 The reactivity of QMs with nucleosomal DNA has yet to be investigated, despite the 
abundance of studies concerning QMs’ dynamic alkylation of DNA. BisQMAcr has been 
demonstrated to dynamically alkylate DNA free in solution, but how this compound responds 
to DNA packaging has not yet been characterized. Here, we compare bisQMAcr’s DNA 
alkylation profile in free and packaged DNA. Furthermore, how bisQMAcr responds to the 
presence of the histones will be characterized, since few studies have examined the ability of 
ortho-QMs to alkylate proteins. Thus, our work will assess how bisQMAcr may behave in a 
cellular environment by examining its ability to alkylate DNA and histones in the NCP. 
 
3.2 Results and Discussion 
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3.2.1 Effect of Nucleosome Assembly on DNA Alkylation by BisQMAcr 
A NCP generated from Widom’s 601 sequence (Figure 3.1) and Xenopus laevis 
histones H2A, H2B, H3, and H4 expressed in E.coli were chosen to provide a homogeneous 
target for QM reaction. Widom’s 601 sequence of DNA was identified for its ability to form 
a stable NCP with uniform rotational and positional orientation.
81 
Heterologous expression of 
the histone proteins (a generous contribution from Dr. Kun Yang) avoids potential 
contamination by natural histone variants and epigenetic modifications that are present in 
NCPs isolated from endogenous sources. 
 
 
To determine the effect of nucleosome assembly on DNA’s reactivity with QMs, 
DNA free in solution and assembled in NCPs were individually treated with increasing 
concentrations of bisQMPAcr for 24 h. The resulting samples were then treated with 
piperidine to induce fragmentation at sites of dGN7 alkylation, bisQMPAcr’s primary target 
(Figure 3.2A).
40
 Full consumption of the parent duplex DNA occurred with 250 µM of 
bisQMAcr for the free DNA. In contrast, only approximately 10% (based on the band 
Figure 3.1 Sequence of the Widom 601 DNA. The “top” 
strand (black) is radiolabeled as indicated and the positions 
of its guanines that are examined by piperidine-induced 
fragmentation after alkylation are indicated relative to the 
5’-terminus. The complementary strand is shown in gray. 
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intensities of fragmented DNA relative to the total intensity of the lane) of the DNA 
assembled in the NCP was consumed after treatment with 500 µM of bisQMAcr after 24 h. 
The profile of alkylation at dGN7 did not differ significantly in the two different DNA 
targets, as the relative distribution of fragments remained similar, as determined by 
densitometry of the relative signals of the bands. Equivalent alkylation profiles were also 
Figure 3.2 BisQMAcr alkyation of DNA in the absence and presence of histone octamer 
and after assembled into a NCP. A) Samples were treated with increasing concentrations 
of bisQMPAcr (0, 5, 50, 100, 250, 500 µM) at 4 ºC for 24 h and then treated with 
piperidine to identify sites of alkylation. B) Samples were treated with bisQMPAcr (500 
µM) and quenched after 0, 2, 4, 8, and 24 h. The samples were then treated with piperidine 






maintained over the time of reaction (Figure 3.2B). 
Diminished reaction with the NCP may result from weakened DNA binding affinity 
of bisQMAcr or inaccessibility of DNA’s nucleophiles to bisQMAcr’s electrophilic sites. 
DNA in the NCP experiences kinking and bending into the major and minor grooves, which 
impairs binding of other DNA targeting drugs.
82
 BisQMAcr’s alkylation at dGN7 was 
suppressed uniformly throughout the DNA sequence, suggesting that QM access to the DNA 
was not selectively blocked. A uniform suppression of binding to and reaction with DNA in 
the NCP also occurred for several other electrophiles, such as the nitrogen mustards, 
mitomycin C, and benzo[α]pyrene diol epoxide.
72, 73, 83, 84
  
DNA distortion may disrupt the base stacking that permits intercalation of 
bisQMAcr’s acridine ligand. The intercalators ethidium bromide and aflatoxin B1 bind more 
weakly to the NCP than to unpackaged DNA due to changes in DNA’s conformation.
72, 76, 85
 
Inability to effectively bind the NCP would suppress reaction of bisQMAcr because 
intercalation has been postulated to drive its reaction by positioning the electrophiles to react 
with DNA, especially at dGN7s.
40, 41
 Thus, a weakened ability to intercalate with packaged 
DNA may lead to suppressed alkylation of DNA in the NCP. Despite diminished binding and 
reaction with the NCP, some intercalators accumulate at the nucleosome dyad axis, where 
base pair unstacking that arises from minor groove kinking induced by DNA stretching 
creates an opening in the otherwise compact NCP structure. The alkylating agent N-(2,3-
epoxypropyl)-1,8-naphthalimide reacts strongly at the dyad due to increased accessibility for 
its intercalation.
77
 However, the differences in binding and reactivity profiles of these various 
intercalators may reflect differences in the orientation of the electrophiles when bound to the 
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DNA in the NCP. Acridine may still bind the dyad axis, but in a conformation that precludes 
bisQMAcr’s reaction with the DNA. 
The reactivity of DNA with bisQMAcr was examined in the competing presence of 
the histone octamer when not assembled into the NCP to determine the contributions of DNA 
packaging and the added concentration of nucleophiles provided by the histones on 
bisQMAcr’s diminished reactivity with DNA assembled in the NCP relative to DNA free in 
solution. The histones provide additional nucleophiles that can compete with the nucleophiles 
in DNA for reaction with bisQMAcr. Full consumption of the parent DNA after incubation 
with 500 µM of bisQMAcr for 24 h was not detected in the presence of the histone octamer. 
However, the yield of alkylation at dGN7s (~80%) compared more favorably to that 
observed with the unpackaged DNA than that with the NCP (Figure 3.2). Nonspecific 
association of the DNA and the histone octamer is possible in the absence of NCP 
reconstitution, but this did not significantly impact the reaction relative to DNA alone. 
Overall, the DNA packaging into the NCP, rather than competition with the histones, is 
responsible for significant suppression of DNA alkylation by bisQMAcr. 
 
3.2.2 DNA- Protein Crosslink Formation with the NCP   
BisQMAcr has the potential to form DNA- protein crosslinks with the NCP due to 
two electrophiles that can react with any pair of reactive nucleophiles.  To investigate the 
efficiency of DNA-protein crosslinking, the NCP was treated with increasing concentrations 
of bisQMAcr for 24 h. A smear with low electrophoretic mobility appeared on the gel with as 
low as 50 µM of bisQMAcr, with the yield of low mobility products increasing to 
approximately 20% after treatment with 500 µM of bisQMAcr (Figure 3.3). The loss of the 
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products after treatment with proteinase K confirmed their identity as DNA-protein 
crosslinks. The heterogeneity of products suggests an equally heterogeneous array of DNA-
protein crosslinks. 
Other electrophiles have also been reported to form DNA- protein crosslinks, albeit in 
lower yields than that of bisQMAcr. The nitrogen mustards react with over 130 proteins in 
cells to form DNA-protein crosslinks, but few contained the histone proteins.
86
 Similarly, cis-
platin generated DNA-protein crosslinks with 250 proteins in vivo, but only sparse reaction 
with the histones was observed.
87
 The limited formation of DNA-histone crosslinks by 
bisQMAcr and other electrophiles is likely to be beneficial, as an abundance of DNA-protein 
crosslinks could impair cellular functions. 
BisQMAcr most likely generates DNA-protein crosslinks in the NCP by direct 
nucleophilic addition to both of its electrophiles. However, recent studies have demonstrated 
Figure 3.3 Formation of DNA-histone crosslinks with the NCP after treatment 
with bisQMAcr. Individual samples of the NCP were treated with the indicated 
concentrations of bisQMPAcr at 4 º C and quenched after 24 h by freezing in 
liquid N2. Samples were then thawed for 5 min at room temperature and divided 
into two sets. One set was analyzed directly, and the second set was treated with 
proteinase K (2 µL, 1.6 U) for 15 min at room temperature. All samples were 






that DNA-protein crosslinks can result from nucleophilic reaction of lysines from the histone 
tails with abasic sites that may be generated by depurination of alkylated dGN7s.
88
 
Nucleosome assembly significantly suppresses depurination of alkylated dGN7s relative to 
that in free DNA.
89
 Thus, the crosslinks that we observe most likely result from bisQMAcr’s 
bifunctional alkylation. 


















I TESSK H2A 
121-125 
MonoQM 948.3704 948.4460 Yes Yes 







MonoQM 728.2477 728.3990 No No 
III IAGEASR H2B 
74-80 
MonoQM 1100.3669 1100.5522 No Yes 
IV SAK H2A 
126-128 
BisQM 715.1870 715.3615 No Yes 
V DIQLAR H3 
124-129 
BisQM 1126.3824 1126.3734 No No 
Scheme 3.1. Structure of the tert-butyl dimethylsilyl-protected precursor to monoQMAcr. 
Table 3.1 QM-peptide adducts observed from alkylation of histone octamer and NCP. 
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Figure 3.4 Peptides detected by UPLC-MS after trypsin digestion of the histone 
octamer. Sequences highlighted in yellow represent peptides that were detected prior to 
bisQMAcr treatment and underlined sequences represent peptides that were detected 
after treatment with bisQMAcr. Spacing indicates the fragments expected from trypsin 
digestion. 
The formation of DNA-protein crosslinks by bisQMAcr with the NCP indicates that 
bisQMAcr alkylates the histone proteins. To determine where and which residues bisQMAcr 
alkylates, we examined QM-treated histones by UPLC-MS. However, monoQMAcr (Scheme 
3.1), the monofunctional analogue of bisQMAcr, was initially used to identify the possible 
sites of QM modification of the histones without the complications of bifunctional alkylation. 
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The histone octamer, rather than the NCP, was initially used to identify the total number of 
sites of histone alkylation. The histone octamer was treated with monoQMAcr (500 µM) for 
24 h, before the histones were digested with trypsin. Six new species were observed by 
UPLC-MS analysis following treatment with monoQMAcr when compared with the digested 
histones in the absence of monoQMAcr treatment (Figure 3.4, 3.5A, and Table 3.1). The 
Figure 3.5 Peptide-monoQMAcr adducts formed with the histone octamer. A) Total 
ion count was monitored during elution of the peptides before (black) and after (red) 
reaction with monoQMAcr. Signals unique to the alkylated samples are labeled 
according to Table 3.1. Signals labeled with “0” do not contain [M+H]
+ 
values that 
correspond to a QM adduct or peptide fragment. Peptide coverage by this analysis is 
summarized in Figure 3.4. B) MS
2
 spectrum of the adduct formed between 
monoQMAcr and TESSK of histone H2A (Table 3.1, entry I). C) MS
2
 spectrum of the 
adduct formed between monQMAcr and RR (Table 3.1, entry II). D) MS
2
 spectrum of 






QM-H2O adduct formed by quenching of monoQMAcr by solvent. The two products labeled 
“0” were observed in the presence, but not absence of monoQMAcr, but did not correspond 
to histone adducts. The remaining products, labeled “I-III”, represent alkylated peptides with 
parent ions that correspond to the combined mass of monoQMAcr and the amino acid 
sequence corresponding to a histone peptide. Signals corresponding to alkylated peptides 
were recognized by the presence of secondary ions in the mass spectra that corresponded to 
monoQMAcr, as well as a characteristic fragment of 9-aminoacridine. MonoQMAcr 
alkylated TESSK and IAGEASR, which are unique to histones H2A and H2B, respectively 
(Figure 3.5B, D, and Table 3.1, entries I and III). The third adduct contains RR, and may be 
derived from multiple sites in histones H2B, H3, and H4 (Figure 3.5C and Table 3.1, entry 
II).  
The analogous experiment was then performed with bisQMAcr to determine its sites 
of alkylation on the histone octamer. BisQMAcr is capable of reacting with one histone 
nucleophile and water, or with two histone nucleophiles. Two products were identified that 
contain peptides and bisQMAcr (Figure 3.6A). BisQMAcr alkylated SAK and DIQLAR 
from histones H2A and H3, respectively (Table 3.1, entries IV and V and Figure 3.6B, C). 
Interestingly, these sites are not identical to the sites of reaction observed for monoQMAcr. 
The lack of common sites of reaction between monoQMAcr and bisQMAcr may indicate 
sensitivity to the orientation of the reactants. Our data indicated reaction of bisQMAcr with 
individual peptides at one of the benzylic positions. The species that reacted at the second 




Both QMs formed few adducts with the histones, with monoQMAcr generating 
slightly more adducts than bisQMAcr. Previous reports have demonstrated that both para- 
and ortho-QMs react favorably with cysteine’s highly nucleophilic thiol side chain.
90, 91
 
However, the presence of only a single cysteine in the NCP and its general inaccessibility 
may explain why no reaction between cysteine and monoQMAcr and bisQMAcr was 
A 
B C 
Figure 3.6 Peptide-bisQMAcr adducts formed with the histone octamer. A) Total ion 
count was monitored during elution of the peptides before (black) and after (red) 
reaction with bisQMAcr. Signals unique to the alkylated samples are labeled 
according to Table 3.1. Signals labeled with “0” do not contain [M+H]
+ 
values that 
correspond to a QM adduct or peptide fragment. Peptide coverage by this analysis is 
summarized in Figure 3.4. B) MS
2
 spectrum of the adduct formed between bisQMAcr 
and SAK of histone H2A (Table 3.1, entry IV). C) MS
2
 spectrum of the adduct formed 





observed. The next most reactive side chain, lysine’s side chain amine, was an expected 
target for QM alkylation, especially in the lysine-rich N-terminal histone tails. Adducts with 
lysine may be too labile for detection by UPLC-MS conditions, as has been noted for 
previous studies of para-QMs.
92
 We were not able to assign the exact residue of QM 
alkylation within an identified peptide due to the loss of the QM during MS
2
 analysis. The 
most nucleophilic site within the peptides from products I, III, and IV is serine, while the 
only possible side chain in product II is arginine. Both amino acids are weakly nucleophilic 
under physiological conditions, and do not seem likely targets of QM alkylation. The 
carboxylate side chain in product V presents the only possible nucleophile for alkylation, but 
QM-carboxylate adducts are typically quite labile. The QM could alkylate lysines and 
arginines at the C-termini of the identified peptides, but alkylation at these sites is expected 
to prevent cleavage by trypsin. However, exceptions have been reported that demonstrate 
cleavage by trypsin at glycinylglycinyl-lysines due to the presence of a positive charge that 
affords recognition by trypsin.
93
 
Despite the abundance of both enzymatic and nonenzymatic electrophilic 
modifications reported to occur on the histone tails, monoQMAcr and bisQMAcr were not 
observed to react with residues on the tails, but rather with residues that are in both surface 
and interior regions of the histone octamer core (Figure 3.7).  This site preference likely 




To determine the effect of nucleosome assembly on protein alkylation, the 
reconstituted NCP was first treated with monoQMAcr for 24 h, followed by digestion with 
trypsin.  Only the adduct at TESSK on histone H2A was observed (Figure 3.8A and Table 
3.1, entry I).  Treatment of the NCP with bisQMAcr revealed a similar trend in the alkylation 
profile, no identifiable protein adducts were observed (Figure 3.8B).  Specific sites of histone 
reaction are suppressed in the NCP relative to that with the unassembled histone proteins.  
Hence, both DNA and protein reaction with QMs are affected by nucleosome assembly. 
 
Figure 3.7 Location of protein adducts formed in the NCP (PDB: 




Figure 3.8 Peptide-QM adducts formed with the NCP after treatment with A) 
monoQMAcr or B) bisQMAcr. Total ion count was monitored during UPLC-MS 
separation and analysis of NCP treated alternatively with each QM under conditions 
equivalent to those used to modify the histone octamer. DNA was degraded prior to 
trypsin treatment by digestion with benzonase. Untreated samples are indicated in black 
and those treated with QM are indicated in red. Signals corresponding to peptide-QM 
adducts are labeled according to Table 1. Signals labeled with “0” are only evident after 
QM exposure, but their [M+H]
+
 values do not correspond to a QM adduct or peptide 
fragment. All unlabeled signals represent tryptic peptides from the histones. 
 
3.2.4 Nucleosome Assembly After Exposure to BisQMAcr.  
Nucleosome assembly is a dynamic process that has the potential to expose both 
DNA and the histones to electrophilic modification. To determine whether bisQMAcr’s DNA 
alkylation affects NCP assembly, the unpackaged DNA was first treated with bisQMAcr 
(250 µM) for 24 h. Excess bisQMAcr was removed via gel filtration chromatography before 
subjection to reconstitution with the histone octamer. The NCP was assembled in 25% yield, 
while 75% of the DNA remained in its unpackaged state, as determined by quantification of 
the radiolabeled DNA by phosphorimagery (Figure 3.9A).  In contrast, reconstitution of the 
NCP using unmodified DNA occurs in greater than 95% yield (Appendix C, Figure C.1). 
Assembly of the NCP with DNA that has been incubated with bisQMPAcr in the absence of 
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Figure 3.9 Reconstitution of the NCP after alternative treatment of the Widom 601 DNA 
with bisQMPAcr in the A) presence or B) absence of sodium fluoride, and the C) histone 
octamer with bisQMAcr. Lanes labeled as DNA contain DNA prior to reconstitution and 
lanes labeled NCP contain the products generated after reconstitution with the histone 
octamer. The relative distribution of species separated by native PAGE (6%) was measured 
by phosphorimaging the [
32
P]-labeled DNA. 
A B C 
fluoride results in similarly high yields of NCP formation (Figure 3.9B). Thus, bisQMAcr’s 
covalent modification of DNA, rather than acridine’s intercalation, significantly impairs its 
reconstitution to form the NCP. 
BisQMAcr’s ability to impair nucleosome assembly may stem from distortions of the 
DNA helical structure after alkylation that prevent wrapping of the DNA around the histones. 
Other bulky forms of DNA damage, such as pyrimidine photodimers caused by UV 
irradiation, impair reconstitution of the NCP by unwinding the DNA double helix.
94  
DNA 
that is unwound may be more susceptible to modification by bisQMAcr. Alkylation of 
unpackaged DNA by bisQMAcr will then hamper its ability to assemble into nucleosomes, 
which may alter regulation and expression of the genome.  
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To determine whether alkylation at specific DNA sites may reconstitute preferentially 
over others, the alkylated DNA used to reconstitute the NCP was separated by native PAGE. 
The samples were then treated with piperdine to detect sites of alkylation at dGN7.  The data 
revealed a decreased yield of DNA alkylation in both of the samples that were incubated for 
over 8 h during reconstitution and gel separation relative to the sample that was immediately 
treated with piperidine (Figure 3.10).  This difference in yield likely results from the 
reversibility of alkylation at dGN7, which permits transfer and quenching of the bisQMAcr 
Figure 3.10 Profile of piperidine-induced fragmentation of DNA 
after NCP reconstitution. The NCP was reconstituted under standard 
conditions using DNA treated with bisQMAcr for 24 h. DNA free in 
solution and reconstituted in the NCP were separated by and 
extracted from native PAGE (6%). The treated DNA prior to 
reconstitution (lane 1), the free DNA after reconstitution (lane 2), 
and the reconstituted DNA after proteinase K treatment (lane 3) 
were treated with piperidine. The resulting fragments were separated 
by denaturing PAGE (10%) and visualized by phosphorimagery. 
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adduct with water during reconstitution. A lower yield of alkylation was observed for the 
sample that reconstituted than for the sample that remained unpackaged, which may indicate 
that a mixture of unmodified DNA and some of the alkylated DNA assembled, while the 
remaining alkylated DNA remained unassembled. In addition, no preferential tolerance for 
alkylation at specific sites along the NCP was apparent from the similarities in sites of 
alkylation between the two samples. 
To compare the effect of DNA alkylation on NCP assembly with that of histone 
alkylation, the histone octamer was incubated with bisQMAcr (500 µM) for 24 h before 
removal of excess QM and reconstitution with unmodified Widom 601 duplex DNA.  
Reconstitution was not impeded, as the NCP was assembled in a comparable yield to that of 
assembly of unmodified DNA and histone octamer (Figure 3.9C).  Hence, only DNA, but not 
protein, alkylation by bisQMAcr affects the assembly of the NCP.  
 
 3.2.5 Transfer of QM Alkylation from DNA to Histone Octamer.   
BisQMAcr’s reversible alkylation of dGN7 permits the QM to transfer to alkylate 
water or other nucleobases within DNA.
42, 43
 The nucleophiles within the histones have the 
potential to capture the QM once released from its initial adduct with dGN7. To determine if 
QMs can transfer their alkylation between DNA and the histones, unpackaged Widom 601 
duplex DNA was treated with monoQMAcr (500 µM) for 24 h, followed by incubation with 
the histone octamer for an additional 24 h. The histones were then digested with trypsin and 
analyzed by UPLC-MS (Scheme 2).  The monoQMAcr adducts of TESSK and IAGEASR 
(Table 3.1, entries I, III), but not RR (Table 1, entry II) were detected (Figure 3.11A).  The 
experiment was then performed with bisQMAcr, which revealed a similar trend to that of 
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monoQMAcr.  BisQMAcr transferred to alkylate SAK (Table 3.1, entry IV), but not 
DIQLAR (Figure 3.11B and Table 3.1, entry V).  In addition, water competed with the 
histones to quench both QMs upon their release from the DNA, as evidenced by detection of 
the QM-H2O adduct.  
The transfer of QM adducts from DNA to the histones may suggest a sacrificial role 
for the histone proteins as terminal acceptors of the QM’s alkylation to essentially repair the 
DNA adducts. Our results indicated that bisQMAcr’s modification of the histone octamer did 
not impair its ability to form NCPs. Thus, the modified histones would likely support NCP 











 We have characterized the response of bisQMAcr to DNA packaging and the 
presence of the histone proteins by investigating its reactivity with the NCP. The NCP 
provides a protective function against DNA modification by bisQMAcr since bisQMAcr’s 
alkylation was significantly suppressed with the NCP compared with DNA free in solution. 
DNA packaging, rather than competing nucleophiles provided by the histones, resulted in 
bisQMAcr’s suppressed DNA alkylation. The NCP also fosters protection against QM-
induced DNA damage by using the histones as sacrificial terminal acceptors of QM 
intermediates that are released from the DNA. This phenomenon essentially functions to 
repair the QM-DNA adducts. Our data suggests that the subsequent modification of the 
histone octamer by the QMs will likely not affect its ability to assemble into NCPs. On the 
A B 
Figure 3.11 Transfer of A) monoQMAcr and B) bisQMAcr from DNA to the histone 
octamer. Widom 601 duplex DNA (0.030 µM) and salmon sperm DNA (2.47 µM) 
were treated alternatively with each QM (500 µM) for 24 h at room temperature. 
Excess QM and its low molecular weight products were removed from the DNA by 
using a Bio-Rad P6 spin column. The isolated DNA was then added to the histone 
octamer (2.5 µM) and incubated for 24 h at 4 ºC. Samples were subsequently 
digested with benzonase and trypsin and analyzed by UPLC-MS. Signals 




other hand, bisQMAcr’s alkylation of unpackaged duplex DNA significantly impeded 
nucleosome assembly, as only 25% of the alkylated DNA reconstituted with the histone 
octamer to form NCPs. BisQMAcr’s preferential alkylation of unpackaged DNA may impair 
its assembly into nucleosomes in vivo. The NCP was also shown to foster toxicity by reacting 
with bisQMAcr to form DNA-histone crosslinks. DNA-histone crosslinks may interfere with 
cellular functions, and result in QM-induced toxicity to cells. This is the first report of 
bisQMAcr’s reactivity with proteins, as the compound was developed as a DNA crosslinking 
agent. Our data suggests that the acridine ligand, originally designed to increase bisQMAcr’s 
affinity for DNA, may also direct its reaction with proteins by binding to hydrophobic 
surfaces. Overall, our characterization of bisQMAcr’s reactivity with the nucleosome core 
particle suggests that the greatest impact of QMs on chromatin will likely occur in the linker 
regions of DNA that are free from the protection afforded by the NCP. 
 
3.4 Materials and Methods 
 3.4.1 Materials 
Oligonucleotides were synthesized by Integrated DNA Technologies with standard 
desalting and were purified by 20% denaturing PAGE prior to use.  BisQMPAcr was 
prepared as described previously.
40
 MonoQMPAcr was provided by Dr. Blessing Deeyaa. 
The Widom 601 DNA was ligated from 30- 35 base pair oligonucleotides and the top strand 
was radiolabeled at its 5’- end with [
32
P] as described previously.
81, 95
 The core histone 
proteins (Xenopus laevis) were expressed in Escherichia coli and assembled in vitro into the 
native histone octamer under standard conditions by Dr. Kun Yang from Prof. Marc 
Greenberg’s lab.
96
 T4 polynucleotide kinase, T4 DNA ligase, and proteinase K were obtained 
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from New England Biolabs. Benzonase and trypsin (powder, Bovine pancreas) were 
purchased from Sigma.  γ- 
32
P-ATP was purchased from Perkin Elmer. C18-Sep Pak 
cartridges were purchased from Waters Corp. Salmon sperm DNA (10 mg/mL) was 
purchased from Invitrogen.  Amicon Ultra centrifugal filters with a 10,000 molecular weight 
cutoff were purchased from Millipore.   
 
 3.4.2 Methods 
General Procedures. All reactions and digestions were conducted in siliconized 
tubes that were purchased from Bio Plas Incorporated.  Radiolabeled oligonucleotides were 
detected and quantified using a Typhoon 9400 phosphorimager and ImageQuant TL 
software.  Oligonucleotide concentrations were calculated from their absorption at 260 nm 
and extinction coefficients that were provided by the manufacturer. Histone concentrations 




Ligation of the 601 Sequence DNA for Reconstitution of the Nucleosome Core 
Particle.
95
 Oligonucleotides (1.5 nmol each) (Appendix C, Figure C.2) were enzymatically 
phosphorylated at their 5’- termini, each in separate 50 µL reactions containing 1x T4 DNA 
ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP) and 5 µL 
of T4 polynucleotide kinase (50 U) at 37° C for 1 h. The solution was then heated at 65°C for 
20 min to inactivate the enzyme. The phosphorylated oligonucleotides were mixed with the 
unphosphorylated 5’- end oligonucleotides (1.5 nmol) and 2 nmol of the corresponding 
scaffold strands.  Hybridization was carried out by heating the resulting mixture at 95° C for 
2 min followed by slow cooling to room temperature. 3 µL of T4 DNA ligase (1200 U) and 5 
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µL of 10x T4 DNA ligase buffer were added to the solution containing the hybridized strands 
(200 µL total volume).  The ligation was incubated at 16°C overnight. The DNA in the 
ligation reaction was extracted with phenol (equal volume) and precipitated from 0.3 M 
NaOAc pH 5.2.  The ligated products were purified by 8% denaturing PAGE and the desired 
bands were excised from the gel. The DNA was eluted from the gel in 1 mL of elution buffer 
(0.2 M NaCl and 1 mM EDTA) overnight.  The slurry was filtered, concentrated to 
approximately 75 µL, and washed two times with 400 µL of water. The concentration of the 
ligated products was determined by their absorption at 260 nm.    
5’- [
32
P] Radiolabeling and Hydridization of the Widom 601 Duplex DNA.
 
The Widom 
601 DNA top strand  was 5′- 
32
P-labeled in a 50 µL reaction mixture containing 20 pmol  of 
Widom 601 DNA “top” strand, 1 x T4 polynucleotide kinase buffer (70 mM Tris-HCl pH 
7.6, 10 mM MgCl2, 5 mM DTT), 40 µCi of γ- [
32
P]-ATP, and 50 U of T4 Polynucleotide 
Kinase (5 µL) at 37 °C for 4 h. Unincorporated γ-[
32
P]- ATP was removed by passing the 
reaction mixture through a Bio-Rad P6 spin column prewashed with water (1000 g, 4 min).  
To the mixture was added the complementary strand of Widom 601 DNA (30 pmol), NaCl 
(0.1 M), and potassium phosphate buffer (10 mM, pH 7.2) to yield a total volume of 80 µL.  
This mixture was heated at 95 °C for 2 minutes and slowly cooled to room temperature (2- 3 
h).    
 
Reconstitution of the Nucleosome Core Particle.
95
 The preassembled histone octamer (84 
pmol) in 2 M NaCl (1 µL) was added to a solution of salmon sperm DNA (84 pmol) and 5’-
[
32
P]-radiolabeled Widom 601 duplex DNA (~1 pmol) in 2 M NaCl, 10 mM HEPES pH 7.8, 
and 1 mM EDTA (10 µL) with 1 mg/mL BSA. The mixture was then incubated for 1 h at 
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room temperature before serial dilution with nucleosome reconstitution buffer (10 mM 
HEPES pH 7.5, 1 mM EDTA, and 1 mg/mL BSA) as indicated below and incubated for the 
designated time. Dilutions were as follows (dilution number: volume of buffer added in µL, 
incubation time in min): 1:12, 60; 2:6, 60; 3:6, 60; 4:10, 30; 5:10, 30; 6:20, 30; 7:50, 30; 
8:100, 30.  After the final dilution (224 µL total volume), a small aliquot (5 µL) was removed 
and analyzed by native gel electrophoresis (6% acrylamide/bis(acrylamide), 59:1, 0.6 x TBE) 
to determine the reconstitution efficiency. The final solution was stored at 4 ºC until use. 
 
Treatment with BisQMAcr. 5’-[
32
P]-radiolabeled Widom 601 duplex DNA (0.08 pmol) in 
the alternative presence and absence of the histone octamer (5.6 pmol) was added to a 
solution of salmon sperm DNA (5.6 pmol) in 10 mM MES, 10 mM NaF, 7.5 mM HEPES, 
0.75 mM EDTA, 0.75 mg/mL BSA and 67 mM NaCl at pH 7.0.  An equivalent concentration 
of reconstituted NCP was supplemented with 10 mM MES pH 7.0 and 10 mM NaF to 
maintain similar solvent conditions.  BisQMPAcr, in acetonitrile, was added to the three 
individual samples above to generate a constant 20% solution. Samples (20 µL) were 
incubated at 4 ºC for 24 h. Samples were treated with proteinase K (1.6 U) for 15 min at 
room temperature just prior to quenching by freezing in liquid nitrogen. 
 
Piperidine Treatment of Alkylated DNA. Frozen samples treated with bisQMP above were 
lyophilized and dissolved in 5% piperidine (10 µL). The solutions were heated at 90 ºC for 
30 min and then lyophilized. To remove residual piperidine, samples were dissolved in water 
(30 µL) and lyophilized in three consecutive repetitions.  Samples were dissolved in water 
(10 µL) and formamide containing bromophenol blue and xylene cyanol (10 µL). Samples 
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were analyzed by 10% denaturing PAGE using 42 x 20 x 1 cm gel plates that were run at 65 
W until the bromophenol blue dye migrated three-quarters of the gel length. 
 
Protein Adducts Detected by Liquid Chromatography-Mass Spectrometry. Equal 
concentrations of the histone octamer and reconstituted NCP in 10 mM HEPES, 1 mM 
EDTA, 1 mg/mL BSA, and 89 mM NaCl were individually combined with of 10 mM MES 
pH 7.0 and 10 mM NaF.  The mixtures were treated alternatively with monoQMPAcr or 
bisQMPAcr (500 µM) in acetonitrile to a final volume of 20 µL with 20% acetonitrile, and 
incubated at 4 ºC for 24 h. Samples containing the NCP were subsequently treated with 
benzonase (250 U) for 30 min at 37 ºC. All samples were then lyophilized, resuspended in 
3.6 M guanidine-HCl, 50 mM Tris-HCl pH 7.2, and 2 mM DTT to a final volume of 20 µL, 
and heated at 65 °C for 45 min to denature the protein.  Samples were subsequently diluted 
with 1 mM CaCl2 and 50 mM Tris-HCl pH 7.2 to a final volume of 75 µL. Trypsin (in 111 
mM potassium phosphate buffer pH 7.4) was added to generate a final trypsin to histone ratio 
of 1:20 and incubated at 37 °C for 24 h.  The resulting peptides were desalted using a C18 - 
Sep Pak and eluted with 50% aqueous CH3CN and 0.1% formic acid and analyzed by UPLC-
MS on an Acquity UPLC H-Class/Xevo G2 QTof from Waters equipped with a 2.1 mm x 
100 mm HSST3-C18 column (1.7 µm pore size). Sample separation was accomplished with 
an initial 5% aqueous CH3CN solution with 0.1% formic acid for 1 min, followed by a linear 
gradient to 40% aqueous CH3CN over 36 min, and then to 95% aqueous CH3CN for 3 min 
with a flow rate of 0.3 mL/min. Mass spectra were acquired in the ESI positive ion mode 
with MS
E
 using a capillary voltage of 3 kV, a sample cone voltage of 30 V, and an extraction 
cone voltage of 4 V.  The cone gas flow was set up to 30 L/h and desolvation gas flow was 
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800 L/h.  Desolvation temperature and source temperature were set to 400 °C and 150 °C, 
respectively.  The scan acquisition rate was 10 Hz over a range of m/z 100-3000. MassLynx 
and BioPharmaLynx software were used to analyze the resulting data. 
 
Reconstitution of the Nucleosome Core Particle with Alkylated DNA. 5’-[
32
P]-
radiolabeled Widom 601 duplex DNA (1 pmol) and salmon sperm DNA (84 pmol) were 
incubated with bisQMPAcr (250 µM) in 10 mM MES pH 7.0 and 10 mM NaF for 24 h at 
room temperature. Excess bisQMPAcr and its low molecular weight products were removed 
by passing the reaction mixture through a Bio-Rad P6 spin column prewashed with water 
(1000 g, 4 min).  The eluant was lyophilized, resuspended in 5 µL of H2O, and used for 
nucleosome reconstitution as described above for the parent unmodified DNA. 
 
Reconstitution of the Nucleosome Core Particle with Alkylated Histone Octamer. 
BisQMPAcr (250 µM) was incubated with the histone octamer (84 pmol) in 2 M NaCl, 10 
mM MES pH 7.0, and 10 mM NaF for 24 h at 4 °C.  The reconstitution was then performed 
as described above for the alkylated DNA. 
 
Distribution of Alkylated DNA after NCP Reconstitution. Solutions of NCP reconstituted 
with alkylated DNA described above were concentrated to 30 µL at 4 °C using a 0.5 mL 
Amicon Ultra centrifigal filter with a molecular weight cutoff of 10,000 Da. DNA associated 
with reconstituted NCP and the remaining free DNA were separated by native PAGE (6%, 
acrylamide/(bis)acrylamide, 59:1, 0.6 × TBE buffer) using a running buffer of 0.2 x TBE and 
200 V (1 h, 4 ºC).  The DNA species were detected by phosphorimagery and extracted from 
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the gels by excision, maceration, and finally immersion in 2 mL of elution buffer (0.2 M 
NaCl, 1 mM EDTA) overnight at 4°C.  Solid material was removed by passage through a 
Bio-Rad Poly-Prep column and the eluant was lyophilized.  The isolated DNA was treated 
with proteinase K (1.6 U) for 15 min at room temperature, heated with piperidine for 
cleavage at sites of guanine N7 alkylation, and analyzed as described above. 
 
Transfer of MonoQMAcr and BisQMAcr from DNA to the Histones. MonoQMPAcr and 
bisQMPAcr (500 µM) were alternatively incubated for 24 h at room temperature with duplex 
601 DNA (0.03 µM) and salmon sperm DNA (2.47 µM) in 10 mM MES pH 7.0 and 10 mM 
NaF.  Excess QM and its low molecular weight products were removed from the DNA by 
passage through a Bio-Rad P6 spin column prewashed with water (1000 g, 4 min). Histone 
octamer (2.5 µM) in 10 mM HEPES pH 7.8, 1 mM EDTA, 1 mg/mL BSA, and 89 mM NaCl 
was added to the resulting DNA and incubated at 4 ºC for 24 h. Samples were then digested 












Chapter 4: Effect of QM-DNA Crosslinks on Primer Extension 
by DNA Polymerases 
 
4.1 Introduction 
DNA ICLs are commonly considered absolute blocks to DNA replication. ICLs 
prevent the necessary separation of DNA’s strands by helicases and polymerases during 
DNA replication. Thus, ICLs inhibit DNA replication by preventing the action of the 
enzymes that move along DNA to transmit its genetic information. Further, ICLs also block 
the activity of RNA polymerases, which impairs gene expression. However, reversible DNA 
ICLs may not be resistant to the action of the enzymes involved in replication, since these 
enzymes generate mechanical force while moving along DNA. Determining whether 
bisQMAcr’s DNA crosslinks block the action of DNA replication enzymes will address the 
potential toxicity of a reversible ICL on cells by elucidating the effect of the ICL on DNA 
replication. 
DNA polymerases process DNA during both replication and repair to ensure the 
integrity of the genome. Polymerases must balance fidelity with processivity to synthesize 
DNA both quickly and with the correct sequence.
97, 98
 Several DNA polymerases across 
different forms of life, such as DNA polymerase I from E.coli, φ29 DNA polymerase from 
bacteriophage φ29, and DNA polymerase ε from eukaryotes, possess exonuclease activity in 
addition to DNA synthesis activity.
99
 Exonuclease activity functions as a proofreading 
mechanism by allowing the polymerases to excise misincorporated bases before synthesizing 
the correct DNA sequence using their polymerase activity (Figure 4.1). Proofreading 
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improves fidelity by correcting mistakes that may arise due to the quick speed of replication 
required to permit sufficient processivity. Misincorporation rates for replicative polymerases 




 errors/base pair replicated, which is a testament to the delicate 
balance of processivity and quality of replication that is achieved by polymerases.
100
 The 
mechanism of DNA and dNTP binding to DNA polymerases is tightly coordinated to ensure 
faithful replication in a quick manner. The enzyme first binds a single-stranded DNA primer 
before then binding the incoming dNTP.
1
 Fidelity of dNTP binding is ensured by shape 
complementarity and hydrogen-bonding interactions of the dNTP with the polymerase-DNA 
primer/template complex.
101, 102
 Furthermore, amino acid residues in the active site serve as a 
Figure 4.1 Partitioning between DNA polymerase and exonuclease activities. 
When DNA polymerases incorporate an incorrect nucleotide (red X), the 
polymerase changes conformation to allow its exonuclease active site to 
remove the incorrect base, before DNA synthesis continues using the 







steric gate to exclude incorrect dNTPs from binding. The Klenow polymerase, a fragment of 
DNA polymerase I that lacks 5’-3’ exonuclease activity, but still possesses polymerase and 
3’-5’ exonuclease activities, contains a glutamate in its active site that precludes incorrect 
dNTPs from binding.
103
 The steric gate not only precludes mismatched dNTPs, but may 
prevent synthesis of DNA containing bases with bulky lesions. The phosphoric acid 
anhydride bonds of the incoming dNTP must then be hydrolyzed to incorporate the dNMP, 
with the energy produced from release of the pyrophosphate aiding the polymerase’s 
movement along DNA to the next nucleotide.  
DNA polymerases will encounter DNA lesions if damage is not repaired prior to 
replication.
104
 The DNA will either be replicated successfully, mutated, or not replicated, 
depending on the interactions of the lesion with the polymerase. In addition, different 
polymerases process DNA lesions differently.
105-107
 For example, DNA adducts formed by 
the enediyne neocarzinostatin block full primer extension by the Klenow, T4, and herpes 
simplex virus DNA polymerases.
108
 However, each polymerase processes the lesion 
uniquely, as Klenow polymerase stops synthesis one base before the adduct, while the 
Klenow Exo
-
 polymerase synthesizes an additional nucleotide at the site of the adduct. Other 
lesions, such as deaminated nucleobases or abasic sites, do not always impair DNA 
polymerases and may facilitate incorporation of a new nucleotide. However, the fidelity of 
incorporation often suffers. For instance, the translesion synthesis polymerase, DNA 
Polymerase η, bypasses O
2
-alkylthymidine lesions, but misincorporates deoxycytidine upon 
encountering the lesions.
109 
Despite the diversity of DNA lesions whose effects on DNA synthesis by 
polymerases have been investigated, few investigations concerning reversible DNA lesions 
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have been conducted. However, reversible acrolein adducts on guanine and adenosine 
prevent DNA synthesis beyond the adducts by the replicative eukaryotic polymerase Pol δ 
and Pol ε, but do not inhibit adduct bypass by the translesion synthesis (TLS) polymerases 
Rev1, Pol κ, and Pol γ.
110
 Acrolein’s DNA adducts do not cause mutagenicity in mouse and 
human cells as a result of their bypass by TLS polymerases.
111
 BisQMAcr’s reversible 
chemistry may also permit bypass of its lesions by DNA polymerases, especially if the QM 
regenerates from its DNA adducts upon encountering the polymerase. Previous studies 
demonstrated that an N-methylquinolium QM’s DNA lesions caused extensive stops in 
primer extension by the T7 DNA polymerase.
112
 However, the QM’s adducts were 
irreversible adducts with dGN2.
113
 Reversible QM-DNA adducts may affect the polymerase 
differently than irreversible QM-dGN2 adducts. Reversible adducts may not only permit 
polymerase bypass, but they may also be subject to polymerase-mediated migration along 
DNA. A polymerase may stall at the lesion until the QM regenerates. If so, the polymerase 
may continue its activity along the DNA sequence and cause the QM to alkylate the DNA 
further downstream. Otherwise, the polymerase may promote hydrolysis of the QM to break 
its DNA adducts.  
The Klenow fragment of DNA polymerase I has seen widespread use in primer 
extension synthesis of damaged and undamaged DNA templates due to its high fidelity and 
processivity, as well as its ease of handling.
113-116
 In addition, mutations to its exonuclease 





 Thus, the Klenow Exo
- 
polymerase may be an ideal candidate 
enzyme to facilitate bisQMAcr’s migration along DNA, since it cannot excise QM-DNA 
adducts through its proofreading mechanism.  
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The φ29 DNA polymerase may also facilitate bisQMAcr’s migration since it 
functions as a pseudo polymerase-helicase. The φ29 polymerase possesses strand 
displacement activity in addition to polymerase and exonuclease activities.
115
 Helicase 
activity may facilitate dissociation of DNA ICLs more easily than with a polymerase that 
lacks this capability. However, a reversible DNA ICL formed between an abasic site (AP) 
and the N6 position of adenine (dAN6) remained stable in the presence of the φ29 
polymerase and blocked primer extension beyond the lesion. The AP-dAN6 ICL is nominally 
reversible, as its half-life is 84 h within duplex DNA.
119
 Thus, the reversibility of this ICL 
may be too slow to permit its modulation by the φ29 polymerase. BisQMAcr’s adducts with 
GN7 regenerate with a half-life of 2 h with dG nucleosides, and may regenerate even more 
quickly within duplex DNA.
37
 BisQMAcr’s DNA ICLs may be reversible on a time scale 
that is similar to that of φ29 polymerase’s action along DNA, since bisQMAcr transfers it 
adducts between complementary DNA strands in as few as 4 h.
41
 
BisQMAcr’s greatest impact on a biological system will likely occur on DNA that is 
free from the histones, since nucleosome assembly significantly suppressed its DNA 
alkylation.
120
 DNA replication presents a scenario during which cellular DNA is free from 
the protective function of nucleosomes and may be a more efficient target for bisQMAcr’s 
alkylation. How DNA polymerases respond to reversible bisQM DNA ICLs and the effect of 
the polymerase’s action on the ICLs, as described below, begins to address the potential 
effects of QMs on DNA replication.  
 
4.2 Results and Discussion 
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4.2.1 Primer Extension by the Klenow Exo
-
 and φ29 DNA Polymerases in the Presence 
of a BisQMAcr DNA Crosslink  
 To determine whether a DNA polymerase will modulate migration of bisQMAcr’s 
crosslink along DNA, the integrity of bisQMAcr’s DNA ICL was assessed following primer 
extension by the Klenow Exo
-
 polymerase to determine whether the ICL was broken apart 
due to hydrolysis of the QM. BisQMAcr’s crosslink was formed through transfer of its intra-
strand crosslink to an inter-strand crosslink in order to localize the adducts to the 5’-end of 
the template strand (Scheme 2.1A) .
41
 This localization of the crosslink provides a stretch of 
nucleotides between the adduct and the 3’-end of the primer for the polymerase to begin 
DNA synthesis. Furthermore, intra- to inter-strand transfer ensures a high yield of DNA 
crosslinks rather than monoadducts, since bisQMAcr was reported to form 4 monoadducts 
for every one crosslink of duplex DNA.
40
 BisQMAcr’s adducts were initially trapped by 
reacting with the G-rich sequence OD11 for 24 h. Excess QM was removed via a gel 
filtration spin column before addition of the complementary sequence [
32
P]-OD12 for an 
additional 24 h. A ternary complex was formed by addition of the primer OD10, followed by 
initiation of primer extension via addition of dNTPs and the polymerase (Figure 4.2A). The 
crosslink did not dissociate and remained intact over 8 h of incubation with the polymerase 
(Figure 4.2B). The Klenow Exo
-
 polymerase has also been reported to fail to extend primers 
beyond oxidized abasic sites and dG-C8-(acetylamino)fluorene lesions.
116, 121
The precedent 
for aborted primer extension suggests that the polymerase may also abort synthesis in the 
presence of bisQMAcr ICLs, which likely distort the DNA more than dG-C8-
(acetylamino)fluorine monoadducts.  
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The ability of the polymerase to extend a primer in the presence of bisQMAcr’s DNA 
crosslink was determined to further characterize Klenow Exo
-
‘s response to crosslinks. 
BisQMAcr crosslinked OD11/OD12 was prepared as described above, followed by initiation 
of primer extension via addition of [
32
P]-OD10, dNTPs, and the polymerase (Figure 4.3A). 
Additionally, monoQMAcr DNA adducts were prepared analogously to those for bisQMAcr 
in order to compare the effect of monoQMAcr adducts with bisQMAcr ICLs on primer 
extension (Schemes 2.2 and 3.1). Both monoQMAcr and bisQMAcr adducts stalled Klenow 
Exo
-
 at several sites up to the crosslink, while also inhibiting the polymerase’s ability to 
extend the primer relative to the reaction with no QM present (Figure 4.3B). Major products 
were evident at sites 2, 5, 13, and 14 nucleotides away from OD11 on its 5’-end.  
Figure 4.2 Persistence of bisQMAcr’s DNA crosslink during primer extension by the 
Klenow Exo
-
 DNA polymerase. A) Scheme depicting the experimental setup. B) 
Crosslinked OD11/[
32
P]-OD12 was prepared by first treating OD11 (3 µM) with 
monoQMPAcr or bisQMPAcr (500 µM) for 24 h in MES (10 mM, pH 7) and NaF (10 
mM), followed by removal of excess QM with a P6 spin column. OD12 (3 µM) was then 
added for an additional 24 h. The crosslinked OD11/[
32
P]-OD12 (200 nM) was added to a 
mixture of OD10 (240 nM) and dNTPs (100 µM) in Klenow polymerase reaction buffer. 
The primer/template complexes were incubated with the DNA polymerase (60 nM) for 0-








aborts synthesis prior to reaching OD11 and the bisQMAcr crosslinks. Klenow 
Exo
-
 also failed to extend a primer at positions distant from dG-C8-(acetylamino)fluorene 







 Klenow’s products of primer extension in the presence of 
Figure 4.3 Primer extension by Klenow Exo
-
 DNA polymerase in the presence of a 
bisQMAcr DNA crosslink. A) Scheme depicting the experimental setup. B) OD12 (3 µM) 
was then added for an additional 24 h. Alkylated OD11/OD12 was prepared by first 
treating OD11(3 µM) with monoQMPAcr or bisQMPAcr (500 µM) for 24 h in MES (10 
mM, pH 7) and NaF (10 mM), followed by removal of excess QM with a P6 spin column. 
OD12 (3 µM) was then added for an additional 24 h. Alkylated OD11/OD12 (200 nM) 
was added to a mixture of OD10 (240 nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in 
Klenow polymerase reaction buffer. The primer/template complexes were incubated with 
the DNA polymerase (60 nM) for 0-8 h. Products were separated by denaturing PAGE 
(20%) and detected by phosphorimagery. 
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a bisQMAcr ICL are aborted synthesis products and unextended primer. Thus, Klenow Exo
-
 
fails to dissociate bisQMAcr’s crosslinks because it aborts primer extension before reaching 
the site of the crosslinks.  
The φ29 DNA polymerase was then utilized to determine whether its additional 
strand displacement activity may result in dissociation or migration of bisQMAcr’s crosslink. 
As was the case for the Klenow Exo
-
 polymerase, the φ29 polymerase did not break apart 
bisQMAcr’s DNA ICLs (Figure 4.4). Furthermore, primer extension produced fewer 
products than those for Klenow Exo
-
, as φ29 produced only one minor aborted product 
before the site of OD11 (Figure 4.5). Additionally, φ29’s exonuclease activity predominated, 
Figure 4.4 Persistence of bisQMAcr’s DNA crosslink during primer extension by the φ29 
DNA polymerase. A) Scheme depicting the experimental setup. B) Crosslinked OD11/[
32
P]-
OD12 was prepared by first treating OD11(3 µM) with monoQMPAcr or bisQMPAcr (500 
µM) for 24 h in MES (10 mM, pH 7) and NaF (10 mM), followed by removal of excess QM 
with a P6 spin column. OD12 (3 µM) was then added for an additional 24 h. The crosslinked 
OD11/[
32
P]-OD12 (200 nM) was added to a mixture of OD10 (240 nM) and dNTPs (100 µM) 
in φ29 polymerase reaction buffer. The primer/template complexes were incubated with the 
DNA polymerase (12 nM) for 0-8 h. Products were separated by denaturing PAGE (10%) and 




as the major products produced during synthesis were fragments of the primer. The presence 
of exonuclease degradation products indicates that φ29 does recognize and bind the primer 
template complex, despite its failure to extend the primer. Distant lesions may affect φ29’s 
polymerase activity in a similar manner as they did for Klenow Exo
-
, while also triggering its 
exonuclease activity.  
DNA polymerases may dissociate from the DNA once they stall at a lesion and aborts 
primer extension. This dissociation may allow a polymerase to find a primer/template 
complex that will provide productive and complete DNA synthesis. The polymerases’ 
detachment from the DNA likely occurs within minutes, whereas bisQMAcr’s reversible 
chemistry with DNA requires hours, since the half-life of QM-dGN7 adducts is 
approximately 2 hand the time frame required for bisQMAcr to traverse 10 base pairs is  7 
days. As such, a polymerase will not have an opportunity to affect bisQMAcr’s migration 
along DNA. Thus, bisQMAc’s crosslink will likely be deleterious to cells due to its potential 
to block DNA replication by inhibiting the action of DNA polymerases if it is not repaired by 
DNA repair enzymes. Although the crosslink does prevent the polymerases from initiating 
synthesis and exonuclease degradation on the primer/template complex, it may distort the 





4.2.2 Stalling of DNA Polymerases at QM-DNA Adducts 
 The abortion of primer extension and stalling of polymerases at QM-DNA lesions 
may explain the inability of the polymerases induce separation of bisQMAcr’s ICLs. The 
Figure 4.5 Primer extension by φ29 DNA polymerase in the presence of a bisQMAcr 
DNA crosslink. A) Scheme depicting the experimental setup. B) OD12 (3 µM) was then 
added for an additional 24 h. Alkylated OD11/OD12 was prepared by first treating 
OD11(3 µM) with monoQMPAcr or bisQMPAcr (500 µM) for 24 h in MES (10 mM, pH 
7) and NaF (10 mM), followed by removal of excess QM with a P6 spin column. OD12 
(3 µM) was then added for an additional 24 h. Alkylated OD11/OD12 (200 nM) was 
added to a mixture of OD10 (240 nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in φ29 
polymerase reaction buffer. The primer/template complexes were incubated with the 
DNA polymerase (12 nM) for 0-8 h. Products were separated by denaturing PAGE (20%) 





template strand OD12 was treated alternatively with monoQMAcr and bisQMAcr to 
determine whether the polymerases stall at QM lesions and abort synthesis. The template 
strand OD12 was treated with a 1.3-fold stoichiometric excess of either monoQMAcr or 
bisQMAcr to produce a range of stalled products and prevent over-alkylation of the DNA by 
ensuring that each DNA duplex contains one bisQMAcr adduct at most. Over-alkylation may 
inhibit annealing of the primer or result in an inability of the polymerase to extend the 
primer. The primer-template complex was formed by addition of [
32
P]-OD10, followed by 
initiation of the reaction with dNTPs and the indicated polymerase for up to 8 h (Figure 
4.6A). Primer extension by both the Klenow Exo
-
 and φ29 polymerases was impaired relative 
to that of unmodified DNA (Figure 4.6B, C). Both polymerases stalled at a few sites, 
primarily within the first 8 nucleotides extended. A couple of stall sites at Cs farther 
downstream from the primer start site appear between 4 and 8 h of incubation with the 
Klenow Exo
-
, but not φ29 polymerase (Figure 4.6B). The φ29 polymerase stalls at fewer 
sites than Klenow Exo
-
, since its exonuclease activity is also activated while it processes the 
alkylated DNA. The exonuclease degradation of the primer increases in a time-dependent 
manner, and to a greater extent than extension of the primer (Figure 4.6C). The presence of 
aborted synthesis products suggests that the polymerases may stall on the alkylated template 
DNA. 
 The difficulty of both polymerases to extend the DNA primer may result from the 
homogeneity of the template strand. The template sequence is A-C rich, while the newly 
synthesized sequence will be G-T rich. Polymerases face difficulty replicating G-C-rich 
sequences, as well as those that contain several dinucleotide repeats.
122
 Both polymerases 




Figure 4.6 Primer extension of a template strand alkylated with monoQMAcr and 
bisQMAcr. A) Scheme depicting the experimental setup. B) OD12 (3 µM) was 
treated with monoQMPAcr or bisQMPAcr (4 µM) in in MES (10 mM, pH 7) and 
NaF (10 mM) for 24 h, followed by removal of excess QM using a P6 spin column 
(1000 g, 4 min). Alkylated OD12 (200 nM) was added to a mixture of OD10 (240 
nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in the appropriate polymerase 
reaction buffer. The primer/template complexes were incubated with the B) 
Klenow Exo
-
 (60 nM) or C) φ29 DNA polymerase (12 nM) for 0-60 min. Products 
were separated by denaturing PAGE (20%) and detected by phosphorimagery. 
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sequence homogeneity and A-C-rich character of OD12. Use of a heterogeneous template 
sequence may provide a more extensive profile of stall sites when analyzing primer extension 
of an alkylated DNA. 
The heterogeneous sequence OD2 was used as the template strand to induce a greater 
degree of products of aborted synthesis than those generated using OD12 as a template, since 
a heterogeneous DNA sequence may facilitate greater processivity of the polymerases 
(Figure 4.7A). A shorter incubation time (60 min) was used for the heterogeneous template 
sequence because the polymerases were quicker to process it than the homogeneous A-C-rich 
OD12 sequence. Both polymerases stalled at a wider variety of nucleotides located along the 
entire length of the DNA (Figure 4.7B, C). The Klenow Exo
-
 polymerase did not exhibit 
much time dependence for its activity, as it had completed synthesis by 1 min, and failed to 
overcome the lesions that resulted in aborted synthesis. No new products of primer extension 
were evident after 1 min. Meanwhile, the φ29 polymerase was slower to extend the primer, 
but stalled at many of the same sites as Klenow Exo
-
. The φ29 polymerase did not 
significantly degrade the primer, as it did with OD12. This suggests a more facile extension 
of the primer with OD2 than with OD12. 
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Little difference in sites of aborted synthesis occurred between the template DNA 
treated with monoQMAcr and bisQMAcr. However, OD2 treated with monoQMAcr 
supported a greater degree of full-length extension of the primer than when treated with 
Figure 4.7 Primer extension of a heterogeneous template strand alkylated with 
monoQMAcr and bisQMAcr. A) Scheme depicting the experimental setup. B) OD2 (3 µM) 
was treated with monoQMPAcr or bisQMPAcr (4 µM) in in MES (10 mM, pH 7) and NaF 
(10 mM) for 24 h, followed by removal of excess QM using a P6 spin column (1000 g, 4 
min). Alkylated OD2 (200 nM) was added to a mixture of OD10 (240 nM), [
32
P]-OD10 (5 
nM) and dNTPs (100 µM) in the appropriate polymerase reaction buffer. The 
primer/template complexes were incubated with B) Klenow Exo
-
 (60 nM) or C) φ29 DNA 
polymerase (12 nM) for 0-60 min. Products were separated by denaturing PAGE (20%) and 




bisQMAcr. MonoQMAcr alkylates DNA with a lower yield than bisQMAcr, and forms 
fewer adducts than bisQMAcr since it contains one, rather than two electrophiles.
53
 In both 
cases, some full-length extension is observed, since not every DNA molecule is alkylated 
with QM. Generally, a 20-30-fold stoichiometric excess of bisQMPAcr is required to achieve 
alkylation of every DNA molecule in solution.  
The presence of an assortment of aborted synthesis products supports the hypothesis 
that QM-lesions on the template strand induce polymerase stalling, preventing full-length 
extension of the primer. Thus, DNA polymerases will not be modulate bisQMAcr’s 
migration along DNA, since its lesions halt their polymerase activity. Furthermore, like most 
DNA ICLS, bisQMAcr’s intra- and inter-strand crosslinks will likely pose as blocks to DNA 




4.2.3 Primer Extension of DNA Containing Crosslinks from Ammonium-Linked 
BisQMs  
BisQMs linked to polyammonium ligands associate to DNA via electrostatic 
interactions with the phosphodiester backbone and form a significant yield of irreversible 
QM-DNA adducts.
45, 124
 Furthermore, acridine’s intercalation may distort the DNA in such a 
way that prevents the initiation of primer extension. Comparing primer extension in the 
presence of bisQMN2 and bisQMN3 lesions with that for bisQMAcr lesions will address how 
the binding mode affects polymerase activity. Thus, these bisQMs may impact the 
polymerases’ primer extension of alkylated DNA differently than bisQMAc did.  
The preference for ammonium-linked bisQMs to form irreversible DNA adducts 
suggests that polymerases likely will not induce dissociation of their ICLs. To confirm the 
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resistance of these ICLs to the action of DNA polymerases, bisQMN2 and bisQMN3 
crosslinks were generated with OD10 and [
32
P]-OD12 (Figure 4.8A). The G-T-rich OD10 
and its complementary A-C-rich OD12 sequence were used to ensure crosslink formation via 
isomerization from an intra- to inter-strand crosslink. This isomerization does not occur when 
using the heterogeneous OD1, 2, and 4 sequences. The primer/template complex was formed, 
and reaction was initiated via addition of dNTPs and the indicated polymerase. As 
hypothesized, the Klenow Exo
-
 polymerase failed to alter the integrity of both bisQMN2 and 
bisQMN3’s DNA ICLs (Figure 4.8B, C).  
To determine whether the ammonium-conjugated bisQM’s also impair primer 
extension of an alkylated template strand, OD2 was alkylated alternatively with each bisQM 
for 24 h, before the primer-template complex was formed and extension was initiated with 
Figure 4.8 Persistence of bisQMN2 and bisQMN3 DNA crosslink during primer 
extension by the Klenow Exo
-
 DNA polymerase. A) Scheme depicting the experimental 
setup. B) Crosslinked OD11/[
32
P]-OD12 was prepared by first treating OD11(3 µM) with 
B) bisQMPN2 or C) bisQMPN3 (500 µM) for 24 h in MES (10 mM, pH 7) and NaF (10 
mM), followed by removal of excess QM with a P6 spin column. OD12 (3 µM) was then 
added for an additional 24 h. The crosslinked OD11/[
32
P]-OD12 (200 nM) was added to a 
mixture of OD10 (240 nM) and dNTPs (100 µM) in the polymerase reaction buffer. The 
primer/template complexes were incubated with the Klenow Exo
-
 polymerase (60 nM) for 





dNTPs and each polymerase (Figure 4.9A). Primer extension resulted in a pattern of multiple 
Figure 4.9 Primer extension by Klenow Exo
-
 and φ9 DNA polymerases of a heterogeneous 
template strand alkylated with bisQMN2 or bisQMN3. A) Scheme depicting the 
experimental setup. B) OD2 (3 µM) was treated with B) bisQMPN2 or C) bisQMPN3 (4 
µM) in MES (10 mM, pH 7) and NaF (10 mM) for 24 h, followed by removal of excess QM 
using a Bio-Rad P6 spin column (1000 g, 4 min). Alkylated OD2 (200 nM) was added to a 
mixture of OD10 (240 nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in the appropriate 
polymerase reaction buffer. The primer/template complexes were incubated with the DNA 




stall sites at a wider variety of nucleotides than that of bisQMAcr (Figure 4.9B, C). 
BisQMAcr primarily stalled the polymerases at C’s and T’s, while bisQMN2 and bisQMN3 
stalled the polymerases at all four bases. Both bisQMN2 and bisQMN3 affect the polymerases 
to the same extent and produce a similar primer extension profile. Little difference occurs 
when increasing the charge of the linker on the polymerases’ processing of the damaged 
DNA. But, the binding mode of the ligand conjugated to the bisQM changes the identities of 
the aborted synthesis products. This likely occurs due to the differences in sites of reaction 
that result from each binding ligand directing the bisQM to react with different nucleophiles 
within DNA. Thus, the differences in aborted products of primer extension between 
bisQMAcr and bisQMN2 and bisQMN3 also support the differences in sites of reactivity that 
became apparent in previous work (refer to Chapter 2).
45 
  
4.2.4 Effect of DNA Binding Ligands on Primer Extension by the Klenow Exo
-
 
and φ29 DNA Polymerases 
Although the bisQMs impair primer extension by the Klenow Exo
-
 and φ29 DNA 
polymerase, whether ligand binding or covalent QM reaction causes the aborted synthesis 
products is not known. To determine whether and to what extent ligand binding impedes the 
primer extension of OD2 template DNA treated with the bisQMs, OD2 was treated with 9-
aminoacridine, the diammonium linker, or the triammonium linker, rather than bisQMAcr, 
bisQMN2, or bisQMN3, respectively (Schemes 2.2 and 2.3). The template DNA was passed 
through a spin column after ligand treatment to maintain equivalent conditions to those used 
for experiments involving the bisQMs (Figure 4.10A). However, it is possible that ligand 




Figure 4.10 Primer extension of a heterogeneous template strand treated with 9-
aminoacridine using either the Klenow Exo
-
 or φ29 DNA polymerases. A) Scheme 
depicting the experimental setup. B) OD2 (3 µM) was treated with 9-aminoacridine (4 
µM) in MES (10 mM, pH 7) and NaF (10 mM) for 24 h, followed by removal of excess 
ligand using a P6 spin column (1000 g, 4 min). Alkylated OD2 (200 nM) was added to a 
mixture of OD10 (240 nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in the appropriate 
polymerase reaction buffer. The primer/template complexes were incubated with the 
indicated DNA polymerase for 0-60 min. Products were separated by denaturing PAGE 
(20%) and detected by phosphorimagery. 
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Treatment with 9-aminoacridine resulted in suppressed primer extension relative to parent 
OD2 (Figure 4.10B). The level of inhibition of the polymerases’ primer extension activity is 
similar to that of bisQMAcr, with the major difference being that 9-aminoacridine does not 
cause the polymerase to stall, as bisQMAcr does. Rather, the polymerase either extends the 
primer fully or not at all. Abortion of primer extension likely results from covalent QM-DNA 
adducts. Regardless, intercalation by acridine contributes to bisQMAcr’s impairment of the 
primer extension activity of the two DNA polymerases.        
  Both ammonium linkers also did not lead to stalling of the polymerase during 
extension of the primer with OD2 template DNA (Figure 4.11). Like 9-aminoacridine, the 
linkers suppressed the yield of full extension of the primer relative to OD2 in the absence of 
ligand, but did not inhibit the polymerases extending the primer. Thus, bisQMN2’s and 
bisQMN3’s suppression of the polymerases’ primer extension activity also likely derives 
from both covalent reaction of the QMs and binding of the ammonium linkers to DNA. 
Association to DNA may suppress the yield of primer extension, while QMs’ covalent 
reactions contribute to the polymerases’ stalling and inability to extend a primer.  
 
4.3 Summary 
 DNA polymerases were initially considered as candidate enzymes that may modulate 
bisQMAcr’s migration along DNA. Polymerases act as biological machines, proceeding 
quickly along DNA with their motion coupled to energy expenditure from dNTP 
incorporation. This activity may affect reversible reactions with DNA by either hastening the 
chemistry of the DNA adduct or modulating the direction of migration of reversible adducts. 
However, the Klenow Exo
-
 and φ29 DNA polymerases did not cause separation of 
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bisQMAcr’s DNA ICLs during primer extension. Crosslinks did not dissociate upon 
incubation with the polymerases, but rather impaired the polymerases’ ability to extend a 
Figure 4.11 Primer extension by Klenow Exo
-
 and φ9 DNA polymerases of a heterogeneous 
template strand treated with the diammonium or triammonium linker. A) Scheme depicting 
the experimental setup. B) OD2 (3 µM) was treated with the B) diammonium or C) 
triammonium linker (4 µM) in MES (10 mM, pH 7) and NaF (10 mM) for 24 h, followed by 
removal of excess ligand using a P6 spin column (1000 g, 4 min). Alkylated OD2 (200 nM) 
was added to a mixture of OD10 (240 nM), [
32
P]-OD10 (5 nM) and dNTPs (100 µM) in the 
appropriate polymerase reaction buffer. The primer/template complexes were incubated with 
the DNA polymerase for 0-60 min. Products were separated by denaturing PAGE (20%) and 





primer, and triggered φ29’s exonuclease activity. The generation of products representing 
aborted synthesis during extension of a primer in the presence of alkylated template DNA 
and premature termination of extension suggests that the polymerases may stall at QM 
lesions and dissociate from the DNA. Dissociation likely occurs within minutes while 
bisQMAcr’s reversible chemistry requires hours, preventing the polymerase from affecting 
bisQMAcr’s migration along DNA.  
 Comparison of the polymerases’ primer extension activity between DNA treated with 
bisQMAcr and the ammonium-linked bisQMs highlights the differences in sites of reaction 
that the ligands direct the bisQMs to. BisQMN2 and bisQMN3 also suppressed primer 
extension, but led to the formation of terminated synthesis products at different nucleotide 
sites than those detected for DNA treated with bisQMAcr. Overall, our data suggests that 
bisQMs will impair DNA replication in vivo by suppressing DNA polymerases. This effect 
may be significant, unless the DNA is properly repaired, since its transcription and 
translation to express the encoded gene will be prevented. However, polymerase switching to 
a TLS polymerase would likely occur in a cell.
104
 The TLS polymerase Pol ν has been 
demonstrated to bypass DNA ICLs, and thus may either bypass bisQMAcr lesions or 
modulate their migration along DNA.
125, 126
 Investigation of whether Pol ν bypasses 
bisQMAcr’s crosslink would determine whether bisQMAcr would act as an absolute 
replication block in cells, or only pose a hindrance to replicative polymerases. 
 Furthermore, DNA helicases may be a more processive class of enzymes than DNA 
polymerases to investigate the interactions that may result from bisQMAcr’s reversible 
chemistry. Helicases are quite processive, possess strong strand displacement activity, and 
interact with DNA during replication before polymerases. As will be discussed in Chapter 5, 
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helicases do not dissociate from DNA containing lesions as quickly as polymerases do, 
providing a greater likelihood of affecting bisQMAcr’s reversible DNA adducts. 
 
4.4 Materials and Methods 
 4.4.1 Materials 
 T4 polynucleotide kinase, Klenow Exo
-
 polymerase, φ29 DNA polymerase, and an 
equimolar solution containing 10 mM of the four dNTPs were purchased from New England 
Biolabs. γ- [
32
P]-ATP was purchased from Perkin Elmer. The four individual ddNTPs were 
purchased from Sigma. Oligonucleotides were purchased from Integrated DNA Technologies 
with standard desalting and were purified by denaturing PAGE.  BisQMPAcr was 
synthesized as described previously.
40
 MonoQMPAcr was provided by Dr. Blessing Deeyaa. 
BisQMPN2 and bisQMPN3 were provided by Dr. Mark Hutchinson. 9-Aminoacridine was 




 4.4.2 Methods 
General Oligonucleotide Studies. Oligonucleotides were labeled at their 5’- 
terminus with -[
32
P]- ATP using T4 polynucleotide kinase according to the manufacturer’s 
protocol.  Duplex DNA was annealed by heating the [
32
P]- DNA (3 M) with its 
complementary strand (3 M) in MES (10 mM, pH 7) and NaF (10 mM) at 95 C for 2 min 
followed by slow cooling to room temperature over 2-3 h.   
 
DNA Alkylation with QMs. The indicated QMP in acetonitrile was added to the 
preannealed duplex DNA in MES (10 mM, pH 7) and NaF (10 mM) to yield a final reaction 
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volume of 20 L with 20% acetonitrile.  Reactions were quenched by the addition of 2X 
formamide loading dye (0.05% bromophenol blue and 0.05% xylene cyanol in formamide) 
and analyzed by 20% denaturing polyacrylamide gel electrophoresis.  Alternatively, samples 
were subjected to piperidine cleavage as described previously and analyzed by 20% 
denaturing PAGE.  Products were detected by phosphorimagery using a Typhoon 9410 
phosphorimager and quantified with ImageQuant software to determine the reaction yields 
(% product band relative to total material).   
 
Persistence of BisQMs’ DNA Crosslink Following Primer Extension by DNA 
Polymerases. OD11 (3 µM) in MES (10 mM, pH 7) and NaF (10 mM) was treated with the 
indicated BisQMP (500 µM, in CH3CN) for 24 h at ambient temperature in a solution with a 
final concentration of 20% acetonitrile. OD12 (2.8 µM) and [
32
P]- OD12 (0.2 µM) were 
added to the reaction mixture to bring the final volume to 20 µL, and incubated for an 
additional 24 h at ambient temperature. Excess QM was removed via gel filtration 
chromatography by passing the reaction mixture through a Bio-Rad P6 spin column (1000 g, 
4 min). The crosslinked DNA was added to a solution of OD10 (0.24 µM), dNTPs (100 µM), 
and 1x polymerase buffer. The indicated polymerase was added to the reaction mixture to 
bring the final volume to 20 µL. Reactions were quenched at the indicated times with 20 µL 
of formamide loading dye that contained 25 mM EDTA. The products were analyzed by 
denaturing PAGE (20%) and detected by phosphorimagery.  
 
Primer Extension Using Klenow Exo- Polymerase. The 1x reaction buffer used for the 
Klenow Exo
-





 (60 nM) in storage buffer (25 mM Tris-HCl, pH 7.4, 1 mM DTT, 0.1 
mM EDTA, and 50% glycerol) was added to the reaction mixture described above at ambient 
temperature. 
 
Primer Extension Using φ29 DNA Polymerase. The 1x reaction buffer used for the φ29 
DNA polymerase contains Tris-HCl (50 mM, pH 7.5), MgCl2 (10 mM), and (NH4)2SO4 (10 
mM). The reaction mixture described above was supplemented with BSA (10 mg/mL) before 
addition of φ29 DNA polymerase (12 nM) in storage buffer (10 mM Tris-HCl, pH 7.4, 100 
mM KCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.5% Tween 20, and 0.5% IGEPAL 
CA-630) at ambient temperature. 
 
Primer Extension by DNA Polymerases in the Presence of a bisQM DNA Inter-Strand 
Crosslink. OD11 (3 µM) in MES (10 mM, pH 7) and NaF (10 mM) was treated with the 
indicated BisQMP (500 µM, in CH3CN) for 24 h in a solution that contained 20% 
acetonitrile. OD12 (3 µM) was added to the reaction mixture to bring the final volume to 20 
µL, and incubated for an additional 24 h. Excess QM was removed via gel filtration 
chromatography by passing the reaction mixture through a Bio-Rad P6 spin column (1000 g, 
4 min). The crosslinked DNA was added to a solution of OD10 (0.24 µM), [
32
P]-OD10 
(0.005 µM), dNTPs (100 µM), and 1x polymerase buffer. The indicated polymerase was 
added to the reaction mixture to bring the final volume to 20 µL. Reactions were quenched at 
various times with 20 µL of formamide loading dye that contained 25 mM EDTA. The 





Dideoxynucleotide DNA Sequencing. The indicated DNA template strand (0.2 µM) was 
added to a solution of OD10 (0.24 µM), dNTPs (20 µM), and 1x Klenow Exo
-
 polymerase 
buffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9). Each ddNTP 
(600 µM) was added individually to separate reactions before addition of the Klenow Exo
-
 
Polymerase (0.06 µM) to bring the final reaction volume to 20 µL. Reactions were incubated 
for 1 h at ambient temperature before quenching by the addition of 20 µL of formamide 
loading dye containing 25 mM EDTA. The products were analyzed by 20% denaturing 
PAGE and detected by phosphorimagery.  
 
Alkylation and Extension of Template Strand by DNA Polymerases. The indicated DNA 
template strand (3 µM) in  MES (10 mM, pH 7) and NaF (10 mM) was treated with the 
indicated bisQMP (500 µM, in CH3CN) for 24 h to bring the final volume to 20 µL and the 
final acetonitrile concentration to 20% at ambient temperature. Excess QM was removed via 
gel filtration chromatography by passing the reaction mixture through a Bio-Rad P6 spin 
column (1000 g, 4 min). The alkylated DNA (0.2 µM) was added to a solution of OD10 (0.24 
µM), [
32
P]-OD10 (0.005 µM), dNTPs (100 µM), and 1x polymerase buffer. The indicated 
polymerase was added to the reaction mixture to bring the final volume to 20 µL and 
reactions were quenched at the indicated times with 20 µL of formamide loading dye that 
contained 25 mM EDTA. The products were analyzed by 20% denaturing PAGE and 








Chapter 5: Unwinding of DNA Containing BisQMAcr Crosslinks 
by the T7 Bacteriophage Gene 4 Protein Helicase 
 
5.1 Introduction 
 The failure of the Klenow Exo
-
 and φ29 DNA polymerases to extend a primer in the 
presence of bisQMAcr’s ICLs suggests that bisQMAcr’s ICLs may pose a replication block. 
However, helicases must first unwind duplex DNA before DNA polymerases can synthesize 
a new daughter strand, and would encounter DNA damage before a polymerase.
128
 Helicases 
hydrolyze dNTPs to generate power that promotes their processive translocation along DNA 
and concurrent unwinding of the duplex (Scheme 5.1). To determine the full impact of a 
reversible DNA ICL on replication, the ability of a helicase to unwind DNA containing ICLs 
should be evaluated. A reversible ICL may not pose a replication block for helicases, as 
irreversible ICLs may, if the time frame for reversible chemistry aligns with that of the 
helicase’s action. Helicases may stall at lesions without dissociating from the DNA, 
Scheme 5.1 General depiction of translocation and concurrent unwinding of 
duplex DNA by hexameric DNA helicases. 
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providing enough time for the reversible chemistry to occur. Once regenerated, the reactive 
species could dissociate from the DNA, re-alkylate a different site on the DNA, or alkylate 
the helicase. Precedent exists for helicase stalling at DNA lesions, especially during 
nucleotide excision repair. For example, the XPD helicase serves as a means of damage 
recognition by stalling at DNA lesions to recruit the relevant repair proteins.
129, 130
 Reversible 
ICLs may not prevent the action of helicases if they stall at the lesion long enough for the 
adduct to release the electrophile and restore the unmodified DNA. 
 Several DNA helicases have been reported to be inhibited by monoadducts and DNA-
protein crosslinks on the strand upon which the helicase translocates. For example, 
cyclopyrimidine dimers and cisplatin DNA adducts inhibit translocation by Rad3, the 
Saccharomyces cerevisiae homolog of XPD.
131, 132
 However, only adducts on the 
translocating DNA strand, but not complementary strand, prevent DNA unwinding by 
Rad3.
132
 The Werner syndrome (WRN) helicase cannot unwind DNA containing 
benzo[c]phenanthrene (BcPh)-dA adducts on the translocating strand.
4
 However, BcPh 
adducts on the non-translocating strand only impaired helicase activity when the adduct was 
spatially oriented towards the advancing helicase.
131, 133
 The pendant alcohols on the BcPh 
adduct can face towards the 3’-end of the DNA or the 5’-end. When oriented towards the 5’-
end, the BcPh’s alcohols face towards the helicase as it translocates from the 5’-end to the 3’-
end of the DNA. The effect of orientation of BcPh adducts on the translocation of the WRN 
helicase highlights the effect of adduct positioning on facilitating or preventing DNA 
unwinding. Hexameric, replicative helicases from T7 bacteriophage, E.coli, and humans are 
also inhibited by bulky lesions on the translocating strand. DNA-protein crosslinks on the 
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translocating strand prevent DNA unwinding by the T7 bacteriophage Gene 4 Protein 
(T7GP4), DnaB, and Mcm467 helicases.
134 
 All lesions that have been examined for their ability to hinder the activity of DNA 
helicases form irreversibly. How reversible bisQMAcr DNA ICLs respond to the action of a 
DNA helicase may address the question of whether reversible DNA alkylation mitigates the 
potency of an alkylating agent. Regeneration of the reactive species may release the 
unmodified DNA, essentially affording repair of the adduct. However, the regenerated 
alkylating agent may also re-alkylate the DNA at a new site or may alkylate the helicase. 
These latter two possibilities would likely enhance the alkylating agent’s toxicity to cells by 
preventing DNA replication and repair. Helicases have been suggested as catalysts for the 
migration of reversible DNA adducts along DNA.
25
 However, to our knowledge, the 
possibility of this phenomenon has never been investigated. Here, we hypothesize that a 
DNA helicase may modulate bisQMAcr’s migration along DNA, either by causing its 
crosslinks to dissociate or by controlling its direction and speed of migration.  
We chose to utilize the 56 kDa fragment of the T7GP4 helicase for our studies. The 
full-length T7GP4 protein possesses both helicase and primase activities, but the 56 kDa 
fragment contains an N-terminal truncation that abolishes primase activity.
135, 136
 T7GP4 has 
been demonstrated to stall at benzo[α]pyrene adducts on the translocating strand.
137
 These 
lesions inhibit T7GP4’s forward progression along DNA and sequester the helicase with 
bound dTTP.
137, 138
 T7GP4 hydrolyzes dTTP to dTDP to facilitate its translocation along 
DNA, but fails to hydrolyze the bound dTTP when sequestered by the benzo[α]pyrene 
lesion.
137, 139, 140
 However, removal of the lesion may permit reinitiation of T7GP4’s 
translocation along DNA, since it still has bound dTTP. A reversible lesion, such as 
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bisQMAcr’s DNA ICL, may permit lesion bypass by T7GP4 if the QM of bisQMAcr 
regenerates from its DNA adduct and releases the unmodified DNA. Here, we investigated 
T7GP4’s ability to affect bisQMAcr’s reversible DNA-adducts. Helicase-catalyzed migration 
of QM adducts could represent a means by which reversible DNA-adducts afford their own 
repair if the helicase can dissociate a reversible DNA ICL.  
 
5.2 Results and Discussion 
 5.2.1 Unwinding DNA Crosslinks by T7GP4 
 The 56 kDa fragment of the T7GP4 helicase was expressed and purified as described 
previously (Appendix D, Figure D.1).
141, 142
 A mini-replication fork containing a 5’-single-
stranded region on OD13 and a 3’-single-stranded region on OD14 was utilized to determine 
the efficiency of DNA unwinding by T7GP4 with unmodified DNA, as T7GP4 requires 
single-stranded DNA as a model replication fork to initiate its translocation.
143
 The 
OD13/OD14 sequences were chosen for DNA unwinding by T7GP4 due prior reports of its 
ability to be unwound rapidly and for the single strands to be detected by native PAGE.
140, 144
 
T7GP4 unwound OD13/OD14 in a concentration-dependent manner within 10 min 
(Appendix D, Figure D.2).  
 To determine how bisQMAcr’s DNA ICL responds to DNA unwinding by T7GP4, 
OD13/[
32
P]-OD14 duplex DNA was crosslinked with bisQMAcr and used as a substrate for 
unwinding by T7GP4. The duplex DNA was treated with bisQMPAcr in the presence of NaF 
for 2 h, before removal of excess bisQMAcr using a P6 spin column. A 2 h treatment of the 
DNA with bisQMPAcr was chosen in order to ensure a high yield of DNA ICLs, while 
preventing more than one bisQMAcr adduct per duplex DNA molecule (Figure 5.1B). Over-
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alkylation of the duplex DNA may prevent helicase unwinding due to the presence of 
multiple lesions that must be overcome by T7GP4. In addition, the presence of Ts in the 
single-stranded regions of the DNA guarantee that no bisQMAcr adducts will form that may 





P]-OD14 duplex DNA was incubated with dTTP and T7GP4 and 
products were separated by denaturing PAGE to determine whether the ICLs are broken over 
time (Figure 5.1A). A monomer concentration of 55 nM of T7GP4 was chosen to ensure a 
Figure 5.1 Kinetics of unwinding of OD13/[
32
P]-OD14 duplex DNA containing bisQMAcr 
crosslinks by T7GP4. A) Scheme depicting the experimental setup. B) Crosslinked OD13/[
32
P]-
OD14 (10 nM) was incubated with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) 
at 37 ºC and samples were quenched after 0, 1, 5, 10, 20, and 30 min with EDTA (40 mM). 
Samples were separated by 10% denaturing PAGE and visualized by phosphorimagery. C) The 
time-dependent unwinding of crosslinked OD13/[
32
P]-OD14 depicted in (B) was quantified and 
the amount of crosslink remaining was plotted over time. The amount of crosslink (%) was 
expressed relative to the total signal of DNA on the gel. Data from three separate trials of the 
experiment are reported, with bars representing the average of the data from the three 




high yield of duplex DNA unwinding within 10 min, while maintaining a stoichiometric ratio 
of hexameric T7GP4 to duplex DNA (Appendix D, Figure D.2). OD13/[
32
P]-OD14 
containing bisQMAcr crosslinks was unwound by T7GP4 in as quick as 1 min, with the yield 
of unwound DNA increasing to approximately 40% over 30 min (Figure 5.1B, C). 
Unwinding of bisQMAcr’s ICLs requires T7GP4 and dTTP, thus confirming that T7GP4’s 
translocase activity results in ICL unwinding. The observation of single-stranded DNA by 
PAGE that migrate more quickly than crosslinked OD13/[
32
P]-OD14 suggests that 
unwinding by T7GP4 causes the ICLs to dissociate, albeit only 40% of the ICLs are 
consumed. 
 To determine whether crosslink unwinding is sequence independent, the analogous 
experiment was conducted using OD15/[
32
P]-OD16 duplex DNA, rather than OD13/[
32
P]-
OD14 (Figure 5.2A). OD15 and OD16 include the sequences that were used to demonstrate 
ebisQMAcr’s migration along DNA, with the addition of a single-stranded poly-T 
sequences.
41
 OD16 contains many guanines that provide sites of reversible QM-DNA adduct 
formation at dGN7, which may facilitate helicase-catalyzed migration of bisQMAcr’s aducts 
along DNA. OD15/OD16 represents a G-rich DNA duplex, while OD13/OD14 contains a 
heterogeneous sequence of nucleotides. BisQMAcr’s DNA ICLs in OD15/[
32
P]-OD16 
dissociated with similar kinetics and yield as those in the heterogeneous OD13/[
32
P]-OD14 
sequences (Figure 5.2B, C). T7GP4 unwinds bisQMAcr ICLs with similar efficiencies in two 
different DNA sequences, suggesting that crosslink unwinding occurs regardless of the DNA 
sequence. Again, approximately 40% of the ICLs are broken, while the remaining 60% of 
ICLs remain intact in both DNA duplexes. There is an initially burst of crosslink dissociation 
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in both sequences within the first 10 min of incubation, followed by a plateau in the yield of 
crosslinks unwound between 10-30 min of incubation with T7GP4. 
 To ensure that unwinding of bisQMAcr DNA ICLs occurs on both the translocating 
and nontranslocating strands, the translocating, rather than nontranslocating strand was 
radiolabeled, crosslinked to its complementary strand with bisQMAcr, and incubated with 





P]-OD15/OD16 duplex DNA sequences were unwound with the same kinetics and  
Figure 5.2 Kinetics of unwinding of OD15/[
32
P]-OD16 duplex DNA containing bisQMAcr 
crosslinks by T7GP4. A) Scheme depicting the experimental setup. B) Crosslinked 
OD15/[
32
P]-OD16 (10 nM) was incubated with dTTP (1 mM) and T7GP4 (55 nM 
monomer concentration) at 37 ºC and samples were quenched after 0, 1, 5, 10, 20, and 30 
min with EDTA (40 mM). Samples were separated by 10% denaturing PAGE and 
visualized by phosphorimagery. C) The time-dependent unwinding of crosslinked 
OD15/[
32
P]-OD16 depicted in (B) was quantified and the amount of crosslink remaining 
was plotted over time. The amount of crosslink (%) was expressed relative to the total 
signal of DNA on the gel. Data from three separate trials of the experiment are reported, 






Figure 5.3 Kinetics of unwinding of DNA containing bisQMAcr crosslinks by T7GP4 
using radiolabeled translocating strand. A) Scheme depicting the experimental setup. B) 
Crosslinked [
32
P]-OD13/OD14 (10 nM) was incubated with dTTP (1 mM) and T7GP4 (55 
nM monomer concentration) at 37 ºC and samples were quenched after 0, 1, 5, 10, 20, and 
30 min with EDTA (40 mM). Samples were separated by 10% denaturing PAGE and 
visualized by phosphorimagery. C) The time-dependent unwinding of crosslinked [
32
P]-
OD13/OD14 depicted in (B) was quantified and the amount of crosslink remaining was 
plotted over time. The amount of crosslink (%) was expressed relative to the total signal of 
DNA on the gel. Data from three separate trials of the experiment are reported, with bars 
representing the average of the data from the three independent experiments. D) The 
analogous experiment to that conducted in (B) was performed using crosslinked [
32
P]-




yield as the non-translocating strand (Figure 5.3B, C, D). Radiolabeling either the non-
translocating strand or the translocating strand does not alter the percent of crosslink 
dissociation observed after DNA unwinding by T7GP4.   
BisQMAcr’s 9-aminoacridine ligand may inhibit duplex DNA unwinding if its 
intercalation blocks the action of T7GP4. To address whether intercalation of 9-
aminoacridine limits the yield of unwinding of bisQMAcr’s DNA ICLs by T7GP4, 
OD13/[
32
P]-OD14 was first treated with 9-aminoacridine for 2 h before excess ligand was 
removed with a P6 spin column. The DNA was then incubated with T7GP4 and dTTP and 
the products were separated by native PAGE to quantify the loss of duplex DNA over time 
(Figure 5.4A). The heterogeneous OD13/[
32
P]-OD14 sequence was used because the G-rich 
OD15/[
32
P]-OD16 duplex DNA reanneals during native PAGE. 9-Aminoacridine did not 
suppress the rate or yield of duplex DNA unwinding by T7GP4 relative to that of unmodified 
duplex DNA (Figure 5.4B, C). Thus, intercalation by acridine likely does not contribute to 
the lack of a 100% yield of DNA unwinding that is observed following incubation of 
bisQMAcr ICLs with T7GP4.  
 The unwinding of DNA containing bisQMAcr ICLs by T7GP4 is, to our knowledge, 
the first direct example of a DNA ICL that is dissociated by a helicase in vitro. The Fanconi 
anemia translocase complex FANCM/MHF promoted replication bypass of psoralen DNA 
ICLs in vivo.
145
 The FANCM/MHF translocase complex is not hexameric like T7GP4, as 
FANCM binds to a tetramer of MHF before initiating its progression along DNA.
146
 
However, FANCM/MHF’s bypass of psoralen ICLs merely proves that DNA replication 
occurs despite the presence of the ICLs. No data was provided about the stability of the ICLs 
following helicase treatment. Thus, FANCM/MHF may bypass psoralen ICLs to facilitate 
129 
 
replication, but the ICLs remain intact and will require repair post-replication. Although 
Huang et al propose that not all ICLs may pose as absolute blocks to DNA replication, our 
data not only supports this notion but extends it by suggesting that at least the  
 
Figure 5.4 Time-dependent unwinding of OD13/[
32
P]-OD14 duplex DNA by T7GP4 in 
the presence and absence of 9-aminoacridine. A) Scheme depicting the experimental setup. 
B) OD13/[
32
P]-OD14 in MES (10 mM) and NaF (50 mM) was incubated with 9-
aminoacridine (250 µM) for 2 h. Excess 9-aminoacridine was then removed with a P6 
Micro-spin column. OD13/[
32
P]-OD14 (10 nM) with or without 9-aminoacridine treatment 
was incubated in buffer (40 mM Tris-HCl pH 7.5, 10 mM MgCl2, and 50 mM potassium 
glutamate) with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) at 37 ºC and 
samples were quenched after 0, 1, 5, and 10 min with EDTA (40 mM). Samples were 
separated by 10% native PAGE and visualized by phosphorimagery. C) The data depicted 
in (B) were quantified and the amount of duplex DNA remaining was plotted over time. 
The amount of duplex DNA (%) was expressed relative to the total signal of DNA on the 
gel. Data from three separate trials of the experiment are reported, with bars representing 





T7GP4 helicase mediates dissociation of reversible bisQMAcr ICLs.
145
 BisQMAcr ICLs 
should not pose an absolute block to DNA replication, since they will not remain intact 
following T7GP4’s translocation along DNA, unlike the psoralen ICLs. Nevertheless, T7GP4 
only dissociates 40% of bisQMAcr’s DNA ICLs, leaving 60% of the ICLs intact. The lack of 
full consumption of bisQMAcr’s ICLs by T7GP4’s unwinding of DNA will still result in 
blocked DNA replication. 
 
5.2.2 Correlation of T7GP4’s dTTPase Activity with its Translocation along 
DNA 
T7GP4’s translocation along DNA has been suggested to be coupled to its ability to 
hydrolyze dTTP.
137, 147
 T7GP4’s dTTPase activity may correlate with its inability to unwind 
100% of bisQMAcr’s DNA ICLs. T7GP4 hydrolyzes low levels of dTTP in the absence of 
DNA, thus necessitating a determination of its background dTTPase activity before 
investigating its activity with DNA.
135





P]-dTDP and pyrophosphate by thin layer chromatography (TLC) with 
polyethylenimine-cellulose (PEI) coated TLC plates revealed an approximately 10% yield of 
dTTP hydrolysis to dTDP in the absence of DNA after 30 min (Figure 5.5A).
140
 Single-
stranded DNA has been reported to stimulate T7GP4’s dTTPase activity by 100-fold relative 
to that in the absence of DNA.
135, 148
 Reports in the literature utilize long, circular, single-
stranded DNA from the M13 phage to stimulate T7GP4’s dTTPase activity.
149
 T7GP4 was 
incubated with M13 DNA and the products of dTTP hydrolysis were separated by PEI-
cellulose TLC to determine the maximum yield of T7GP4’s dTTPase activity. M13 DNA 
stimulated T7GP4 to hydrolyze 5-fold more dTTP than in the absence of DNA (Figure 5.5B, 
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D). T7GP4’s dTTPase activity in the presence and absence of bisQMAcr ICLs in OD15/O16 
duplex DNA was determined, now that upper and lower limits of T7GP4’s dTTPase activity 
have been established. Incubation of OD15/O16 duplex DNA, with and without bisQMAcr 
Figure 5.5 dTTP hydrolysis by T7GP4 with A) no DNA present, B) M13 single-stranded 
circular DNA or C) unmodified and bisQMAcr crosslinked OD15/OD16 duplex DNA. 
OD15/OD16, or water for the case of no DNA, in MES (10 mM, pH 7) and NaF (50 mM) 
was incubated with or without bisQMPAcr (250 M) for 2 h at ambient temperature. 
Excess bisQMAcr and its low molecular weight products were removed with a P6 Micro 
Bio-spin column.  α-[
32
P]-dTTP (1 mM) was incubated with T7GP4 (55 nM monomer 
concentration) and the relevant DNA (10 nM) in buffer (40 mM Tris-HCl pH 7.5, 10 mM 
MgCl2, and 50 mM potassium glutamate) at 37 ºC and reactions were quenched after 0, 1, 
5, 10, 20, and 30 min with an equal volume of 10% formic acid. Samples were separated 
by PEI-cellulose thin layer chromatography using 0.5 M formic acid and 0.5 M LiCl, and 
visualized by phosphorimagery. D) The data depicted in (A), (B), and (C) were quantified 
and the amount of dTDP formed (%) was plotted against time. The bars represent the 




treatment, with T7GP4 and [
32
P]-dTTP generated a 10% yield of dTDP formation over 30 
min (Figure 5.5C). T7GP4’s dTTPase activity was not stimulated beyond background levels 
with the OD15/OD16 duplex containing relatively short 65mer and 85mer oligonucleotides, 
regardless of whether the DNA was modified with bisQMAcr ICLs or not (Figure 5.5D). As 
such, no conclusion can be made concerning the question of whether translocation correlates 
with dTTP hydrolysis for T7GP4’s unwinding of DNA containing bisQMAcr ICLs. Only 
long, single-stranded DNA activates T7GP4’s dTTPase activity. Thus, dTTP hydrolysis by 
T7GP4 is not always a direct measure of its translocation along DNA and cannot provide 
information about whether T7GP4 is impaired in its traverse of DNA containing bisQMAcr 
ICLs. 
 
 5.2.3 Heterogeneous Response to Crosslinked DNA by T7GP4 
 Although T7GP4 unwinds DNA containing bisQMAcr ICLs, only 40% of the ICLs 
dissociate, while the remaining ICLs stay intact. However, the question lingers of why 100% 
of bisQMAcr’s DNA ICLs aren’t unwound by T7GP4. The possibility that the reaction 
components required for unwinding to occur, such as dTTP, T7GP4, and incubation time, 
may limit the yield of unwinding was investigated. The amount of dTTP could limit 
unwinding if the initial aliquot of dTTP were hydrolyzed within incubation period, while 
T7GP4 could limit unwinding if the enzyme became inactive within 30 min. BisQMAcr 
DNA ICLs in OD15/[
32
P]-OD16 were incubated with T7GP4 and dTTP for 30 min, before 
an additional aliquot of either dTTP or T7GP4 was added to the mixture (Figure 5.6A). 
Neither additional dTTP nor T7GP4 increased the observed 40% yield of unwound ICLs 
(Figure 5.6B, C). Crosslink unwinding is not limited by the amount of dTTP present or by 
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the loss of activity of T7GP4 over time. There may then be a mixture of bisQMAcr-DNA 
adducts, some of which facilitate rapid DNA unwinding, and others that either resist 
unwinding or require a longer incubation time with T7GP4 in order to allow DNA 
unwinding.  
Figure 5.6 Determination of whether dTTP or T7GP4 limit unwinding of DNA 
containing bisQMAcr crosslinks. A) Scheme depicting the experimental setup. B) 
Crosslinked OD15/[
32
P]-OD16 (10 nM) was incubated with dTTP (1 mM) and T7GP4 
(55 nM monomer concentration) for 30 min at 37 ºC. Samples were divided into three 
sets. To one set was added buffer, to the second was added a fresh aliquot of dTTP, and 
to the third was added a fresh aliquot of T7GP4. Samples (10 µL) were incubated at 37 
ºC and quenched at 0, 1, 5, 10, 20, and 30 min with EDTA (40 mM). Samples were 
separated by 10% denaturing PAGE and visualized by phosphorimagery. C) The data 
from three individual experiments were quantified and plotted against time. The amount 
of crosslinked DNA (%) was expressed relative to the total signal of DNA on the gel. 
Data from three separate trials of the experiment are reported, with bars representing the 
average of the data from the three independent experiments. 
134 
 
 While T7GP4 unwinds a stoichiometric concentration of unmodified duplex DNA 
within 10 min, complete unwinding of bisQMAcr’s crosslinks may require a longer 
incubation time since the ICLs may present an obstacle for T7GP4. BisQMAcr may react 
with a variety of DNA nucleobases to form some lesions that present less of a challenge than 
others for T7GP4 to unwind. To determine if a longer incubation time increases the yield of 
bisQMAcr ICLs that T7GP4 unwinds, OD15/[
32
P]-OD16 containing bisQMAcr ICLs was 
incubated with T7GP4 and dTTP for 4 h rather than 30 min, as before (Figure 5.7A). The 
Figure 5.7 Extended time course of T7GP4 unwinding of OD15/[
32
P]-OD16 containing 
bisQMAcr crosslinks. A) Scheme depicting the experimental setup. B) Crosslinked 
OD15/[
32
P]-OD16 (10 nM) was incubated with dTTP (1 mM) and T7GP4 (55 nM 
monomer concentration) at 37 ºC and samples were quenched after 0, 1, 5, 10, 20, 30, 60, 
120, and 240  min with EDTA (40 mM). Samples were separated by 10% denaturing PAGE 
and visualized by phosphorimagery. C) The data in (B) were quantified and the amount of 
crosslink remaining was plotted over time. The amount of crosslink (%) was expressed 
relative to the total signal of DNA on the gel. Data from three separate trials of the 






yield of crosslink dissociation again plateaued after the first 30 min, and remained constant 
from 30 min to 4 h of incubation with T7GP4 (Figure 5.7B, C). The amount of time provided 
for unwinding to occur does not appear to limit the yield of crosslinks that T7GP4 
dissociates.  
 The failure of the reaction components (dTTP and T7GP4) and the incubation time to 
limit the yield of bisQMAcr ICL dissociation by T7GP4 suggests that the helicase may be 
inhibited or sequestered by bisQMAcr DNA ICLs. Benzo[α]pyrene lesions have been 
reported to inhibit T7GP4’s translocation along DNA.
137, 138
 A complex consisting of T7GP4 
and bound dTTP was isolated, suggesting that the adducts sequestered T7GP4 with dTTP and 
was unable to be hydrolyzed to allow translocation along the DNA.
137
 To determine whether 
bisQMAcr’s ICLs inhibit T7GP4, non-radiolabeled bisQMAcr-treated OD15/OD16 was 
incubated with T7GP4 and dTTP for 10 min before addition of radiolabeled bisQMAcr-
treated OD15/[
32
P]-OD16 for 30 min (Figure 5.8A). T7GP4 unwound DNA containing 
bisQMAcr’s ICLs in a time-dependent manner (Figure 5.8B, C). Crosslink unwinding 
proceeded with a yield of approximately 80% of the ICLs remaining intact, as opposed to 
60% remaining intact in previous experiments (Figure 5.2B, C). Prior work has established 
that T7GP4 unwinds duplex DNA in a concentration-dependent manner.
141, 148
 To confirm 
that the lower yield of crosslink hydrolysis results from an increased concentration of 
substrate DNA present in the preincubation experiment, T7GP4 and dTTP were incubated 
with 20 nM of bisQMAcr-treated OD15/[
32
P]-OD16, compared with 10 nM in previous 
experiments (Figure 5.9A). T7GP4 unwound approximately 20% of the ICLs, with the 
remaining 80% of ICLs staying intact (Figure 5.9B, C). Thus, the increased concentration of 
substrate DNA accounts for the lower yield of ICLs unwound by T7GP4.  
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T7GP4 was not inhibited by bisQMAcr’s crosslinks, since further unwinding 
occurred after the initial 10 min preincubation period. To rule out the possibility that T7GP4 
is sequestered in a complex with bisQMAcr’s ICL, T7GP4 was incubated with the unlabeled 
DNA in the presence or absence of dTTP for the initial 10 min preincubation period (Figure 
5.8A). T7GP4 requires dTTP for its loading onto and translocation through single-stranded 
Figure 5.8 Preincubation of T7GP4 with OD15/[
32
P]-OD16 containing bisQMAcr 
crosslinks in the presence and absence of dTTP. A) Scheme depicting the experimental 
setup. B) Unlabeled, preannealed OD15/OD16 (300 nM) in MES (10 mM, pH 7) and NaF 
(50 mM) was treated with bisQMAcr (250 M) for 2 h at ambient temperature. Excess 
bisQMAcr and its low molecular weight products were removed with a P6 Micro-spin 
column. The unlabeled crosslinked OD15/OD16 (10 nM) that was recovered from the spin 
column was incubated in buffer (40 mM Tris-HCl pH 7.5, 10 mM MgCl2, and 50 mM 
potassium glutamate) with T7GP4 (55 nM monomer concentration) at 37 ºC for 10 min in 
the presence or absence of dTTP (1 mM). dTTP (1 mM) was added to the sample that 
lacked dTTP during the preincubation and radiolabeled crosslinked OD15/[
32
P]-OD16 (10 
nM) was then added to all samples and samples were quenched after 0, 1, 5, 10, 20, and 
30 min with EDTA (40 mM). Samples were separated by 10% denaturing PAGE and 
visualized by phosphorimagery. C) The data depicted in (B) were quantified and the 
amount of crosslink remaining was plotted over time. The amount of crosslink (%) was 
expressed relative to the total signal of DNA on the gel. Data from three separate trials of 
the experiment are reported, with bars representing the average of the data from the three 







 Comparing differences in ICL unwinding in the presence and absence of dTTP 
in the preincubation may determine whether or not T7GP4 is sequestered as a complex with 
the ICL. Preincubation in the absence of dTTP will prevent loading of T7GP4 onto the DNA 
containing ICLs, while preincubation in the presence of dTTP will permit T7GP4’s loading 
onto the DNA. T7GP4 unwound 40% of  bisQMAcr’s ICLs in OD15/[
32
P]-OD16 in both the 
presence and absence of dTTP during the initial preincubation (Figure 5.8B, C). These data 
Figure 5.9.  Unwinding of 20 nM of DNA containing bisQMAcr crosslinks by T7GP4. A) 
Scheme depicting the experimental setup. B) Crosslinked OD15/[
32
P]-OD16 (20 nM) was 
incubated with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) at 37 ºC and 
samples were quenched after 0, 1, 5, 10, 20, and 30 min with EDTA (40 mM). Samples were 
separated by 10% denaturing PAGE and visualized by phosphorimagery. C) The data 
depicted in (B) were quantified and the amount of crosslink remaining was plotted over 
time. The amount of crosslink (%) was expressed relative to the total signal of DNA on the 
gel. Data from three separate trials of the experiment are reported, with bars representing the 





suggest that T7GP4 is not sequestered since unwinding occurs with the same yield regardless 
of whether T7GP4 was loaded onto the unlabeled OD15/OD16 bisQMAcr ICLs or not. 
 Our data rule out limitations resulting from dTTP, enzyme, and incubation time as 
causes for the dissociation of only 40% of bisQMAcr’s ICLs by T7GP4’s unwinding of 
duplex DNA. Additionally, T7GP4 is not inhibited or sequestered by the ICLs. Thus, there 
are likely multiple subpopulations of DNA containing bisQMAcr ICLs, some of which resist 
unwinding by T7GP4, while others permit unwinding. BisQMAcr displays a strong 
preference for alkylating reversibly at dGN7s, but may form a mixture of both reversible and 
irreversible DNA adducts.
37, 41
 The subpopulations that permit unwinding may be 
bisQMAcr’s reversible DNA adducts, while those that resist unwinding may be irreversible 
adducts. BisQMAcr may form irreversible adducts by reacting with dAN6, dGN1, or dGN2 
(refer to Chapter 1, Scheme 1.4). BisQMAcr may either immediately form a mixture of 
reversible and irreversible adducts upon reacting with the DNA, or its reversible adducts may 
regenerate and evolve in a time-dependent manner to form irreversible adducts.
37
 A 
possibility is that T7GP4 may promote the migration of reversible to irreversible adducts, 
which could prevent their helicase-mediated dissociation,. Although it is possible for 
bisQMAcr to react immediately to form a mixture of irreversible and reversible DNA 





5.2.4 Failure to Unwind DNA Containing Irreversible Mechlorethamine 
Crosslinks by T7GP4 
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Based on the data obtained so far, we hypothesize that T7GP4 is able to unwind only 
bisQMAcr’s reversible ICLs, but not its irreversible ICLs. To confirm that T7GP4 fails to 
separate irreversible ICLs, DNA containing irreversible ICLs was used as a substrate for 
T7GP4’s unwinidng. The nitrogen mustard mechlorethamine (HN2) crosslinks DNA 




P]-OD16 was treated with HN2 before 
Figure 5.10 T7GP4 does not unwind DNA containing mechlorethamine crosslinks. A) 
Scheme depicting the experimental setup. B) Pre-annealed OD15/[
32
P]-OD16 (300 nM) in 
potassium phosphate buffer (40 mM, pH 8) and NaCl (10 mM) was treated with 
mechlorethamine (5 mM) for 3 h at 37 C. Excess mechlorethamine was removed with a P6 
Micro-spin column. The resulting mixture containing duplex and crosslinked OD15/[
32
P]-
OD16 (10 nM) was incubated in buffer (40 mM Tris-HCl pH 7.5, 10 mM MgCl2, and 50 mM 
potassium glutamate) with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) at 37 
ºC and samples were quenched after 0, 1, 5, 10, 20, and 30 min with EDTA (40 mM). 
Samples were separated by 10% denaturing PAGE and visualized by phosphorimagery. C) 
The data depicted in (B) were quantified and the amount of crosslink remaining was plotted 
over time. The amount of crosslink (%) was expressed relative to the total signal of DNA on 
the gel. Data from three separate trials of the experiment are reported, with bars representing 




incubation with T7GP4 and dTTP to determine whether T7GP4 unwinds DNA containing 
irreversible ICLs (Figure 5.10A). HN2 crosslinks OD15/[
32
P]-OD16 less efficiently than 
bisQMAcr, generating a 60% yield of ICLs as opposed to the 100% yield formed with 
bisQMAcr (Figure 5.10B). Incubation with T7GP4 and dTTP did not change the yield of 
HN2’s DNA ICLs over time (Figure 5.10B, C). T7GP4 fails to unwind DNA containing 
irreversible ICLs induced by HN2, as the ICLs do not dissociate to form single-stranded 
DNA after incubation with T7GP4. T7GP4 is only able to unwind reversible bisQMAcr 
DNA ICLs, but not irreversible HN2 ICLs. This result could be extrapolated to suggest that 
the subpopulations of bisQMAcr ICLs that are not unwound by T7GP4 constitute irreversible 
DNA ICLs formed by bisQMAcr.  
 Several irreversible DNA ICLs have been demonstrated to block DNA replication by 
preventing DNA synthesis by polymerases, while little evidence exists of the effect of 
reversible ICLs on the ability of helicases to unwind DNA. HN2 and psoralen’s potency as 
chemotherapeutics is thought to arise from their capacity to block replication through their 
irreversible covalent chemistry with DNA.
153, 154
 The specific contributions of helicases and 
polymerase in vitro to ICL’s ability to inhibit replication have not been extensively 
developed. Our results suggest that ICLs prevent the action of helicases to unwind DNA 
during its replication, but only if the ICLs are irreversible. BisQMAcr’s reversible chemistry 
likely permits dissociation of its crosslinks to single-stranded DNA by T7GP4 since we and 
reports in the literature have demonstrated the inability of helicases to separate irreversible 
ICLs. Neither supplementing DNA unwinding reactions with dTTP or T7GP4 nor increasing 
the incubation time permit consumption of the 60% of bisQMAcr’s ICLs that resist 
unwinding. BisQMAcr’s ICLs also do not inhibit T7GP4’s ability to dissociate from DNA 
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containing irreversible ICLs and unwind other duplex DNA molecules. Our data suggest that 
bisQMAcr’s ICLs that resist DNA unwinding are irreversible, since other possibilities have 
been ruled out as to why 60% of the ICLs remain intact. If bisQMAcr’s irreversible ICLs do 
not dissociate to single-stranded DNA upon incubation with T7GP4, then it is likely that 
bisQMAcr’s ICLs that do hydrolyze represent reversible DNA adducts.  
 
 
5.2.5 Mechanism of Crosslink Dissociation 
The mechanism for how T7GP4 achieves ICL dissociation remains to be uncovered. 
One mechanism of ICL dissociation could be hydrolysis of bisQMAcr’s ICL from one DNA 
strand, while the other strand maintains a bisQMAcr adduct. The translocating and 
nontranslocating DNA strands were alternatively radiolabeled and treated with piperidine 
after incubation with T7GP4 to examine whether a loss of adducts is evident on either DNA 
strand (Scheme 5.11A). The heterogeneous OD13/OD14 sequences were utilized instead of 
OD15/OD16 because OD15 contains only a single G, which would at most lead to a single 
fragment following piperidine treatment. Furthermore, the DNA was treated with 50 µM, 
rather than 250 µM of bisQMAcr in order to minimize over-alkylation of the DNA. More 
than one adduct per DNA strand would complicate analysis of individual adducts after 
treatment with piperidine. No loss of fragments was evident using either radiolabeled OD13 
or OD14 (Figure 5.11B, C). This result is inconsistent with the dissociation of ICLs that is 
evident from denaturing PAGE analysis that revealed distinct species corresponding to the 
ICL and single-stranded DNA (Figure 5.1B) This result would imply that bisQMAcr’s dGN7 
adducts are not lost from either the translocating or non-translocating DNA strands. Further, 
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the relative quantities of fragmentation at individual dGN7s did not change over time. 
However, comparison of the data to the background fragmentation that resulted from 
piperidine cleavage of DNA that was not treated with bisQMAcr indicates that the signal to 
noise ratio was too low properly to evaluate the data (Figure 5.11B, C).  
As an alternate approach to determine how T7GP4 induces hydrolysis of 
BisQMAcr’s ICLs, T7GP4’s ability to cause the loss of monoQMAcr-DNA adducts was 
investigated. Loss of monoQMAcr adducts would indicate that T7GP4 causes QM adducts to  
dissociate from the DNA. A loss of monoQMAcr adducts from DNA will assess whether or 
not T7GP4 hydrolyzes QM-DNA adducts from a single strand of DNA, just as the 
experiment detailed in Figure 5.11A would have. However, the ease of detecting adducts is 
easier in this case due to a greater signal to noise ratio. Piperidine cleavage can occur if an 
abasic site is present in the DNA, resulting in high levels of background fragmentation. DNA 
containing monoQMAcr adducts migrates distinctly on denaturing PAGE from unmodified 
single-stranded DNA. Comparison of the profile of adducts evident on denaturing PAGE 
following incubation with T7GP4 can provide direct evidence of a loss of QM adducts from 
a particular DNA strand. [
32
P]-OD15/OD16 was treated with monoQMAcr before incubation 
with T7GP4 and dTTP for 30 min to determine whether adducts are lost from the 
translocating strand (Figure 5.12A). Approximately 50% of monoQMAcr’s DNA adducts 
were lost following incubation with T7GP4, as evidenced by the time-dependent 
disappearance of the more slowly migrating species and appearance of the more quickly 
migrating species corresponding to unmodified [
32
P]-OD15 (Figure 5.12B, C). Alternatively, 
OD15/[
32
P]-OD16 was treated with monoQMAcr before incubation with T7GP4 and dTTP 









bisQMAcr crosslinks after unwinding by T7GP4. A) Scheme depicting the experimental 
setup. Either B) OD13/[
32
P]-OD14 (300 nM) or C) [
32
P]-OD13/OD14 in MES (10 mM, pH 
7.0) and NaF (10 mM) was treated with bisQMPAcr (50 µM) for 30 min, before excess QM 
was removed with a P6 spin column (1000 g, 4 min). Crosslinked OD13/OD14 (10 nM) 
was incubated in buffer (40 mM Tris-HCl pH 7.5, 10 mM MgCl2, and 50 mM potassium 
glutamate) with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) at 37 ºC and 
samples were quenched after 0, 1, 5, 10, 20, and 30 min with EDTA (40 mM). Samples 




T7GP4’s unwinding of duplex DNA not only causes the loss of monoQMAcr adducts on the 
translocating strand, but also on the non-translocating strand (Figure 5.12D, E).  
T7GP4’s translocation along DNA affects the stability of monoQMAcr adducts on 
both strands of the duplex. T7GP4 translocates along a single strand of DNA by passing the 
DNA through a central channel formed by its 6 monomers that assemble into a ring-like 
hexamer.
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 Passage of the DNA containing monoQMAcr adducts through the central 
channel may assist in hydrolysis of the QM from its DNA-adducts by providing a mechanical 
force that facilitates bond cleavage. The adducts may not fit within the steric constraints of 
the channel, which may contribute to bond cleavage that hydrolyzes the QM from the DNA. 
T7GP4 also interacts with the non-translocating strand through hydrophobic interactions with 
a phenylalanine residue that exclude the strand from entering the central channel.
18, 25
 The 
dynamic hydrophobic DNA-protein interactions that occur with the phenylalanine on the 
non-translocating strand during T7GP4’s translocation may contribute to the loss of 
monoQMAcr adducts on the non-translocating strand.  
The loss of monoQMAcr adducts on both DNA strands suggests a potential 
mechanism for how T7GP4 mediates dissociation of bisQMAcr’s DNA ICLs (Scheme 5.2). 
T7GP4 binds a 5’-single-stranded DNA tail and translocates along the DNA until 
encountering a bisQMAcr ICL. T7GP4’s translocation likely leads to loss of the QM-DNA 
adduct from the translocating strand by cleavage of the bond between the QM and dGN7. 
The regenerated QM intermediate likely then reacts with a water molecule, before 
dissociation QM-DNA adduct from the non-translocating strand and subsequent reaction 
with water. T7GP4 can complete its translocation along the DNA to fully unwind the duplex 




Figure 5.12 Loss of monoQMAcr-DNA adducts induced by T7GP4. A) Scheme 
depicting the experimental setup. B)  Alkylated [
32
P]-OD15/OD16 (10 nM) was 
incubated with dTTP (1 mM) and T7GP4 (55 nM monomer concentration) at 37 ºC and 
samples were quenched after 0, 1, 5, 10, 20, and 30 min with EDTA. Samples were 
separated by 10% denaturing PAGE and visualized by phosphorimagery. C) The time-
dependent unwinding of alkylated [
32
P]-OD15/OD16 depicted in (B) was quantified and 
the amount of alkylated DNA remaining was plotted over time. The amount of alkylated 
DNA (%) was expressed relative to the total signal of DNA on the gel. Data from three 
separate trials of the experiment are reported, with bars representing the average of the 
three independent experiments. D) Time-dependent unwinding of monoQMAcr alkylated 
OD15/[
32
P]-OD16 was performed analogously to the experiment described in (B). E) 




T7GP4 likely dissociates from the duplex DNA upon encountering an irreversible 
QM-DNA adduct, as its translocation along the DNA will not be able to dissociate an 
irreversible ICL. Ongoing experiments seek to confirm the loss of the QM from the DNA and 
the formation of the QM-H2O adduct by quantifying the time-dependent generation of the 
QM-H2O adduct via UPLC-MS. Achieving this result would provide further support for our 
proposed mechanism of crosslink dissociation.  
 
5.3 Summary 
 T7GP4 causes some of bisQMAcr’s DNA ICLs to dissociate when it unwinds duplex 
DNA that contains bisQMAcr ICLs. Crosslink hydrolysis by T7GP4 depends on the presence 






of dTTP, which suggests T7GP4’s translocation along DNA results in ICL dissociation. 
There does not appear to be sequence dependence for crosslink consumption by T7GP4, as 
incubation with T7GP4 led to the dissociation of bisQMAcr ICLs in two different DNA 
sequences. However, only 40% of bisQMAcr’s ICLs separated into single-stranded DNA, 
while the other 60% of the ICLs remained intact and resisted unwinding by T7GP4. Multiple 
subpopulations of DNA containing bisQMAcr ICLs likely exist because neither increasing 
the concentrations of dTTP or T7GP4 nor increasing the incubation time improved the yield 
of ICL unwinding. Furthermore, T7GP4 was not sequestered by bisQMAcr’s DNA ICL, as 
preincubation with unlabeled DNA containing bisQMAcr’s ICL did not affect T7GP4’s 
unwinding activity. BisQMAcr likely forms a mixture of reversible and irreversible DNA 
ICLs, where the reversible ICLs permit unwinding and the irreversible ICLs resist 
unwinding. T7GP4 is unable to unwind DNA containing irreversible ICLs formed by the 
nitrogen mustard mechlorethamine, which lends support to the notion that irreversible 
bisQMAcr ICLs may resist unwinding. 
 T7GP4 likely causes bisQMAcr’s ICLs to dissociate by first removing the adduct 
from the translocating strand by facilitating regeneration of one of bisQMAcr’s electrophile. 
The QM likely reacts with a water molecule before the lesion on the non-translocating strand 
is removed. This would then allow T7GP4 to complete its translocation along the DNA, 
while generating the bisQMAcr-H2O adduct. Our results suggest that reversible DNA ICLs 
may not pose a replication block, at least for DNA helicases. Helicase unwinding of 
reversible ICLs may represent a means by which reversible DNA lesions can be repaired 
without relying on specific DNA repair enzymes to process the damaged DNA. QMs 
generated from the metabolism of toxins may pose little damage to cells if helicases can 
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remove their reversible lesions from DNA. It remains to be seen whether all hexameric 
helicases can dissociate bisQMAcr’s ICLs, or whether T7GP4 is unique in that respect. 
 
5.4 Materials and Methods 
 5.4.1 Materials 
General Materials. Oligonucleotides (desalted) were synthesized by Integrated DNA 
Technologies (IDT) and PAGE purified prior to use.  BisQMPAcr was prepared as described 
previously,
40
 and monoQMPAcr was a gift from Blessing Deeyaa.
 53
 Oligonucleotides were 
radiolabeled on their 5’-terminus as described in Chapter 2.  M13mp18 single-stranded DNA 





P-dTTP were purchased from Perkin Elmer. PEI-cellulose coated TLC 
plates (20 x 20 cm, 100 µm layer thickness), 5’-ATP agarose resin (catalog number A2767), 
and dTTP (sodium salt solution, PCR grade) were purchased from Sigma-Aldrich. P6 Micro 
Bio-Spin columns and Bradford reagent were purchased from Bio-Rad. HisPur™ Ni-NTA 
resin was purchased from ThermoFisher Scientific. Amicon Ultra centrifugal filters with a 
10,000 molecular weight cutoff were purchased from Millipore. The plasmid harboring the 
gene for the 56 kDa fragment of T7GP4 was a gift from Prof. Charles Richardson. Dr. 
Seung-Joo Lee from the Richardson Lab provided helpful suggestions to troubleshoot the 
purification of T7GP4. 
 
 5.4.2 Methods 
General Methods. Detection and quantification of radiolabeled oligonucleotides was 
carried out using a Typhoon 9410 phosphorimager equipped with ImageQuant TL software.  
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Products were quantified and yields were reported (%) relative to total labeled DNA. The 
concentrations of all oligonucleotides were calculated from their absorption at 260 nm and 
their extinction coefficients that were provided by the manufacturer.  Protein concentration 
was determined by its absorbance at 595 nm after the addition of Bradford reagent. DNA was 
treated with hot piperidine as described in Chapter 2. 
 
Overexpression and purification of T7GP4. Overexpression and purification was adapted 
from a previous protocol.
15
 The plasmid pET19-56-Kan) containing a gene fusion of His10 
and the 56 kDa fragment of T7GP4 was described previously.
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 The plasmid was 
transformed into E.Coli NiCo21(DE3) chemically competent cells on media supplemented 
with kanamycin (50 µg/mL). Cultures were grown in LB media (1 L) supplemented with 
kanamycin (50 µg/mL) at 37 ºC with vigorous shaking (220 rpm) until they reached an OD600 
of ~ 1. Expression of T7GP4 was induced with isopropyl-β-D-thiogalactopyranoside at a 
final concentration of 1 mM at 37 ºC for 3 h with vigorous shaking (220 rpm). Cells were 
harvested by centrifugation (5000 rpm for 15 min, 4 ºC), flash frozen in liquid N2, and stored 
at -80 ºC until use. 
 Frozen cell pellets were thawed on ice and resuspended in 20 mL of Ni-NTA wash 
buffer 1 (50 mM potassium phosphate pH 8, 500 mM NaCl, 10 mM imidazole). Lysozyme 
was added to a final concentration of 100 µg/mL and the cells were incubated on ice for 1 h. 
Cells were lysed by three rounds of flash freezing in liquid nitrogen and thawing on ice. Cell 
debris was removed by centrifugation (35,000 g for 1 h, 4 ºC) and the resulting supernatant 
was applied by gravity to a column containing 1 mL of HisPur™ nickel-nitroloacetic acid 
resin. The column was washed with 30 mL of Ni-NTA wash buffer 1 followed by 20 mL of 
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Ni-NTA wash buffer 2 (50 mM potassium phosphate pH 8, 500 mM NaCl, 100 mM 
imidazole). The protein was then eluted with Ni-NTA elution buffer (50 mM potassium 
phosphate pH 8, 500 mM NaCl, 500 mM imidazole). The protein was desalted to remove 
imidazole using a GE PD-10 spin column (1000 g, 2 min, 4 ºC) equilibrated with ATP-
agarose wash buffer (20 mM potassium phosphate pH 6.8, 0.5 mM DTT, 10% glycerol, 500 
mM KCl, and 10 mM MgCl2. 
 The desalted protein was applied by gravity to a column containing 0.5 mL of ATP-
agarose resin.
139
 The column was washed with 10 mL of ATP-agarose wash buffer. 
Impurities resulting from proteolytic cleavage at the linker connecting the primase and 
helicase domains were eluted first with ATP-agarose elution buffer (20 mM potassium 
phosphate pH 6.8, 0.5 mM DTT, 20 mM EDTA, 10% glycerol, and 500 mM KCl). Pure 
T7GP4 was eluted by increasing the concentration of KCl to 1 M. Protein was concentrated 
to 200 µL with an Amicon Ultra-centrifugal filter with molecule weight cut-off of 10,000 
kDa. The protein was washed three times with 500 µL of H2O in the filter to dilute the salt 
concentration, and then further diluted with glycerol and potassium phosphate pH 7.5 to a 
final concentration of 50% glycerol and 20 mM potassium phosphate. Protein purity was 
determined by SDS-PAGE analysis and staining with Coomassie Blue.  
    
Crosslinking of Preannealed Duplex DNA with BisQMAcr. Duplex DNA was annealed 
by combining a labeled 5’-[
32
P]-oligonucleotide (300 nM) and its complement (300 nM) in 
MES (10 mM, pH 7) and NaF (50 mM), heating the solution at 95 ºC for 2 min and 
subsequently cooling slowly to ambient temperature. BisQMPAcr in acetonitrile was then 
added to the mixture above to generate a final solution of 20 L that contained 20% 
151 
 
acetonitrile and 250 µM of bisQMPAcr. The reaction was incubated at ambient temperature 
for 2 h. Excess bisQMAcr and its low molecular weight products were removed from the 
DNA with a Bio-Rad P6 Micro Bio-Spin column prewashed with water (1000 g, 4 min). The 
eluent was stored at -20 ºC until use. 
 
Unwinding of Unmodified Duplex DNA by T7GP4.
14
 A duplex DNA substrate containing 
noncomplementary single-stranded tails was prepared by annealing 5’-
32
P-labeled DNA to its 
complement, as described above. The indicated amounts of T7GP4 (in 50% glycerol, 20 mM 
potassium phosphate, pH 7.5) were added to the DNA substrate (10 nM) in a buffer 
containing 40 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM potassium glutamate, and 1 mM 
dTTP. Samples (10 µL) were incubated at 37 ºC for 10 min. The reaction was terminated by 
the addition of EDTA to a final concentration of 40 mM (1 µL) and 30% glycerol loading 
buffer containing bromophenol blue and xylene cyanol (4 µL). Aliquots of each sample (4 
µL) were loaded onto a gel (10 x 8 x 0.15 cm) and separated by 10% nondenaturing PAGE 
(0.5 x TBE, 60 V, 2.5 h). 
 
Unwinding of Crosslinked DNA by T7GP4. The experiment was conducted as described 
above, but using crosslinked DNA. Samples were combined with bromophenol blue and 
xylene cyanol in formamide (10 µL) for separation by 10% denaturing PAGE. 
 
Crosslinking of Preannealed Duplex DNA with HN2. Duplex DNA was annealed by 
combining a labeled 5’-[
32
P]-oligonucleotide (300 nM) and its complement (300 nM) in 
potassium phosphate (40 mM, pH 8) and NaCl (10 mM), heating the solution at 95 ºC for 2 
min and subsequently cooling slowly to ambient temperature. HN2 (from a fresh solution in 
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40 mM potassium phosphate buffer, pH 8) was then added to the mixture above to a final 
concentration of 5 mM. The reaction was incubated at 37 ºC for 3 h. Excess HN2 and its low 
molecular weight products were removed from the DNA with a Bio-Rad P6 Micro Bio-Spin 
column prewashed with water (1000 g, 4 min). The eluent was stored at -20 ºC until use. 
 
Hydrolysis of dTTP by T7GP4.
140 
T7GP4 (55 nM monomer concentration, 2 µL, in 50% 
glycerol, 20 mM Tris-HCl pH 7.5) was added to crosslinked OD1-39T/ OD4L-19T (10 nM) 
in a buffer containing 40 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM potassium glutamate, 
and 1 mM [α-
32
P]-dTTP (0.1 µCi). Samples (10 µL) were incubated at 37 ºC and quenched at 
the indicated times by the addition of 10% formic acid (10 µL). Aliquots (1 µL) of each 
sample were spotted onto a PEI-cellulose TLC plate for separation. The TLC plate was 
developed with a solution containing 0.5 M formic acid and 0.5 M LiCl for 1.5 h. The plate 











Chapter 6: Conclusions 
 
 The environment contains numerous compounds that generate electrophiles upon 
metabolic activation.  Pollutants, food additives, products of combustion, and drugs can 
alkylate DNA’s nucleobases following their activation from metabolism. The lesions 
produced by these alkylating agents may prevent replication of DNA and suppress gene 
expression. Accumulation of adducts within DNA may also result in DNA mutations and 
initiate the progression of cancer. Achieving an understanding of the toxicology of naturally 
occurring alkylating agents is necessary to determine the role of environmental electrophiles 
in mutagenesis and disease progression. However, not all alkylating agents react irreversibly 
with DNA, as some agents form lesions that are intrinsically reversible. Reversible lesions 
may not necessarily exhibit the same toxicity as irreversible adducts, since their intrinsic 
chemistry may afford spontaneous repair of their own adducts. This dissertation investigated 
QMs as a model for reversible DNA alkylation to evaluate the consequences of this dynamic 
system in biology. 
 BisQMAcr had previously been demonstrated to migrate along DNA, albeit too 
slowly to be effective in vivo. DiQMs linked to alkylammonium chains and bisQMs 
conjugated to quinoxlines were synthesized in order to enhance the rate of QM migration 
along DNA to be relevant under physiological conditions. Neither diQMN3 nor 
bisQMQuins1-4 migrated along DNA, as their binding precluded dynamic DNA alkylation. 
Polyammonium groups directed diQMN3 to bind in the minor groove and react with the 
accessible nucleophiles that form irreversible QM-DNA adducts, while the quinoxalines may 
have bound DNA too weakly to afford significant yields of ICLs. DiQMs possessed 
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increased conformational flexibility relative to bisQMs and predominantly formed 
monoadducts rather than ICLs with DNA. The conformational flexibility of diQMs may be 
well-suited for future evaluation as DNA-protein crosslinking agents, since coupling to bouth 
targets may require conformational freedom. A delicate balance between strong binding to 
DNA and reaction with nucleophiles that form reversible adducts must be achieved to 
successfully design a bifunctional QM capable of quickly migrating along duplex DNA. 
DiQMN3 likely bound DNA in the minor groove where it predominantly formed irreversible 
DNA-adducts. On the other hand, the bisQMQuins likely bound in a conformation that 
delivered the QMs to the major groove where they could react reversibly with DNA. 
However, the bisQMQuins may have bound too weakly to afford high yields of crosslinks.  
BisQMAcr binds strongly enough and in the major groove to produce high yields of 
reversible DNA ICLs, but still manages to dissociate from the DNA in order to traverse the 
duplex DNA. BisQMAcr represents the best QM to investigate the biological consequences 
of dynamic alkylation even though it required 7 days to migrate. 
 Although BisQMAcr’s dynamic DNA alkylation was demonstrated using DNA free 
in solution, this does not represent DNA as is found in cells. DNA is packaged around an 
octamer of the four core histone proteins to form nucleosomes in order to fit the constraints 
of a cell. The true potency of a DNA alkylating agent in a cell should include evaluation by 
determining its efficiency of alkylation with DNA packaged in the NCP. BisQMAcr’s 
potency for alkylation decreases by 90% with the DNA in the NCP relative to DNA free in 
solution, illustrating a protective function of NCP assembly. NCPs further protect against 
QM-DNA damage by serving as terminal acceptors of bisQMAcr’s DNA adducts, restoring 
the DNA to its unmodified state once bisQMAcr spontaneously releases from the DNA. 
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BisQMAcr adducts on the histones do not prevent formation of nucleosomes as bisQMAcr’s 
histone adducts do not impair assembly of the NCP. This effect differs from suppressed NCP 
formation that occurs using alkylated DNA. Consequently, QMs formed from metabolic 
activation in the body may not significantly affect regulation of the genome, at least at the 
level of DNA packaging, since few DNA adducts will form in the NCP and histone adducts 
will not impair formation of new nucleosomes. The greatest yield of bisQMAcr’s alkylation 
in vivo will likely occur on histone-free DNA, either in the linker DNA connecting 
nucleosomes or during DNA replication. Even if bisQMAcr alkylates histone-free DNA, the 
DNA can be repaired by transfer of the QM’s adducts to nearby histone proteins. BisQMAcr 
previously appeared to represent a promising example of a potential strategy for designing 
new chemotherapeutic alkylating agents based on its efficiency of dynamic alkylation of 
DNA free in solution. However, the significant suppression of its DNA alkylation with DNA 
in the NCP discounts its efficacy as a potential drug. Rather, our results suggest that QMs 
that form naturally as toxins may not cause as much harm as once thought, since their DNA 
adducts can be captured by the histone proteins. Whether this phenomenon extends to other 
reversible alkylating agents remains to be determined. 
 The significant suppression of bisQMAcr’s DNA alkylation with DNA packaged in 
the NCP relative to DNA free in solution suggests that bisQMAcr may have a pronounced 
effect on histone-free DNA. DNA is free from the protective functions of the nucleosome 
during its replication. BisQMAcr’s DNA crosslinks may affect the activity of the processive 
proteins that function to replicate DNA, namely polymerases and helicases. Polymerases and 
helicases were postulated to hasten bisQMAcr’s migration through DNA based on a 
mechanical force applied to reversible bisQMAcr-DNA adducts. The T7GP4 DNA helicase, 
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but not the Klenow Exo
-
 and φ29 DNA polymerases, induced dissociation of bisQMAcr’s 
DNA ICLs during its translocation along DNA. The polymerases likely stalled at sites near 
bisQMAcr’s adducts and dissociated from the DNA upon failure to bypass the lesions. 
BisQMAcr’s DNA ICLs may pose a roadblock to the primer extension activity of DNA 
polymerases and prevent DNA replication.  
Interestingly, DNA helicases unwind DNA before polymerases initiate synthesis, and 
will likely break reversible QM-DNA ICLs before the polymerase initiates its activity. Thus, 
the evolutionary role of helicases acting on DNA before polymerases may facilitate DNA 
replication in the presence of reversible DNA ICLs. Dissociation of reversible DNA ICLs by 
helicases represents a second mechanism by which the reversibility of bisQMAcr’s chemistry 
with DNA enables repair of its adducts. Furthermore, our observation that DNA helicases 
dissociate bisQMAcr’s reversible DNA ICLs challenges the paradigm that the severe toxicity 
of DNA ICLs to cells derives from their ability to block DNA replication. Our data, while 
specific to bisQMAcr and T7GP4, suggests that reversible DNA adducts, unlike irreversible 
adducts, may not inhibit DNA replication by preventing separation of DNA’s strands.  
 The work presented in this dissertation uncovered several mechanisms by which 
reversible QM-DNA adducts are repaired during the packaging and processing of DNA by 
the histone proteins and DNA helicases. Reversible  QMs may lead to reduced toxicity for 
cells than irreversible alkylating agents due to the reduction in their potency of DNA 
alkylation that results from their reversible chemistry. QMs formed as undesired byproducts 
of metabolism, such as the QM formed from oxidation of BHT, may not induce toxicity to 
cells, since their adducts should not resist unwinding by DNA helicases and will not preclude 
DNA replication. Future efforts can be directed towards understanding the properties that 
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permit DNA helicases to break apart bisQMAcr’s reversible DNA ICLs. Presumably, the 
force generated by helicases during their translocation may facilitate cleavage of the bond 
formed between bisQMAcr and dGN7, but would need to be verified experimentally. 
Additionally, the generality of bisQMAcr’s ICL dissociation by helicases could be 
established by examining whether other hexameric helicases, such as DnaB from E.coli, are 
also able to break reversible ICLs. T7GP4 belongs to helicase superfamily 4, but helicases 
from the other five superfamilies could be evaluated for their ability to break apart 
bisQMAcr’s revesible ICLs to further generalize the phenomenon of crosslink unwinding. 
Helicases across different superfamilies differ in their sequence motifs, polarity of 
translocation, ring structure, and preference for translocating along duplex or single-stranded 
DNA. How the characteristics of helicases in each superfamily affect their ability to break 
apart bisQMAcr’s ICLs could be evaluated more comprehensively to understand the 
mechanistic basis of how T7GP4 dissociates reversible bisQMAcr ICLs. Our work has 
provided a glimpse into how QM’s reversible alkylation will affect biochemical processes 
within the cell. However, determining the consequences of bisQMAcr’s alkylation in vivo 
and its potential effect on cellular fitness represents the next step towards elucidating the 
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Sequence (5’ to 3’) 
OD1  GTA TGG CAC ACA CAG GTC AGT CAT GTC GTT AAT CGC 
GCG CAT AA 
OD2  TTA TGC GCG CGA TTA ACG ACA TGA CTG ACC TGT GTG 
TGC CAT AC 
OD3  ATG TCG TTA ATC GCG CGC ATA A 
OD4  GTA TGG CAC ACA CAG GTC AGT C 
OD5  GTC GTT AAT CGC GCG CAT AA 
OD6  TTA TGC GCG CGA TTA ACG ACA TGA C 
OD7  TGA CCT GTG TGT GCC ATA CT 
OD8  AGT ATG GCA CAC ACA GGT CAG TCA T 
OD9  TTA TGC GCG CTT GAT TAA CGA CAT GAC TGA CCT GTG 




ATC GAT GTA TAT ATC TGA CAC GTG CCT GGA GAC TAG 
GGA GTA ATC CCC TTG GCG GTT AAA ACG CGG GGG 
ACA GCG CGT ACG TGC GTT TAA GCG GTG CTA GAG CTG 






ATC AGA ATC CCG GTG CCG AGG CCG CTC AAT TGG TCG 
TAG ACA GCT CTA GCA CCG CTT AAA CGC ACG TAC GCG 
CTG TCC CCC GCG TTT TAA CCG CCA AGG GGA TTA CTC 
CCT AGT CTC CAG GCA CGT GTC AGA TAT ATA CAT CGA 
T 
OD10  GTA TGG CAC ACA CAG 
OD11  GTG TGT GGT GGG TGG CGG TTG AAG AGG TAA A 
OD12  TTT ACC TCT TCA ACC GCC ACC CAC CAC ACA CCC AAC 
CAC CAC ACC ACT GTG TGT GCC ATA C 
OD13 TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT 
GGC ATG TCA CGA CGT TGT AAA ACG ACG GCC AGT 
GAA TTC GAG CTC GGT ACC CGG CG 
OD14  CGC CGG GTA CCG AGC TCG AAT TCA CTG GCC GTC GTT 
TTA CAA CGT CGT GAC ATG CCT TTT TTT TTT TTT TTT 
TTT 
OD15  TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT ACC TCT TCA ACC GCC ACC CAC CAC ACA CCC AAC 
CAC CAC ACC A 
OD16  TGG TGT GGT GGT TGG GTG TGT GGT GGG TGG CGG TTG 
AAG AGG TAA ATT TTT TTT TTT TTT TTT TT 
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H NMR of 2 in CD3OD at 400 MHz 
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C NMR of 3 in CDCl3 at 101 MHz 
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Figure B.5
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C NMR of 5 in CDCl3 at 101 MHz 
 
Chemical Shift (ppm) 
Intensity  


































C NMR of 6 in CDCl3 at 101 MHz 
 
Chemical Shift (ppm) 
Intensity  



































C NMR of 7 in CDCl3 at 101 MHz 
 
Chemical Shift (ppm) 
Intensity  
































C NMR of 8 in CDCl3 at 101 MHz 
Figure B.13
  1
H NMR of 8 in CDCl3 at 400 MHz 
 
Chemical Shift (ppm) 
Intensity  















H NMR of 16 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Figure B.16
  13
C NMR of 16 in CDCl3 at 101 MHz 























H NMR of 18 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Figure B.18
  1
H NMR of 19 in CDCl3 at 400 MHz 























C NMR of 21 in CDCl3 at 101 MHz 
Figure B.19
  1
H NMR of 21 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 























H NMR of 23 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Figure B.22
  13
C NMR of 23 in CDCl3 at 101 MHz 




















 Figure B.24  13C NMR of 24 in CDCl3 at 101 MHz 
Figure B.23
  1
H NMR of 24 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 























H NMR of 26 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Figure B.26
  13
C NMR of 26 in CDCl3 at 101 MHz 























H NMR of 28 in CDCl3 at 400 MHz 























C NMR of 29 in CDCl3 at 101 MHz 
Figure B.28
  1
H NMR of 29 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 























C NMR of 31 in CDCl3 at 101 MHz 
Figure B.30
  1
H NMR of 31 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 





















Figure B.32 Quenching of bisQMQuin3 by water. BisQMPQuin3 (500 μM) was 
incubated in MES (10 mM, pH 7), NaF (10 mM) and 20% acetonitrile for 0-24 h.  At 
each time point, duplex DNA OD1/[
32
P]-OD2 (3 μM) was added and allowed to react 
























H NMR of 32 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Figure B.34
  13
C NMR of 32 in CDCl3 at 101 MHz 























C NMR of 34 in CDCl3 at 101 MHz 
Figure B.35
  1
H NMR of 34 in CDCl3 at 400 MHz 
Chemical Shift (ppm) 
Chemical Shift (ppm) 
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Figure C.1 Reconstitution of the nucleosome core 
particle. [
32
P]-labeled Widom 601 duplex DNA (~1 
pmol) and salmon sperm DNA (84 pmol) in NaCl 
(2 M) and BSA (1 mg/mL) were combined with the 
histone octamer (84 pmol) in 2 M NaCl, 10 mM 
HEPES pH 7.8, and 1 mM EDTA (1 µL). The 
samples were incubated under ambient conditions 
for 1 h before standard serial dilution with 
nucleosome reconstitution buffer (10 mM HEPES 
pH 7.5, 1 mM EDTA, and 1 mg/mL BSA). Each 
lane (1-3) represents independent reconstitution 
experiments that were analyzed by native PAGE 









































I: 5’- A1TC GAT GTA TAT ATC TGA CAC GTG CCT GGA30 -3’ 
II: 5’- G31AC TAG GGA GTA ATC CCC TTG GCG GTT AAA ACG CG65 -3’ 
III: 5’- G66GG GAC AGC GCG TAC GTG CGT TTA AGC GGT GCT AG100 -3’ 
IV: 5’- A101GC TGT CTA CGA CCA ATT GAG CGG CCT CGG CAC CGG GAT TCT   GAT145 -3’ 
V: 5’- C251TC CCT AGT CTC CAG GCA CG270 -3’ 
VI: 5’- C216GC TGT CCC CCG CGT TTT AA235 -3’ 
VII: 5’- G181TA GAC AGC TCT AGC ACC GC200 -3’ 
VIII: 5’- A146TC AGA ATC CCG GTG CCG AGG CCG CTC AAT TGG TC180 -3’ 
IX: 5’- G181TA GAC AGC TCT AGC ACC GCT TAA ACG CAC210 -3’ 
X: 5’- G211TA CGC GCT GTC CCC CGC GTT TTA ACC GCC AAG GG245 -3’ 
XI: 5’- G246AT TAC TCC CTA GTC TCC AGG CAC GTG TCA GAT ATA TAC ATC GAT290 -3’ 
XII: 5’- A101GC TGT CTA CGA CCA ATT GA120 -3’ 
XIII: 5’- G36GG AGT AAT CCC CTT GGC GG55 -3’ 
Figure C.2 Oligonucleotides used to ligate the Widom 601 duplex DNA. 
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Figure D.1 Expression and purification of T7GP4. A) T7GP4 containing a His10-tag 
was purified by affinity chromatography using a Ni-NTA column. Impurities were 
removed by washing with a gradient of 10-100 mM imidazole followed by elution with 
500 mM imidazole. Fractions were collected, separated by 10% SDS-PAGE, and 
visualized by staining with Coomassie Blue. B) T7GP4 was further purified via affinity 
chromatography using an ATP-agarose column. The crude protein was loaded onto the 
column in buffer containing 10 mM Mg
2+
, and impurities were removed by washing 
with buffer. Pure T7GP4 was eluted from the column using a buffer containing 20 mM 
EDTA and a gradient of 0.5-1 M KCl. Fractions were collected, separated by 10% 





























Figure D.2 Concentration dependent unwinding of OD13/[
32
P]-OD14 duplex DNA by 
T7GP4. Preannealed OD13/[
32
P]-OD14 (10 nM) was incubated with dTTP (1 mM) in 
buffer (40 mM Tris-HCl pH 7.5, 10 mM MgCl2, and 50 mM potassium glutamate) and 
increasing monomer concentrations of T7GP4 (0, 2, 6, 18.5, 55, 166, and 500 nM) for 10 
min at 37 ºC. Reactions were quenched with EDTA (40 mM) and combined with 
bromophenol blue and xylene cyanol in 30% glycerol. Products were separated by 10% 
native PAGE and visualized by phosphorimagery. Yields are reported as the band intensity 
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